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The bovine respiratory disease complex (BRDC) is a major concern for the 
beef industry throughout the United States of America and the rest of the world. In 
the USA, BRDC is estimated to cost more than $700 million dollars every year in 
losses due to reduced production of the beef cattle, loss of health, and increased 
rates of morbidity and mortality. To address this pressing concern, many producers 
use vaccines to provide protection within their herds. These vaccines have been 
developed and designed by many companies, all with a goal of reducing the 
incidence rate of BRDC in cattle herds and hopefully improving host protection 
against pathogens associated with BRDC. Viral pathogens are some of the most 
common, and standard, pathogens associated with BRDC. The following four viruses 
are often included in standard vaccines against BRDC due to their commonality 
within BRDC cases: bovine viral diarrhea virus 1 and 2 (BVDV1; BVDV2), bovine 
respiratory syncytial virus (BRSV), and bovine herpesvirus (BHV1). The objective of 
this thesis was to evaluate factors associated with response to vaccination and 
antibody titer traits, identify genomic regions of association, and investigate 
methods of detecting inter- and intrachromosomal interactions as well as epistatic 
networks. . 
 Serum samples were extracted from calves at up to four time points (pre-
vaccination, initial vaccination, booster vaccination, and final titer) each at 
approximately three weeks apart each.  These serum samples then underwent serial 
dilutions to quantify the amount of antigen binding antibodies present within the 




post booster vaccination were analyzed as individual titer traits, while initial 
vaccination response (booster vaccination – initial vaccination), booster vaccination 
response (final titer – booster vaccination), and overall vaccination response (final 
titer – initial vaccination) were analyzed as response to vaccination traits. Maternal 
decay (change of initial vaccination – pre-vaccination / number of days) was also 
analyzed, however this and pre-vaccination titer score were only analyzed for 
BVDV1 and BVDV2 due to availability of data. An effect of time of weaning (initial 
vaccination versus booster vaccination) and infection status (pink eye positive or 
negative) were identified, in addition to subsets of individuals who appear as non-
responders. Genomic regions associated with antibody titer and response to 
vaccination traits were identified, although no potential genes of control could be 
identified within the regions.  
Finally, detection of epistatic interactions was done with antibody titer and 
response to vaccination traits at 770k SNP genotype density. Interchromosomal 
interactions were identified within the initial titer and overall vaccination response 
traits for BRSV, but no significant interactions were identified in other traits. A tag 
SNP filter was applied to attempt identification of intrachromosomal interactions, 
but only a single previously undetected interaction was discovered. This tag SNP 
filtering was applied to the 50k SNP genotype used with previously studied fatty 
acid traits, but did not result in a reduction in SNP number. This allowed for the 
further detection of intrachromosomal interactions in fatty acid traits, and the 






CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
With BRDC being a consistent and expensive problem for the beef cattle 
industry, it is imperative that research pushes the understanding of how this 
complex functions. Economic losses greater than $700 million due to production 
losses through reduced performance through morbidity or even mortality are a 
constant impact that research attempts to reduce[1, 2]. A great amount of effort has 
gone into researching managerial and environmental effects that impact the 
incidence rate of BRDC in herds[3]. Findings have shown that factors such as 
transportation (hence the colloquial name “shipping fever”), weather, mode of 
initial calf purchase prior to feedlots, and weaning all play a role in BRDC 
incidence[4-7]. While some of these factors are unavoidable due to the nature of the 
industry or location of feedlots, there are things that can be done to minimize their 
impacts and in particular the stress often associated with them. Multiple studies 
have investigated the effects of stress on the immune system, and have found that 
the immune system is negatively impacted and the risk of infection or increase in 
the severity of an already present infection increases when stress is present[8-11]. 
Many producers and feedlots look to minimize the amount of time handling calves 
to reduce labor efforts and indeed stress of handling animals, however in doing so 
they may be overlapping multiple stressors within the same period of time[12]. For 




timing of stressful events if it is shown to improve resistance to BRDC and result in a 
less repressed immune system. 
The viral pathogens bovine viral diarrhea virus 1 and 2 (BRSV1; BRSV2), 
bovine respiratory syncytial virus (BRSV), and bovine herpesvirus (BHV1) are the 
primary drivers behind BRDC[13, 14]. Vaccination is the primary method through 
which producers protect their herds against these BRDC associated viruses. 
Research into increased vaccination efficacy is of great importance as increased 
efficacy can have tremendous effects on BRDC incidence rates[15, 16]. Calculated 
antibody levels from serum samples can be used to identify changes in a host’s 
immune systems response to vaccination. This can also be used to identify 
individuals who are poor responders to vaccination, or those that appear to be more 
robust in their response. 
Iowa State University has utilized their Angus beef herd to obtain a wide 
variety of phenotypes and perform extensive studies in nutrition, management, and 
genetic analysis. Due to diligent sample collection and routine vaccination against 
BRDC, serum samples had been collected from 2006 to 2014. This provided an 
opportunity to do a wide-scale study on factors associated with response to 
vaccination, and to identify trends within the herd that may point to genetic 
differences underlying that variation in response. While research has been done to 
identify trends and factors associated these traits before[17, 18], the number of 
individuals with recorded phenotypes and genotypes allowed for a much greater 
analysis to be performed. By doing so, it was hoped that additional associations and 




and increased success in the genomic selection of individuals genetically 
predisposed towards more robust antibody response. 
Models were fit in a Bayesian analysis using the program GenSel to identify 
regions of genomic association for these antibody titer and response to vaccination 
traits[19, 20]. By examining multiple antibody time points and changes across time 
for a given virus, it became possible to identify an individual’s overall response to a 
vaccine rather than making inference between single time points. Additionally, 
accuracies of prediction were calculated by using K-means clustering and testing 
using all but one group as a test and validating on the final group[21, 22]. These 
results would be used to identify the possibility of using identified genes and 
regions in genomic selection for individuals predisposed to a more robust response 
to vaccination. 
In addition to examining associations with single markers, a study was done 
to identify the epistatic interactions associated with the antibody titer and response 
to vaccination traits. This study used epiSNPmpi to identify regions of epistatic 
association and filter interactions based on various filters including minimum 
number of individuals per genotype combination and adjusted p-values[23, 24]. 
This was done to identify portions of the non-additive genetic variation that were 
missed in the single marker analysis (Chapter 4) and possibly explain further the 
underlying genetic architecture of these traits. 
A limitation of this study was the use of response to vaccination to infer 
potential robustness of the immune system in individuals. By not performing an 




vaccination[25]. Antibody titer could be used as a proxy for protection, but could 
not be a direct stand in. Furthermore, while the population was of decent size in 
comparison to many research studies (around 2,500 total head of cattle), the power 
of detection for some research such as identification of significant epistatic 
interactions remained low. A much larger population with the same phenotypes 
could give even greater insight into these results, and help validate the ones already 
identified. 
Organization of Thesis 
 Chapter 2 is a literature review on the current understanding and knowledge 
of the bovine respiratory disease complex and factors associated with incidence 
rates. It also describes the process of vaccination and the immune system, as well as 
genome-wide association studies and genomic selection. 
 Chapter 3 is a paper titled “Evaluation of responses to vaccination of Angus 
cattle for four viruses that contribute to bovine respiratory disease complex” that 
was published in the Journal of Animal Science (Kramer et al, 2017). An evaluation 
of stressors on the response of Angus calves to vaccination was performed, and the 
effects of co-infection by pink eye, weaning status, and the quantity of circulating 
maternal antibodies were identified. Additionally the work identified antibody 
thresholds that appeared to prevent the host’s immune system from responding to 
vaccination. Lastly, subsets of individuals were identified that never produced 
discernable antibody titers that may lay the framework for future work. 
 Chapter 4 is a paper titled “Genome-wide association study for response to 




This publication performed a GWAS to identify regions of genomic association with 
antibody titer and response to vaccination traits. A few 1-megabase windows were 
identified as associated with these traits, however no genes could be designated as 
potential candidates for the association due to a lack of annotation. Additionally, 
heritabilities and accuracies were calculated for all traits of interest that indicated 
that these antibody traits were of low heritability and the accuracy of prediction 
was moderate to low. 
Chapter 5 contains a publication titled “Epistatic interactions associated with 
fatty acid concentrations of beef from Angus sired beef cattle.” This publication 
investigated the presence of interchromosomal SNP-by-SNP epistatic interactions 
for fatty acid traits, and the potential genes that may be related in those regions. 
 Chapter 6 contains a conference proceeding from the World Congress on 
Genetics Applied to Livestock Production 2018, titled “Identification of fatty acid 
single marker effects and epistatic interactions in whole genome sequence imputed 
angus sired beef cattle.” This conference proceeding took regions of epistatic 
interactions identified in the paper from Chapter 5 and investigated them at a whole 
genome imputed sequence level to determine which genes were really interacting. 
 Chapter 7 is a paper titled “Identification of intrachromosomal interactions 
through utilization of tag markers for fatty acid, titer score and response to 
vaccination traits in Angus cattle” which is yet to be published. This paper looks into 
the identification of both inter- and intrachromosomal epistatic SNP-by-SNP 
interactions, and how to improve the detection of them. In it, tag SNP filtering was 




was used to identify networks of epistatic interactions that can provide insight into 
how epistasis is structured for traits.  
 Chapter 8 is a general conclusion that summarizes the research chapters and 
general information on BRDC. This will also describe the benefit of this research and 
how it may impact and drive future work relate to BRDC, response to vaccination, 





















CHAPTER 2. LITERATURE REVIEW 
 
Bovine Respiratory Disease 
Bovine Respiratory Disease (BRD), also sometimes known as Bovine 
Respiratory Disease Complex (BRDC), is one of the most common disease conditions 
affecting cattle producers internationally. In the USA, this affliction is responsible for 
more than $1 billion in feedlot costs alone[16, 26]. It can impact animal growth, 
production, and welfare[3]. With such a massive impact on the economic production 
and maintenance of cattle it becomes imperative that it is well understood, 
analyzed, and that proper responses are set in place to minimize negative impacts. 
This, however, is a difficult task once it is understood what BRD really is: a complex 




Viral and bacterial agents are both found to be causal factors for BRD, often 
working in tandem by weakening the immune system and allowing for higher rates 
of co-infection. Due to its complexity, not all BRD cases consist of the same bacterial 
and viral makeup although there are some that seem to be predominantly involved 
in the disease complex. These more common bacterial and viral agents are the 
subjects of many studies looking at clinical cases and treatment trials. Solutions that 
could decrease the impact of BRDC would be of enormous benefit to the industry. 




are most prevalent in populations and how they are potentially interacting with one 
another to result in the BRD complex. 
 
Primary bacterial agents that have been studied with their common 
association to BRD include Mannheimia haemolytica, Pasteurella multocida, and 
Histophilus somni. Mannheimia haemolytica is a gram-negative bacterium, non-
motile, and an opportunistic pathogen and the most common bacterial agent found 
in cases of BRD[27]. It can be found throughout the respiratory tract in healthy 
calves, and maintains a basal level symbiotic relationship with the host given 
normal conditions[28]. It can be transmitted between individuals through nasal 
secretions[29]. Normally M. haemolytica is easily cleared from the lungs with a 
study by Lillie and Thomson finding more than 90% of the bacteria cleared in less 
than four hours[30]. Under stress conditions, however, this bacterium can 
transform its symbiotic relationship into a disease state. When an individual 
experiences multiple stress situations such as unfavorable weather and 
transportation such as shipment to feedlot[4, 6, 7, 31, 32], blood cortisol levels have 
been found to increase within the blood of calves and are known to reduce the 
immune system effectiveness[9]. Furthermore, co-infection by viruses such as 
bovine viral diarrhea virus, bovine herpes virus, parainfluenza virus, or bovine viral 
syncytial virus assist in breaking down antimicrobial barriers in the respiratory 
tract and thereby allow M. haemolytica to flourish[33]. Once this happens, the 
normal clearance of bacteria from the lung becomes overwhelmed and the lungs can 




inhibiting clearing of the lungs and impairment of leukocytes[34-36]. M. haemolytica 
infection results in pulmonary infection characterized by lung lesions, accumulation 
of fibrin in the lungs, and necrosis of the alveolar epithelium[37]. This can result in 
morbidity or mortality of the individual depending on the severity. Antibiotic 
treatments such as penicillin, ampicillin, tilmicosin are common ways to treat 
infected individuals [38-41]. The widespread use of these has resulted in some 
isolates evolving to become resistant to these common antimicrobials[42]. 
 
Pasteurella multocida is another gram-negative bacterium and is also an 
opportunistic pathogen that lives within the respiratory tract of many species 
including cattle[43, 44]. Similar to M. haemolytica, P. multocida can be found in 
healthy individuals and results in a disease state when stressors weaken the 
immune system[43]. Co-infection by the viruses stated prior predisposes 
individuals to secondary infection with P. multocida, while transportation and other 
environmental factors inhibit the immune systems ability to respond. When P. 
multocida causes a disease state, individuals exhibit pneumonic symptoms just as 
they do with M. haemolytica, and these symptoms can range from mild to 
severe[45]. Virulence factors for P. multocida such as lipopolysaccharides (LPS) can 
stimulate inflammatory cytokines and pulmonary inflammation[36]. Transmission 
of P. multocida is often through nasal secretions, and can be transmitted between 
animals and humans, which adds another potential vector of infection for cattle 
herds [46, 47]. Treatment for P. multocida has had similar results due to widespread 





Histophilus somni, like M. haemolytica and P. multocida, is a gram-negative, 
opportunistic bacterium that resides in the respiratory tract of its host[48]. Co-
infection by other pathogens increases the pathogenicity of the bacterium. The 
primary virulence factors associated with H. somni seem to be lipooligosaccharide 
(LOS), oligosaccharide, and apoptosis of endothelial bovine cells. LOS phase 
variation specifically results in modification of the structure that can render 
immune system responses unable to contend with the new variant[36, 49]. H. somni 
in a disease causing state induces lung lesions and fibrinous pleuropneumonia. 
Symptoms can range from mild to severe just as in P. multocida. H. somni is 
transmitted between individual via nasal secretions. While one of the more common 
bacteria found in association with BRD, it usually consists of a much smaller 
proportion than that of M. haemolytica or P. multocida[50]. Widespread antibiotic 
use has resulted in some antimicrobial resistance in H. somni [41]. 
 
Viral agents that contribute to the BRD complex do so in multiple ways, 
whether through direct infection and damage to the respiratory tract or through 
inhibiting the host’s immune system and allowing for secondary infection by 
bacteria or other viruses[44, 51, 52]. There are four viruses most commonly 
discussed when talking about BRD: bovine viral diarrhea virus 1 and 2 
(BVDV1/BVDV2), bovine respiratory syncytial virus (BRSV), bovine herpesvirus 1 
(BHV1), and parainfluenza virus 3 (PI3). Although these viruses can cause BRD 




alongside bacterial agents and outside stress factors together result in full blown 
clinical BRD[13, 14]. 
 
Bovine viral diarrhea virus is one of the most implicated viruses with BRD 
and has been found to cause clinical symptoms of BRD when co-infected with M. 
haemolytica and other bacteria[53, 54]. BVDV comes in two primary varieties, 
bovine viral diarrhea virus 1 and 2 (BVDV1, BVDV2), which can both be either 
cytopathic or noncytopathic, with a majority of infections being of the noncytopathic 
form[55]. A study by Peterhans et al. 2010 examined cytopathic BVDV, and found 
that many cytopathic BVDV had unrestrained replication, recombination, and 
mutations[56]. This led to wide varieties in efficacy as the viral genome frequently 
changes, and often results in strains of cytopathic BVDV that fails to replicate and 
cannot cause persistent infection, but can be deadly to a host due to the 
development of unique sequences. A study by Ammari et al.  2010 identified more 
than 300 cytopathic and noncytopathic BVDV biotypes[57]. The study identified 
different signaling pathways for cytopathic versus noncytopathic strains, and that 
there were differences in the regulation of integrin alpha 2b and integrin beta 3 
between the two as well. Overall, signaling was strongest in the acute phase of 
infection and many host proteins responded the same between the two types. When 
considered with the body of research into effects of cytopathicity[58], it appears 
that cytopathic strains result in a stronger initial reactions by the immune system, 
and that differences in regulation and pathways are the ultimate reason for 





Furthermore, BVDV has the possibility for persistent infection via a pregnant 
dam as the fetal calf will become a lifetime carrier of BVDV[59]. It has been 
postulated that persistently infected individuals are the primary mode of 
transmission and continuation for BVDV in feedlots[60]. Acute infections of an 
individual with BVDV can cause respiratory complications, and lead to pneumonic 
conditions. Just as with the other viruses previously mentioned, BVDV by itself 
usually does not lead to severe cases, rather it is the combination of multiple factors 
that lead to full pneumonia and potentially mortality of the individual. BVDV is 
critical in its suppression of the immune system, which allows for the proliferation 
of bacterium such as M. haemolytica and P. multocida[61].  Due to its widespread 
impact on the cattle industry and its different strains, many vaccines have been 
developed and evaluated for effectiveness in an attempt to reduce the impact BVDV 
has on cattle health and production. Tests to identify persistently infected 
individuals have also been developed to better manage the spread of BVDV[60].  
Strain differences usually result in different levels of displayed epitopes, rapidity of 
infection for cells, and changes in the response of the immune system[62]. Variation 
is greater within the structural genes of BVDV, allowing for different efficacies of 
avoiding immune detection and changes in replication of the virus. Identification of 
viral genomic regions that remain relatively stable allows for the potential of a 
general vaccine target, however with strains varying in severity of infection and 





Bovine herpes virus, like BVDV, primarily targets the respiratory tract of 
infected individuals[63]. It has multiple varieties with unique antigenic differences 
and different genetic makeup. As with all herpesvirus, BHV1 can maintain a latent 
form while its host recovers from other infections. Additionally, stress can cause 
significant shedding of the virus. Like BVDV, BHV1 has been found to cause clinical 
symptoms of BRD when co-infected with P. multocida and other bacteria[64, 65]. 
Extensive research has been done to investigate the efficacy of vaccines against 
BHV1. These studies have shown that while vaccination may repress BHV1 activity 
for a period of time, the virus routinely rebounds due to multiple methods of 
evading the immune system in its latent phase[66]. BHV1 primarily becomes latent 
within the peripheral nervous system, and is able to avoid detection by down 
regulating antigen presentation[67, 68]. Through this mechanism, it can be almost 
impossible for an individually to fully clear BHV1, and as such they act similarly to 
individuals persistently infected by BVDV: as an infectious carrier that can cause 
ongoing herd outbreaks despite treatment. 
 
Bovine respiratory syncytial virus is a ubiquitous virus, with some estimates 
placing it as a primary cause of respiratory disease in more than 70% of beef 
herds[69]. BRSV causes wheezing, cough, and pyrexia, and is more severe in calves 
rather than older individuals. Additionally, in necropsies there is evidence of 
pneumonia and widespread infection of the bronchial epithelial cells[70]. 
Interestingly, the extent of the damage does not match the viral infection duration 




damage that makes it so interesting. Furthermore, BRSV is very similar to the 
human virus respiratory syncytial virus (RSV). This similarity has allowed for cross 
species research as findings appear to be relatively compatible between the 
two[71]. BRSV infection and manipulation of the host immune system has been 
found to enhance the severity of bacterial infection after BRSV exposure[72, 73]. It 
likely does so by increasing the abundance of pro-inflammatory elements in the 
lung, some of which the bacteria utilize to further damage the host[71]. 
 
Bovine parainfluenza virus 3 is similar to BRSV in that it tends to be 
ubiquitously found in herds. PI3 primarily infects the respiratory epithelial cells, 
and follows similar patterns of infection to the human variant[74]. Studies show 
that PI3 is able to infect these cells at even small concentrations[75]. Although PI3 is 
highly infectious, its pathological effects are usually minimal with symptoms 
including coughing, nasal discharge, and pneumonic like characteristics. Due to this, 
PI3 is regarded as a primary infectious agent which paves the way for further 
infection by other viral or bacterial agents[76]. It is primarily through interference 
of the immune system in the respiratory tract that allows for the secondary 
infections to occur. In feedlot situations, infection by PI3 occurs quite rapidly, 
usually within the first month of arrival at the feedlor[77].  
 
Environmental Factors 
While the primary negative effects of BRD are a result of biological factors, 




increased incidence rate and susceptibility of BRD. Weather effects such as extreme 
temperature, wind speed, humidity, and drought have all been implicated in some 
way as having an association with BRD incidence[6, 78-81]. Not all studies have 
been able to verify the associations, however, due to confounding issues such as the 
time of year with time of animals typically being moved to feedlots. Furthermore, 
other studies have found conflicting results on the effect of temperature [5, 82, 83]. 
Together, this indicates that climate variables may be having an effect, but may not 
be as clear-cut and direct as would be desired. 
 
One non-biological factor that has been well documented to have an 
association with BRD incidence is transportation, which gave rise to this complex’s 
more colloquial name: shipping fever. Factors such as mode of transportation, 
distance, time, and proximity to exhaust from the transporting vehicle have all been 
considered as factors for its implication for increased BRD incidence. Studies 
examining shipping distance/time have found conflicting results, with some 
showing increased incidence for cattle with shorter transportation times [4, 7, 84, 
85]. While the distances studied were different, the general conclusions were that 
loading, removal, and initial transportation of the cattle to and from the feedlots 
were the primary factors. Other studies found no association with BRD incidence 
and transportation distance [80], or found an association but had to contend with 
large confounding factors that could not be easily accounted for [86, 87]. No effect of 
type of transportation/proximity to exhaust was found in studies comparing train 




transportation appears to be potentially associated, although studies are not 
completely conclusive. Despite this, it remains the most accepted reason for 
increased BRD outside of biological factors, and the body of evidence is much more 
supportive of this than it is for climatic variables. 
 
Managerial Factors 
Managerial factors are another reason for increased incidence of BRD, and is 
much more difficult to quantify due to the human aspect. Calf source has been found 
to be associated with increased BRD incidence, specifically that calves purchased 
from a sale barn rather than from a direct source have a higher incidence rate [89, 
90]. Given that calves are at the greatest risk for BRD[5, 83, 91], this means 
purchasing needs to be controlled to alleviate this risk. One explanation for why 
barn sale calves have a greater incidence of BRD isn’t the sale itself, but rather the 
conditions surrounding the sales. Commingling of calves from multiple sources has 
been shown to increase the incidence rate of BRD due to greater exposure to 
individuals who may be carrying BRD associated pathogens, especially those who 
are persistently infected [31, 32]. Studies have also shown that repeated entry of 
new individuals into a herd results in higher incidence of BRD than one large influx, 
which may indicate that stress due to repeated commingling events and movement 
may be another factor[11, 83, 92]. It is important to evaluate calves for clinical signs 
of BRD prior to purchase to reduce the risk within a herd, especially if coming from 




of knowledge may increase the incidence rate due to the now present infected 
individuals[6, 93]. 
 
Individual Specific Factors 
Physical factors also have been found to play a role in BRD incidence for 
cattle. It has been postulated that age, weight, and sex may all be risk factors for BRD 
incidence. Age of calves was found to be associated tangentially to BRD through 
fever diagnosis, with younger calves having a greater likelihood of diagnosis[94]. 
Studies are relatively inconclusive on this measure with others finding no uniform 
relationship [79, 95], or showing an increase in outbreak with increased age but 
attributing it to loss of maternal antibody protection [96]. 
 
The association of calf weight with BRD incidence has been thoroughly 
investigated. Multiple studies have identified a negative association between calf 
weight and incidence of BRD; with lighter weight calves compared to herd averaged 
having an increased incidence rate when compared to heavier calves[32, 38, 97]. 
One difficulty in the study of weights is that average herd weight can skew incidence 
rates higher or lower, as indicated in Thompson et al [98] where they had a lower 
mean herd weight than normal beef cattle herds. Furthermore, location and breed 
impact weight at different time points, and as such alter associations with incidence 
rates for BRD. Weight at feedlot arrival has been examined with results showing no 
association with BRD incidence rates[83, 86]. Another study by Gardner et al. found 




was no difference in reported incidence rates [99]. This may indicate that overt 
clinical signs were not present to be classified, or that the human factor was unable 
to correctly classify the individuals.  
 
Sex of calf follows a similar trend of conflicting results from investigation of 
its association with BRD incidence rates. A few studies have found that up to the 
time individuals are moved to feedlots, male calves had a higher incidence of BRD 
than female calves[100-102]. Additional studies looked at cattle post transport to 
feedlots, and again found that males had a higher incidence rate of BRD than 
females[83, 103]. A contrasting study was done for more than 21 million feedlot 
cattle, and looked at the incidence rate of BRD between heifers and steers. In that 
study they found that heifers had a higher incidence rate from 1997 to 1999, but not 
for the period between 1994 and 1996 [79]. This study did note that heifers were 
often mixed into larger groups more frequently than the steers, which is known to 
be associated with increased BRD incidence rates[11, 83, 92]. Further muddling the 
association between sex and BRD incidence rates was a study that found no 
differences between sexes, but an increased incidence in mixed pens versus sex 
separated pens[32]. One reason given for an increased incidence rate of BRD in 
steers could be due to additional stress caused by castration. If this were to occur 
during feedlot times, the additional surgical stress may inhibit the immune system, 





Castration is a stressful time for an individual and is associated with higher 
incidence rates of BRD. Like all other factors, however, this is not a consistent 
finding. Many studies that examine castration and its effect on steer health, use 
phenotypes that can only be a proxy or extrapolation for BRD [9, 104]. Chase et al. 
[9] found that castration of bulls resulted in increased plasma cortisol 
concentration, with a higher concentration in larger bulls compared to smaller ones. 
This may indicate that individuals castrated later in life are at increased risk for BRD 
due to a greater suppressive effect on the immune system due to plasma cortisol 
levels. Like all potential factors associated with BRD, some findings support the 
association between castration and BRD incidence [8, 105] while others find no 
association[106]. Dehorning was another factor known to increase stress in 
individuals [10] and lead to increased plasma cortisol concentrations[107]. A study 
from Martin et al [11] found a higher incidence rate of BRD in herds with more than 
30% of the calves dehorned. For both castration and dehorning, having these 
procedures occur before transfer to a feedlot will help in reducing the incidence of 
BRD as the calves will have time to recover from the stress before commingling[12]. 
 
Vaccines and Vaccination 
Bovine respiratory disease is one of the most economically important 
complexes affecting the cattle industry, both within the USA and the rest of the 
world. For this reason, prevention and treatment rank high on the needs of 
producers. Accurate identification of individuals infected with BRD can aid in 




identify specific viral and pathogenic agents responsible for the outbreak. 
Furthermore, appropriate steps can be taken to reduce environmental and 
managerial factors that lead to increased stress. Vaccination remains the strongest 
preventative tool in a producer’s toolkit, and can drastically reduce the incidence 
rate of BRD on a farm or feedlot. 
 
Vaccines can come in two main forms: modified live virus vaccines (MLV) 
and killed virus vaccines (KV), and each come with benefits and drawbacks. MLV 
contain the virus/bacteria that protection is desired for, but have been altered so 
that they are incapable of producing a true clinical disease state[108]. Rather, they 
are still able to infect, replicate, and otherwise thrive in the individual animal. The 
benefit of this is that the individual’s adaptive immune system will be able to 
respond to a real pathogenic infection occurring, although the virus cannot cause a 
disease state. This gives individuals a quicker, and generally stronger, immune 
response to vaccination. Usually MLV result in a longer lasting protection due to the 
more similar state of the modified live virus/bacteria, resulting in a better 
protection profile for the individual when it encounters the real virus/bacteria 
during its life[109, 110]. Specifically, because the virus/bacteria can replicate 
throughout its entire life cycle, the immune system is exposed to all forms of the 
infectious agent and is able to develop the ability to recognize them and remember 





Modified live vaccines disadvantages include a few that can be quite costly if 
they occur. The primary concern is that due to the infectious agent being live, it has 
the potential to mutate to a completely virulent form. When this happens, the 
vaccine becomes a vector for disease rather than as a preventative measure[111]. If 
this happens, the individual will likely experience reduced performance, or even die 
depending on the severity of the infection. Further concerns are that if the mutation 
occurs, it can spread as normal and result in herd-wide infection. For individuals 
with poorly functioning immune systems, MLV may prompt too much of an immune 
response or cause enough stress that other already present infectious agents may 
take advantage and cause harm[108]. Additionally, because the virus/bacteria are 
live, they must be maintained in such a way that the cells are not killed. This 
includes temperature, light, transportation, and other handling procedures that 
need to be taken into account[111]. As such they are also not as stable and could 
lose efficacy over time more quickly than KV when in storage. 
 
Killed virus vaccines contain actual dead organisms, or by-products of those 
organisms. It requires a large number of the organisms and/or products because, 
unlike MLV, they cannot replicate and spread like a normal infection[108]. Usually 
KV are mixed with oils or other adjuvants to enhance the immune response to the 
vaccine due to this. These adjuvants are used because many KV are designed to only 
include the most important antigens required to recognize the pathogen once the 
innate immune system has been stimulated. Antigens alone are usually not enough 




assist by prompting further immune response[112]. Killed virus vaccines also have 
the advantage that the vaccine cannot result in a virulent variety in the individual 
and cannot spread between organisms. This provides some assurance that the 
efficacy of the vaccines is all that would occur, and that there is little risk of 
mortality. As a final benefit to KV, they tend to be very stable due to their 
composition, and therefore can be kept for a long period of time without much 
worry about degradation given standard storage procedures[108]. 
 
Disadvantages of KV mirror the advantages of MLV. They are not likely to 
elicit as strong an immune response as MLV. This may result in a reduced efficacy of 
the vaccine, and a shorter lasting period of immunity. This lack of a strong response 
when compared to MLV also means that additional doses are usually needed to 
reach an acceptable level of immunity[109, 110]. With the cells being dead, there is 
also no exposure to the full replication cycle of the pathogenic agent, so there is a 
more narrow range to which the immune system may recognize as an infectious 
agent. This again may reduce efficacy of the vaccine due to less recognizable forms 
of the pathogen, or result in a slower responding immune system when exposed to a 
virulent strain. Lastly, KV tends to be more expensive given the composition of these 
vaccines[108]. While it provides more longevity in storage, the creation of these 
vaccines requires many more components and the mixture will cost more than MLV.  
 
The goal of a vaccine is not to prevent infection by a pathogenic agent. 




inevitable encounter. By doing so, the immune system is now better prepared to 
both recognize and respond to the presence of a given pathogen. With this 
preparation pathogens may be eliminated before a disease state can be achieved, or 
the severity of the disease state can be reduced through a reduction in the quantity 
of pathogens in the individual. While some vaccines can be used to provide life long 
protection, not all need to be as long lasting. For animal vaccines their purpose may 
only be needed for a small period of time, such as those made to protect against a 
reproductive disease only relevant during the breeding season period[108]. For 
such vaccines, it is important to reassess the need for vaccines when these 
situations arise again, such as vaccinating dams prior to breeding each year. For 
other vaccines with limited time protection, it may not be necessary due to the 
production goals of the animals. For beef calves, vaccines may only be needed for a 
period of time until they are sent to processing, while for dairy cattle they may need 
longer lasting vaccines to account for the length of their production cycle. 
 
Vaccination management is nearly as vital to a vaccine’s success as the actual 
vaccine composition itself. Many factors such as transportation[7], castration[9], 
and commingling[11] to name a few result in higher stress levels for individuals and 
in turn cause a suppressed immune system state. Vaccination during stressful times 
is associated with a poorer immune activation, and therefore potentially a lesser 
protective status[108]. There are a multitude of scheduling recommendations for 
producers to ensure they achieve the highest efficacy possible from their vaccines. 




period, prior vaccinations, type of vaccinations, and what will happen with the 
individuals post vaccination[15]. These are all questions and concerns that can 
cause a vaccine to “fail” to provide protection with no fault of the vaccine itself[108]. 
Delaying of vaccination after transportation is one such recommendation, as it 
allows individuals to acclimate and reduce stress and cortisol levels[113]. Other 
studies have reported minimal to no differences by delaying vaccination, however 
they note that inadequate statistical power is a problem with the studies[114-116]. 
 
Weaning of calves is a common time point for producers to vaccinate them at 
due to the movement of calves from one location to another[90]. Weaning, however, 
is a well-known stressful time for calves as they are being removed from their dams 
and being grouped with other individuals in a new location. Additionally, calves are 
now entering a new stage of production that comes with further management 
changes. All of these stresses can cause a suppression of the immune system to 
varying degrees. Downey et al. [17] and Kramer et al. [117] both found an effect of 
antibody response to vaccination with respect to weaning status, with Kramer et al. 
finding a difference in response to vaccination between the viruses the calves were 
being vaccinated against. This may indicate that vaccination at the time of weaning 
alters the efficacy of the vaccine, and that while it may be convenient to vaccinate at 
time of weaning it may not be the best option if the goal is to obtain the highest 





Another concern is the presence of maternally circulating antibodies. The 
presence of antibodies to a specific antigen already in the individual at the time of 
vaccination may result in lower activation of the immune system due to clearance of 
those antigens. Woolums et al. [118] looked into the effect of maternal antibodies 
and vaccine administration on the immune response of young calves aged 2-70 days 
and found that older calves had higher titers to BVDV1 compared to younger calves. 
The researchers made a point to note that other studies have indicated that 
vaccination at very young ages can have some benefit even while calves have high 
concentrations of maternal antibodies, so early vaccination is not completely 
irrelevant[119, 120]. These studies indicate that early vaccination can help to prime 
an immune system, even though a majority of the vaccine’s antigen load will be dealt 
with by maternally circulating antibodies. A further vaccination once the maternal 
antibody concentration has decreased can then prompt the calf’s immune system to 
recognize the antigens and provide a stronger acquired immunity. Although it can 
be agreed that maternal antibodies have an effect on a calf’s response to vaccination, 
studies repeatedly find varying results on a calf’s immune response following 
vaccination, especially between various viral studies[119, 121, 122]. 
 
To measure the efficacy of vaccines, there are two options: vaccinate 
individuals and then perform a disease study, or measure antibody titer levels as a 
response to vaccination. Studies such as Woolums et al. [118] and Kramer et al. 
[117] utilize antibody titer level as a measure of immune response strength to 




strength of those vaccines. Woolums et al. specifically mentions the herd 
management as a reason for being unable to directly expose calves to infectious 
agents. In many cases it is not possible to perform a disease study due to shared use 
of animals between many various projects. A study by Downey-Slinker et al. [25] 
performed a disease challenge after obtaining antibody titer levels to vaccination 
against BVDV, and attempted to identify associations between protection of vaccines 
and antibody titer levels. Their findings found that the titer levels obtained from an 
individual were not predictive of the level of protection. 
There are a multitude of vaccines that exist with a goal to provide immunity 
to BVDV (1 and 2), BHV1, PI3, and BRSV. These vaccines can be monovalent or 
multivalent, intranasal or parenteral, as well as MLV or KV. Typically, the 
multivalent vaccines will be parenterally administered and done in two doses with a 
period of a few weeks between them[76], although some vaccines are designed for a 
single dose. The original baseline for vaccines in the USA included the ‘big four’: 
BVDV, BHV-1, BRSV, and PI3. An outbreak of BVDV in Canada in 1993 was caused by 
the BVDV2 strain[60], and as it was not present in vaccines at that time new 
terminology was need. Now, with these five as a common baseline for vaccines, 
differences tend to be the inclusion of various bacterial antigens, or variant sub-
strains of BVDV1 and BVDV2. 
 
Multivalent vaccines, or vaccines designed to be a single injection that 
contains antigens to multiple viral and/or bacterial, are commonly used by 




as management will have to expend less effort to vaccinate against the desired 
pathogens. Data from vaccinations in humans has also indicated that multivalent 
vaccines show longer lasting protection with fewer dosages required, although it is 
important to note these findings may be solely relevant to the studied pathogens. As 
many producers look to insure against as many causes of BRD as possible, these 
multivalent vaccines tend to contain the common viral agents BVDV (1 and 2), BRSV, 
BHV-1, and PI3 as previously mentioned. Other common inclusions to vaccines are 
antigens for the bacteria M. haemolytica, P. multocida, and H. somni. These 
multivalent vaccines come in both MLV and KV forms, and as previously stated each 
come with their own set of advantages and disadvantages. Although different 
vaccine brands may offer protection against the same pathogens, efficacy can still 
differ based on the exact strain used and the company’s rigor of testing for 
protection[123-125]. 
 
The Immune System and Responses 
The immune system is an individual’s primary defense against infection by 
virulent pathogens. By identifying foreign entities and working to remove them 
from the body, the immune system can either prevent a disease state from occurring 
through complete elimination of a pathogen load, or reduce the severity of the 
disease state through partial elimination. The immune system is comprised of the 
innate immune system and the adaptive immune system. While the innate immune 




immune system that can be responsible for long-term protection through antibody 
production. 
 
The innate immune system is the first line of defense against pathogens, and 
includes physical barriers such as the skin and mucosal barriers, as well as the cells 
of the innate immune system: natural killer cells, neutrophils, and macrophages to 
name some. This portion of the immune system is non-specific; that is, the innate 
immune system does not specifically recognize particular antigens of pathogens, 
and is able to interact with the pathogens in an attempt to eliminate them. 
Inflammation is generally caused by the innate immune response activating due to 
the presence of these pathogens. Infected cells release cytokines that signal to the 
immune system that a foreign agent has entered the body[126]. Common cytotoxins 
produced by infected cells include interferon-ALPHA and interferon-BETA, 
interleukins, and tumor necrosis factor alpha. These cytokines recruit cells such as 
macrophages, neutrophils, natural killer cells, and dendritic cells to the location of 
the infection. Dendritic cells and macrophages are constantly scanning for infection 
in an individual. Upon binding to cytokines from these infected cells, they produce 
additional cytokines to signal more cells to accumulate at the location. If the 
pathogens are present outside of the cells, macrophages are able to directly 
consume them and prevent further infection[127]. Natural killer cells also search for 
infection, although in a different way. Antigens presented on the outside of infected 
cells signal infection, but also often contain pathogen specific proteins that can be 




proteins in an attempt to hide from detection. Natural killer cells are able to identify 
cells that fail to present these proteins, as the suppression also reduces the natural 
cells signaling. Once detected, the natural killer cells are able to induce apoptosis in 
the infected cells. 
 
While the innate immune system and its rapid response is usually enough to 
handle pathogens, this is not always the case. It could be that the immune system 
was suppressed due to a current infection or external stressors such as 
transportation or weaning. It could also be that the pathogens were too numerous to 
be dealt with solely by the innate immune system, or were evasive enough to avoid 
complete detection until the infection became too much to handle by the innate 
immune system. It is at this point that the adaptive immune system steps in and 
begins to interact with the pathogens. The adaptive immune system is named so due 
to its memory of pathogens, and its functionality to respond to pathogens in a very 
specific manner. This allows for a specifically driven response when encountering 
the pathogen in the future, rather than needing to expend more effort for a 
generalist response that may not be as effective and cost more energy. Essential to 
the adaptive immune system functioning correctly is the major histocompatibility 
complex (MHC). The MHC displays surface proteins on cells that represent the 
current protein makeup of a cell, and can act as a sign of infection. While the MHC 
displays proteins normal for a cell, and therefore “self”, they also display the 




enough frequency, they can be recognized as an infected cell and dealt with 
accordingly. 
 
The adaptive immune system is comprised of lymphocytes, the majority of 
which are classified as B and T cells. These are produced in the bone marrow of an 
individual, and are indistinguishable until they become activated[126]. The T cells 
are part of cell-mediated immunity that also includes the macrophages and natural 
killer cells. These T cells fulfill multiple purposes, either signaling additional 
macrophages to activate, stimulating antibody production from B cells, or actively 
inducing apoptosis in infected cells. This final activity can be done by cytotoxic T 
cells, which circulate and are primed to deal with infection. They are capable of 
recognizing a specific pathogen’s antigens being presented on the outside of a cell, 
and upon identification induce apoptosis. CD8 is a glycoprotein required for the T 
cells to bind to the MHC molecules on cells, and as such they are also known as CD8+ 
T cells. B cells are part of humoral-mediated immunity and are more commonly 
known as they directly result in antibodies[128]. These cells are activated by T-
helper cells, which are in turn activated through binding to macrophages that 
exhibit pathogen antigens. Once activated, the B cells either enter a memory state or 
enter the blood stream. Those that enter a memory state keep the information from 
the pathogen antigen for future encounters with the pathogen with the express goal 
of increasing response time. Those that enter the plasma then begin to produce 
antibodies specific to the antigen presented to the B cell, and it is these antibodies 





Antibodies are a Y shaped structure that binds to pathogens based on antigen 
structure. The binding occurs on the tips of the Y structure, and can either impair 
the pathogen directly through the binding or signal other immune cells to interact 
with the pathogen. When in B cells that are stored for future encounters, they are 
primed for exposure to their respective antigen to facilitate quicker response to 
infection. Others are released from B cells in the blood system and are the ones that 
remove pathogens from the individual. Diversity amongst antibodies allows for a 
wide range of potential recognition to foreign antigens.  The diversity in these 
antibodies is due to recombination in the antigen-binding site, which is located on 
the arms on the Y shape and are called complementary-determining regions[130]. 
This region is comprised of three gene segments known as V (variable), D 
(diversity), and J (joining). In cattle, these are randomly selected from the present V, 
D, and J segments through recombination made possible by RAG proteins[131]. The 
recombination is not clean, resulting in segments being cut slightly longer or shorter 
than the actual segment lengths themselves. This, along with repair linking between 
the segments, results in unique sequences for every B cell. It is this sequence that 
the T helper cells match antigens to, and result in antibody production. B cells 
present in the blood stream rapidly divide, and during this division they undergo 
point mutation at a high rate. These point mutations further diversify the antigen-
binding recognition sequence. With high variability in the B cells, and further 




occur[132]. This allows the individual’s energy input to be directed towards the 
most appropriate response to pathogen presence. 
 
There are multiple types of antibody isotypes, including IgA, IgD, IgE, IgG, 
and IgM. These immunoglobulins are generally expressed at specific times in the B 
cell life, and can be switched through the mechanism called class switching[133]. 
IgM and IgD are expressed early on in the B cell life cycle, being present on naive B 
cells. IgM in particular has broad antigen recognition, allowing it to have an early 
response to the presence of pathogen antigens without the need for specific 
activation[134]. IgA, IgE, and IgG are generally produced after activation of the B cell 
from antigen presence, for example through T helper cells. IgG is the most common 
antibody isotype found in serum, and comes in four subclasses: IgG1-IgG4. These 
subtypes are nearly identical in terms of sequence, however they have different 
functions towards antigen binding and immune response. A paper by Vidarsson et 
al. 2014 [135] found differences in antibody response between proteins, 
polysaccharides, and allergens. They described the main type of response that each 
subclass was found to be most attributable to, and noted that lower concentrations 
of specific subclasses can be linked to greater risk of infection, such as lower IgG2 
and IgG4 being linked to an impaired response to encapsulated bacteria[136]. 
 
In cattle, there is no passive transfer of the immunoglobulin from dam to 
fetal calves[137]. Due to this, calves are born with a naive immune system, 




within the first 12-24 hours is essential for calf protection against pathogens. The 
colostrum is rich in both nutrients and maternally derived antibodies which persist 
in the body of the calf for a period of time while the calf’s own immune system is 
able to develop and be brought online[138]. While the colostrum provides locale 
specific protection, the adaptive immune system will begin to generate B cells and T 
cells capable of identifying and neutralizing pathogens. The period of protection 
afforded to the calf differs based on the antigen being observed, yet it is still possible 
to find maternal antibodies to BVDV, BRSV, BHV1, and PI3 past even 150 days post 
colostrum intake. A failure to ingest colostrum within the first 6-12 hours is 
associated with increased incidence of morbidity and mortality. This is attributed to 
an inadequate concentration of immunoglobulin in addition to missing the 
abundance of nutrients that are present within the colostrum[139]. 
 
Genomic Selection 
In animal industries, selection of individuals is done to improve production, 
increase animal welfare, or to drive new markets. Selection of individuals in the past 
was based solely on phenotypes or a producer’s intuition. True animal breeding as it 
is known today began with the work done by Jay Lush. An advocate for using 
statistics and genetic information in breeding, he pioneered a new age of animal 
breeding and selection by combining the idea of standard animal breeding with the 
statistical and quantitative work done by individuals such as Sewall Wright, R.A. 
Fisher, J. Haldane, and T. Morgan. Lanoy Hazel developed selection index theory for 




theory defined specific weights for various traits of interest for selection that would 
then be combined to assign a selection value for each individual. These values could 
then be used to select individuals for higher/lower traits on a quantitative level 
rather than previously subjective levels. Hazel also improved calculations for 
genetic correlations, which further drove weights for traits in a model closer to the 
proper values. C. Henderson, a student of L. Hazel, used mixed model equations to 
obtain estimated breed values through the development of best linear unbiased 
prediction (BLUP). This development led to increased accuracy of calculated EBVs. 
Integration of pedigree information to use relative’s performances was also 
suggested, however, at the time computational power was not typically sufficient to 
reliably do so[141]. Computation time and efficiency would improve over time with 
the improvement of mixed models, more efficient A matrix inverses, and 
technology[142, 143]. 
 
When direct interrogation of features of the DNA began to be used in 
selection processes, it was limited to a low density throughout the genome and 
research focused primarily on large quantitative trait loci (QTL) that were deemed 
to explain a significant portion of the estimated genetic variance. This method, 
known as marker-assisted selection, used small regions within the genome to 
represent the trait and relied on linkage between a QTL and the trait[144, 145]. This 
was not always consistent, especially when the effect of specific QTL was not as 
large as originally estimated. Family structure of individuals is important to know, 




the quality of findings[146]. Additionally, while marker-assisted selection works 
well with large effect QTL and relatively few of them, it begins to break apart when 
complex traits that are more polygenic are considered. Furthermore, if substantial 
proportions of the genetic variance is due to dominance or epistasis, marker 
assisted selection may have problems with accuracy of estimates. 
 
Goddard, Meuwissen, and Hayes proposed a methodology in 2001 that went 
on to be known as genomic selection[147]. This methodology subsequently led to 
genome wide association studies and increases in genetic prediction of individuals. 
This landmark paper discussed the use of high-density markers across the entire 
genome with an expectation that every QTL would be in LD with at least some of the 
markers. By doing this, one could account for all QTL with small effects rather than 
just larger effect QTL, and result in improved accuracy of estimation for genomic 
EBVs (GEBV)[148]. Genomic selection can be done many ways, such as with the 
tools genomic best linear unbiased prediction (GBLUP) [149] and SNP-BLUP, but 
need to fit genomic information as a random effect as often there are more markers 
than there are individuals. These methods assume a normal distribution of SNP 
effects, with a standard variance across all SNPs. It is known that this is not the case, 
as not all SNPs will be associated with a given trait[150]. SNPs closer to genes 
relevant to a trait will have an effect while those not near any genes related to a trait 
will have little to no additive effect. As such, variable selection approaches are 
needed to account for the fact that a portion of SNPs will have no effect for a given 




are normally distributed; all SNPs have the same variance. Bayes B assumes a T 
distribution for its SNP effects with unequal variance for the SNPs. These two both 
use a mixture model to represent the two groups of markers: those with a specified 
distribution and those with an effect of zero. This is represented by the value pi, 
where pi-proportion of SNPs are from a distribution of zero while the rest are from 
either their respective distribution designated by the type of Bayesian analysis. 
Other variations of Bayesian analysis exist such as Bayes A, Bayes Cpi[20], Bayes N, 
and others, each with their own parameters and characteristics. 
 
The effectiveness of variable selection methods are theorized to be better at 
accurately estimating GEBVs due to assuming (likely reasonably) that many 
markers have an effect of zero for a given trait. Meuwissen et al. [151] noted that in 
simulations, often the variable selection methods outperformed non-variable 
selection methods of GBLUP, but that a paper by Erbe et al. [152] has found that in 
real data the distinction is not as great. With many traits being polygenic of nature, 
along with large blocks of LD in our livestock populations, this leads to linear 
methods of analysis for genomic selection predicting relatively well[153]. 
Additional, it is noted that with low-density marker panels, it becomes important to 
ensure that every QTL is represented by associated SNPs in the model. The 
improvement of variable selection methods over non-variable selection methods as 
SNP chip density increases becomes evident due to the nature of SNP density and 
sampling[154]. With the end goal of whole genome sequence, variable selection 




be directly within the set of markers being analyzed. Improvements in accuracy of 
these GEBVs will further increase with variable selection methods as whole genome 
sequencing itself improves. Currently cost is prohibitive for sequencing of large 
populations. To resolve this conflict, many researchers will perform whole genome 
sequencing on important individuals from a population structure, and then impute 
other individuals from lower density SNP chips[155]. Imputation relies on 
estimating unknown markers based on haplotype combinations from higher density 
chips and from known pedigree information. Due to the way imputation infers 
missing genotypes, it is unlikely to pick up novel marker differences that may be 
responsible for some of the genetic effect for a given trait. As such, using GBLUP, 
Bayes, or other genomic selection methods with whole genome sequence compared 
to lower density SNP chips does not generally confer large enough increases in 




Genome Wide Association Study 
While genomic selection’s goal is to obtain GEBV for individuals with the 
purpose of selecting those who best fit a breeding goal, it behaves similarly to a 
black box. Genetic and phenotypic information is input, and a GEBV is output. The 
causal variants and genes of interest that are behind controlling the variation in a 
trait are just as interesting to understand. Genome wide association studies (GWAS) 




to identify the bits and bolts of a biological process, many of which may still not be 
fully understood even after identification. Through the identification of causal 
variants and associated genes, one can establish a better idea of how a biological 
system results in a phenotype of interest[156]. 
 
Genome wide association studies use dense SNP chips, or whole genome 
sequence, to identify regions or markers that account for various proportions of 
genetic variation associated with a trait of interest[157]. It is also commonplace to 
use imputed genotypes rather than genotype whole populations at very high 
densities, although this carries the same challenges as it does in genomic 
selection[158]. Often times, GWAS is performed on quantitative phenotypic data, 
with an express goal of linking particular regions of the genome to the trait. 
Bayesian methods are frequently used to perform GWAS due to their ability to use a 
mixture model with variable selection of SNP for a trait[159]. Once regions are 
found, researchers can characterize the proportion of total estimated genetic 
variation within each region. Often times this is visualized with Manhattan plots, 
which illustrates the variable peaks and valleys of the statistical significance of 
genetic variation across the genome. Regions with steep, thin peaks are usually 
indicative of a causal variant or gene of important function near, or within that 
region. Manhattan plots can also be used to illustrate the negative log P values 
associated with either individual markers or genomic windows examined. A 
threshold cutoff can be determined with various methods to account for multiple 




regions with sharp peaks tend to be associated with important variants or genes for 
a trait. 
 
Another statistic obtained that is often used to describe GWAS results is the 
posterior probability of inclusion (PPI) that is calculated in Bayesian methods[162]. 
The posterior probability of inclusion represents the proportion of times that a 
marker, or a genomic window, was included in Bayesian iteration. A posterior 
probability of inclusion greater than 0.9, for example, would indicate that among all 
iterations of a Bayesian analysis, that marker or window is included 90% of the 
time. This can be useful for describing the confidence in a given marker or window, 
as those with high PPIs are more likely to be real as they were found to be 
associated with genetic variation to a trait more often than other markers and 
windows. Often times a marker’s/window’s genetic variation that can be accounted 
in tandem with its PPI will be used to describe regions of large association to a trait. 
When discussing polygenic traits with no regions associated with large proportions 
of estimated genetic variation, then PPI becomes more useful.  
 
Once these windows/markers are identified, identifying the causal variant or 
gene of association becomes the next step. One way to identify associated genes is to 
scan the genomic region around the identified marker/window for genes with an 
overrepresentation of specific gene ontology terms. Identification of these genes 
may indicate association with a trait of interest if the gene ontology terms are 




genes with traits does have some flaws. Gene association via gene ontology terms is 
based off of annotation from previous research and functional analysis[163, 164]. 
Therefore, if there has been no research on the functional background of a gene 
found near an identified marker/window, then the gene cannot be directly 
associated with a trait. Lack of gene annotation, or a lack of gene discovery in a 
genomic region can both make gene ontology an effort in futility. Despite this 
potential pitfall, gene ontology improves in its usefulness with each new gene 
discovery and annotation project. Furthermore, with higher density genotypes, 
accuracy of identifying genes associated with a trait improves as well. Similar to 
gene ontology terms, networks of genes can be identified through genome wide 
association studies. These networks indicate a cluster of genes that interact with 
each other based on their products and expression levels. Previous genes not 
suspected to interact might now be identified with high accuracy as being involved 
in the same trait of interest. Identification of these networks can lead to deeper 
understanding of the biological pathways and how genes are related within the 
context of a trait. When there is a strong indication that something associated with a 
trait is in a region that shows no functional relevance, it provides guidance to 
investigative studies into the functional analysis of that region[165]. 
 
Genome wide association studies also allow for a dissection of the genetic 
variation that a trait is comprised of. While most research looks into additive genetic 
variation, it is known that non-additive genetic variation can comprise a non-




been developed with identification of dominance and epistatic variance and effects. 
Knowledge of dominance and epistatic involvement in a trait further enhances the 
understanding of underlying gene mechanisms and biological pathways. To 
accurately identify epistatic and dominance effects, requirements of data do become 
more strict than with solely additive variance and effects. Large animal populations 
are important for accurately finding regions of association to traits and correctly 
estimating genetic variation. When looking at dominance and two-way epistatic 
effects, the number of calculations that are required account for all possible effect 
combinations increases drastically. To account for multiple test correction the 
population size needs to increase beyond what would be an acceptable range for 
single marker effects and GWAS. Validation of these effects and associated estimated 
variance also requires a large population size to be accurate. Alongside additive 
variation (narrow sense heritability) comprising a majority of the genetic variation 
in many traits[168], the number of individuals required to obtain acceptable results 
is likely the reasons why epistatic and dominance analysis is not more 
commonplace. 
 
Genome wide association studies have been integral to understanding the 
basis behind many functions in animal genetics, and two examples to highlight this 
are the interaction of genetics and BRD susceptibility/resistance and the 
immunogenetics of response to vaccination. Prior to the discovery of DNA and the 
slew of genetic information that came afterwards, research focusing on 




able to study an antigen to understand a gene was, understandably, desirable due to 
the infeasibility of studying specific genes directly. MR Irwin and LJ Cole were two 
pioneers in the realm of gene study through immunogenetics[169]. In studies with 
pigeons and doves, Cole and Irwin began to unravel the basis of species-specific 
antigens. They found that species hybrids contained differences in antigens to the 
two parental breeds, and that through reactivity of blood samples to serums specific 
antigens could be attributed to a particular species while others appeared to be 
common across species[170-172]. This was at the time being used by many as a way 
to determine evolutionary relationships as the assumption as that species closer in 
evolutionary history would be more likely to contain similar antigenic characters, 
but their findings indicated the antigens are a direct consequence of genes. 
 
Hybrid substance was the term coined for the antigenic specificity of hybrid 
cells, which were agglutinated by hybrid antigens but not something that could be 
found in either parental breed alone. This finding indicated that single gene control 
of antigens was not the complete story, rather genes had to interact in some way to 
create these hybrid substances that were unique once crossbreds or backcrosses 
occurred[173-175]. In 1940, L.C. Ferguson was researching the heritability of 
antigens in cattle, and discovered that there were antigenic differences within a 
herd. Some of these differences were only apparent when particular combinations 
of cellular antigens were already present, indicating further that gene interaction 
was likely responsible for antigen production in at least some cases. Ferguson went 




chromosomes[176], which indicated that these genetic factors had to be interacting. 
Furthermore, antigenic factors only occurred if at least 1 parent already possessed 
it, indicating the heritability of these factors. 
 
Study of antigens eventually led to the study of response to vaccination 
against various pathogens and disease conditions. Genome wide association studies 
have been used to glean genetic associations to immune response traits, 
susceptibility to disease, disease traits, and vaccination. This also required antigenic 
information to be characterized on a genetic level from cattle, which required the 
MHC region to be identified. The bovine MHC is mapped to chromosome 23[177, 
178]. Investigation into the MHC revealed differences between the cattle MHC 
structure and its structure in other species such as humans and rabbits[179]. These 
differences and characterizations of the MHC genes in cattle allowed for a better 
molecular understanding of cattle specific immune development[180]. The 
understanding of the MHC in bovine allowed for future research to build off 
information pertinent to the immune system development, and give strong 
annotation to the MHC region of the genome for the purpose of investigative GWAS. 
B. Mallard’s group has been involved in immune response trait characterization for 
years. In the process of this, many publications have come from their groups 
detailing findings of genes, or genomic regions associated with these immune 
response traits. Their group has identified cattle from their dairy herd with superior 
cell mediated and antibody mediated immune responses[181]. Cattle with higher 




vaccination[182]. By utilizing this ability to classify animals by immune system 
quality, their group was able to perform GWAS to identify regions and genes 
responsible for this quantitative difference[183]. This was unique in dairy cattle as 
it examined the actual immune response, rather than genomic regions associated 
with a specific disease or pathogen. It was known from previous research that cattle 
with superior immune responses had lower incidence of disease, so by identifying 
regions associated specifically with cattle who had superior immune systems, the 
understanding of what is responsible could be characterized and eventually added 
to a selection procedure[184]. Their findings found a large number of significantly 
identified SNPs mapped to chromosome 23, the location of the bovine MHC[183]. 
This finding corroborates previous research that have extensively characterized and 
described the function of MHC in the immune system[185-187]. Furthermore, SNPs 
specific to antibody mediated and cellular mediated responses were identified. 
These findings allow for a better understanding of what is responsible for 
differences in immune system quality for bovine. 
 
Genome wide association studies have also been useful for identifying 
genomic regions and markers associated specifically with BRDC. Snowder 2009 
noted that heritabilities for resistance to BRDC are generally low, indicating that 
direct selection will be slow to take effect[188]. D. McVey wrote in 2009 that 
research for BRDC needed to include further research into the heritability and 
genetics of resistance for specific pathogens and characterization of vaccination to 




characterize various portions of the BRDC. A publication by Eenennaam et al. 2014 
reported the results of the BRD CAP project, one part of which was a GWAS to 
identify genetic loci associated with susceptibility[190]. Heritabilities were 
estimated at 19-21% for dairy cattle, and up to 29% with beef cattle. This was done 
with a binary phenotype of case vs control. The authors do note that this is a higher 
estimate than when studies were done with continuous scales for incidence, and 
that it may also be partially due to improved methods of BRDC identification. A 
genome wide association study with dairy calves found that single marker effects 
accounted for approximately 20% of the estimated genetic variation with BRDC 
incidence, and slightly less with clinical classification variation[191]. Significant 
single markers associated with BRDC incidence were identified across multiple 
chromosomes, including chromosome 23 where MHC is found. A study by Neibergs 
et al. 2011 identified markers on chromosomes 2 and 26 which were linked to BRDC 
and persistent infection with BVDV[192]. This was done using microsatellites rather 
than SNPs, and multiple markers were found to be associated with both BRDC 
incidence and BVDV persistent infection. 
 
Other studies utilizing GWAS look at genomic regions associated with lung 
lesion conditions caused by pathogens associated with BRDC. A study by Kiser et al. 
2017 identified multiple QTL associated with subclinical lung lesion development in 
cattle that were not outwardly presenting BRDC[193]. The authors note that the 
presence of lung lesions is not always indicative of BRDC, and that the QTL 




BRDC at subclinical levels, helping overall herd health. Another study by Keele et al. 
2015 also looked at lung lesions in cattle as related to BRDC[194]. Their findings 
indicated the complex genetic nature behind susceptibility to development of lung 
lesions due to BRDC. With a case control study, they were able to identify specific 
SNPs associate with the presence of lung lesions, and more specifically identify 
potentially associated genes with this factor of BRDC.  Lipkin et al. 2016 used GWAS 
to study BRDC QTL in their calf population[195]. To do this, calves were placed 
either high or low scoring groups, which represented susceptible and resistant 
classes respectively. Their findings identified many QTL across more than 13 
chromosomes, with some being associated with genes related to immunology and 
others being previously identified in other lung lesion GWAS studies. 
 
Vaccination, as mentioned in section 2.5 is one of the best ways to reduce the 
incidence rate of BRDC. Research into the genetics of vaccination to pathogens 
associated with BRDC has not been greatly studied, however responses to 
vaccination to various other diseases have been researched. Leach et al. 2012 
looked into QTL associated with a response to vaccination against BRSV[196]. In 
this study they examined a population of 500 crossbred cattle using microsatellite 
markers and identified 27 QTL on 13 chromosomes. Associations were examined 
across multiple time points both pre- and post-BRSV vaccination to identify 
potential differences in genetic associations in response to vaccination. Many of 
these QTL were associated with overall IgG response, with 16 associated directly 




vaccination and were not present prior to vaccination. Although some were found 
within the MHC region, most were not directly related to MHC. A study with foot and 
mouth disease virus found QTL that had also been present within the study toward 
BRSV, indicating that there may be associated genes that control response to 
vaccination against a variety of pathogens. Glass et al. 2012 described the previous 
work using single markers or microsatellites. The markers associated with the MHC 
region tended to be within the DRB3 portion[197]. Specifically, they were 
concentrated in peptide binding portions. These associations were not found both 
pre- and post-vaccination, which may indicate that genetic association to response 
to vaccination, are not controlled by the same mechanisms that clear maternal 
antibody levels. Work done by Ou et al. 1998 and Baxter et al. 2009 indicates that to 
improve genetic response to vaccination, it may be necessary to ensure that specific 
epitopes are present that bind to these specific regions of DRB3[197, 198]. In more 
recent studies, Peters et al. 2018 described the genetic diversity in the DRB3 locus 
amongst cattle breeds from different continents[199]. They discovered a large 
amount of variance due to within breed variations and much less due to between 
breed variations. This indicates that there is a commonality that could be discovered 
within DRB3 that could be used to select for genetically more resistant cattle. 
 
The genetics of immune response has also been studied in other species, 
which may give further insight into the immunological processes that exist in cattle. 
Extensive research has been completed on the genetics of vaccination in porcine. 




response to a vaccine for influenza virus[200]. They found four genomic regions 
associated with immune response on four chromosomes, each harboring candidate 
genes related to immune function and response. Work by Dunkelberger et al. 2017 
characterized an interaction between vaccination against PRRS and the WUR 
genotype, a major QTL responsible for resistance to PRRS[201]. Further work by the 
same group attempted to identify additional genomic regions associated with 
response traits to PRRS vaccination, and described multiple regions with an 
overrepresentation of health related QTL and enrichment for immune related traits 
and pathways[202].  
 
Purpose of research 
 BRDC is one of the most impactful and economically damaging concerns 
facing beef producers and the industry to date. Research and investigation into the 
biological and non-biological components of BRDC have shown that co-infection by 
multiple viruses and bacterial pathogens, along with environmental factors such as 
transportation and atypical weather impact the wellbeing and production of beef 
cattle. To address this concern and reduce the incidence rate of BRDC in herds, 
widespread use of vaccination occurs throughout the USA.  While vaccination has 
helped to reduce the rate of infection by BRDC, differences in strains, cytopathicity, 
and the components involved make vaccination an imperfect solution at the best, 
and if inappropriately used can result in little protection. Investigative genome-wide 
association studies have been routinely used to identify regions of genetic 




response to vaccination. The identification of these regions of association in turn 
allow for genomic selection of individuals which may be predisposed genetically to 
better handle or even prevent infection by pathogens associated with BRDC, or 
perhaps perform more robustly when encountering different environmental 
conditions. The research presented in the next few chapters expands the 
understanding of a host’s response to vaccination, with the goal to find factors and 
regions of association that can inform vaccine use strategies and allow for selection 
of individuals who appear to respond more robustly to vaccination. By adding more 
research with a relatively large sized herd of study, we hope to improve the future of 
the beef production industry by providing a greater insight into the genetics behind 
response to vaccination and thus improving the well-being of beef cattle and 
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While vaccination is an effective measure in reducing the risk of bovine 
respiratory disease complex (BRDC) in cattle, BRDC losses remain significant. 
Increasing the efficacy of vaccination depends on elucidating the protective immune 
response to different antigens included in vaccines, determining the best timing for 
vaccination and understanding the impact of the age of calf on vaccination. This 
study measured the serum antibodies present in calves following vaccination 
against four viruses commonly associated with BRDC: bovine viral diarrhea virus 1 
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and 2 (BVDV1 and BVDV2), bovine respiratory syncytial virus (BRSV), and bovine 
herpesvirus (BHV1). Serum antibody titers were measured in more than 1600 
calves at 3-week intervals starting at time of first vaccination. This first vaccination 
occurred at weaning for approximately half of the individuals, and three weeks 
before weaning for the other half. Dam age (years), time of weaning (initial 
vaccination or booster vaccination), and age of calf within year-season (days within 
Year-Season) classification all were found to have a significant effect on measured 
traits such as initial titer and overall response. Increased initial titer was negatively 
correlated with each response trait (initial, booster, and overall response). Calves 
that were weaned at initial vaccination had greater overall antibody response to 
BVDV1 and BVDV2 compared to calves weaned 3 weeks before initial vaccination. In 
contrast, calves given their initial vaccination 3 weeks before weaning had greater 
overall antibody response to BRSV and BHV1 compared to calves that were 
vaccinated at weaning. Furthermore, the circulating antibody titer at which each 
virus needed to be below for an individual calf to positively respond to vaccination 
was determined (log base-2 titer of 0.38 for BVDV1, 1.5 for BVDV2, 3.88 for BRSV, 
1.5 for BHV1). This information can be used to improve vaccination protocols to 
allow for a greater response rate of individuals to vaccination and hopefully 
improved protection. 
 







As one of the most costly diseases in the beef cattle industry, Bovine 
Respiratory Disease Complex (BRDC), results in an estimated loss of more than 
$750 million a year due to morbidity, mortality, reduced growth performance, and 
reduced carcass quality (Snowder et al., 2007; Irsik, 2010; Van Eenennaam, 2012). 
Vaccines vary in efficacy (Theurer et al., 2015), resulting in reduced overall herd 
immunity when calves are grouped in feedlots. Maternally-derived antibodies 
passively obtained via colostrum are vital for early calf health (Roth, 2008) and 
assist protection, but present barriers to vaccination. Calves may not mount a 
vaccination antibody response if maternal antibody levels are too high (Niewiesk, 
2014), and if too low, calves may be at risk before vaccination induces protective 
immunity. As such, vaccination should occur at a time that calves can positively 
respond, but still remain protected by maternal antibodies. 
 Environmental stressors are often associated with an altered immune state 
(Salak-Johnson and McGlone, 2007; Wein et al., 2016). Weaning has been shown to 
lower the immune response in calves, and therefore may reduce the effectiveness of 
vaccination depending on its timing (Hulbert and Moisa, 2016). 
 This study built upon previous work (Downey et al., 2013) with vaccination 
against Bovine Viral Diarrhea Virus type 2. By examining response to vaccination 
traits to four viruses associated with BRDC (Bovine Viral Diarrhea Virus type 1 
[BVDV1], Bovine Viral Diarrhea Virus type 2 [BVDV2], Bovine Respiratory Syncytial 
Virus [BRSV], Bovine Herpesvirus [BHV1]), it was possible to identify 




objectives were to identify management and environmental factors that 1) that 
impact the level of BVDV1, BVDV2, BRSV, and BHV1 circulating maternal antibodies 
at initial vaccination, 2) influence the rate of BVDV1 and BVDV2 maternal antibody 
decay prior to initial vaccination, and 3) influence response to vaccination against 
BVDV1, BVDV2, BRSV, and BHV1 to improve vaccination practices. 
 
Materials and Methods 
Animals 
 Purebred American Angus calves (n = 2,834) from the Iowa State University 
herd were utilized for this study. Not all individuals had recorded response to 
vaccination phenotype records for each of the 4 viral antigens due to samples being 
analyzed in batches according to contemporary group and differences in time 
between samples being analyzed for each antigen. Due to these time differences, 
only a subset of the total herd number could be used when examining response to 
vaccination for a given virus. Phenotypic data (body weights, ages, infectious bovine 
keratoconjunctivitus classification score(Lepper et al., 1992), and weaning status) 
were collected on each animal when serum samples were taken. Calves were born in 
either of 2 seasons (spring or fall) across multiple years (2006 to 2012, 2014). The 
number of calves with recorded measurements was on average about 350 per year, 
with more individuals in the spring season compared to the fall season. The only 
exceptions to this were years 2012 and 2014, in which only spring born calves had 






 Calves were vaccinated with a modified live vaccine (Bovi-Shield Gold 5, 
Zoetis). This vaccine contained antigens of 4 viruses that are associated with bovine 
respiratory disease: BVDV1, BVDV2, BRSV, and BHV1. Bovine parainfluenza 3 virus 
was also part of the modified live vaccine but was not included in this study. The 
vaccine was administered per manufacturers recommendation to the calves at 2 
separate time points, designated initial vaccination (week 0) and booster 
vaccination (week 3). Calves were given the initial vaccine either at the time of 
weaning or 3 weeks prior, which resulted in weaning at booster vaccination. This 
was done to evaluate the effect of weaning as a stressor on response to vaccination. 
(Figure 1). 
Dams of the calves studied received standard herd vaccinations during the course of 
this study. They received vaccinations approximately 40 days prior to breeding, and 
again at pregnancy check in the fall. These timings would have had negligible effects 
on circulating maternal antibodies for the calves studied. 
Serum sample collection 
 Serum samples were collected at 3 time points. The first sample was 
collected at initial vaccination (week 0), the second sample was collected at booster 
vaccination (week 3), and the third sample was collected 6 weeks after initial 
vaccination. Additionally, a subset of the total population used for this study had 
serum samples collected 3 weeks prior (week -3) to the initial vaccination (subset n 




allowed to coagulate overnight at 4 C. Tubes were centrifuged, after which serum 
was collected and separated into multiple 1.5 ml tubes and frozen at -20 C.  
Viral neutralization 
 Viral neutralization (VN) assays were performed to quantify the level of 
neutralizing antibodies present in serum against 4 viruses: BVDV1, BVDV2, BRSV, 
BHV1. Viral neutralization assays used the following virus strains, cytopathic BVDV1 
strain Singer, cytopathic BVDV2 strain A125-C (both obtained from the National 
Animal Disease Center, USDA-ARS, Ames, IA) BRSV strain ATCC VR-794 and BHV1 
strain Cooper (both obtained from National Veterinary Services Laboratory, Ames 
IA)(Fulton et al., 2000). Viral neutralization assays were performed as previously 
described (Downey et al., 2013)(Bolin and Ridpath, 1990) with a few modifications 
between viruses. For BVDV1, 5 replicates were tested for each serum sample. For 
BVDV2, 5 replicates were tested for each serum sample for animals born before 
2014, and 3 replicates were tested for individuals born in 2014. All serum samples 
were diluted 1:4 to 1:2048. For the BRSV and BHV1 assays 2 replicates were tested 
for each serum sample and serum samples were diluted between 1:8 and 1:2048. 
Two-fold dilutions of serum were done using phosphate-buffered saline. The titer 
was recorded for each calf as the log base 2 reciprocal of the greatest dilution at 
which neutralizing antibodies were detected. A cell control and viral control were 
run alongside BVDV1 and BVDV2. A cell control, positive serum control, and 
negative serum control were run for BRSV and BHV1. Antibody titer score was 
recorded as the average log base 2 reciprocal of the greatest dilution that 




with 3 replicates. An average log base 2 reciprocal was taken across the 2 replicates 
for BHV1 and BRSV. If all wells within the first dilution showed a cytopathic effect, a 
titer score of 0 was given for the calf. Not all samples were available for analysis for 
antibodies to each of the 4 viruses, which resulted in different subsets of individuals 
being tested for each virus.  
Response traits 
Seven antibody titer traits were analyzed. Maternal Antibody Titer Level at 
week -3 and Maternal Decay (MD; rate of change between week -3 and week 0) 
were only analyzed for BVDV1 (622 head) and BVDV2 (1137 head). Maternal 
antibody decay (MD) was defined as the difference between week -3 and week 0 
divided by the difference in calf age between the 2 serum collection dates (average 
calf age difference: 22 days for both BVDV1 and BVDV2). This was not exactly 21 
days for each calf as all individuals in a single location had samples taken at the 
same time to minimize number of times interacting with the herd. 
Initial Antibody Titer Level was defined as the log base 2 antibody titer score 
observed at week zero. Initial Vaccination Response (IVR) was defined as the 
difference between antibody titer level observed at week 3 (booster vaccination 
time point) vs. week 0 (initial vaccination time point). Booster Vaccination Response 
(BVR) was defined as the difference in antibody titer level observed between week 
6 (booster response time point) and week 3 (booster vaccination time point). 
Overall Vaccination Response (OVR) was defined as the difference in antibody titer 




vaccination time point). Final Antibody Titer Level was defined as the log base 2 
antibody titer score observed at week 6 (Tait et al., 2013) (Fig. 1).  
Statistical analysis 
Environmental and systemic factors were evaluated to determine their 
potential effect on response to vaccination traits. Year-season classification were 
considered a single variable for the purpose of this study, as previously described 
(Downey et al., 2013). Age within year-season was fit as a covariate. Additional 
contemporary group categories (date of serum batch analyzed, lab technician 
analyzing data, farm) were fit as covariates, but showed no statistical significance. 
 
Pre and initial antibody titer levels were analyzed using the following statistical 
model: 
 = μ + 
 +  +  +  +  + 
 +  
 1 
Where  was the pre or initial antibody titer for calf m. µ = overall mean, 

 = year-season classification [i = 2006 S, 2006 F, 2007 S, 2007 F, 2008 S, 2008 F, 
2009 S, 2009 F, 2010 S included for BVDV1, BRSV and BHV1. 2010 F included for 
BVDV1. 2011 S, 2011 F, 2012 S, 2014 S but not 2006 S and 2006 F included for 
BVDV2],   = dam age [j = 2 to 11 years of age. Ages 12 to 14 included for BVDV2], 
and  = calf sex (k = bull, steer, or heifer) were fit as fixed effects in the model. 
  = Dam ID for calf m, which was fit as a random effect to account for multiple 
progeny.  = Birth weight for calf m and 
 = calf age at pre or initial 




 = error term which was assumed to be normally distributed (mean = 0, 
variance = ). Variables were removed from the model systematically until only 
variables with P < 0.05 remained in the models. This resulted in a model with only 
significant factors and  . 
 
Maternal antibody decay rate was analyzed using the following statistical model: 
 = μ + 
 +  +  +  + 
 +  +  
 2 
Where  was the maternal antibody decay rate in titer level per day for 
calf m. µ =overall mean, 
 = year-season classification [i = 2006 S, 2006 F, 2007 S, 
2007 F, 2008 S, 2008 F, 2009 S, 2009 F, 2010 S included for BVDV1, BRSV and BHV1. 
2010 F included for BVDV1. 2011 S, 2011 F, 2012 S, 2014 S but not 2006 S and 2006 
F included for BVDV2],   = dam age [j = 2 to 11 years of age. Ages 12 to 14 
included for BVDV2], and  = calf sex (k = bull, steer, or heifer) were fit as fixed 
effects in the model.   = Dam ID for calf m, which was fit as a random effect to 
account for multiple progeny. 
 = calf age at pre-vaccination within year-
season classification and  = pre-vaccination antibody titer level for calf m were fit 
as covariate effects.  = error term, which was assumed to be normally 
distributed (mean = 0, variance = ). Variables were removed from the model 
systematically until only variables with P < 0.05 remained in the model. This 





Response to vaccination traits (IVR, BVR, OVR, Final antibody titer) were analyzed 
using the following statistical model: 
 ! = μ + 
 +  +  + "# +  +  + ! + !! + !

+ $! +  !  
 3 
Where  ! = IVR/BVR/OVR or final antibody level measured on calf o. 

 = year-season classification [i = 2006 S, 2006 F, 2007 S, 2007 F, 2008 S, 2008 F, 
2009 S, 2009 F, 2010 S included for BVDV1, BRSV and BHV1. 2010 F included for 
BVDV1. 2011 S, 2011 F, 2012 S, 2014 S but not 2006 S and 2006 F included for 
BVDV2],  = calf sex (k = bull, steer, or heifer),  = weaning time (k = weaned at 
initial or booster vaccination), "#  = pinkeye classification at weaning (l = 0 for 
unaffected, 1 for affected), and  = dam age [j = 2 to 11 years of age. Ages 12 to 
14 included for BVDV2] were fit as fixed effects in the model.   = Dam ID for calf 
m, which was fit as a random effect to account for multiple progeny. ! = initial 
antibody level for calf o for IVR/OVR/final antibody level and booster antibody level 
for BVR, !! = quadratic effect for IVR/OVR/final antibody level and booster 
antibody level for BVR, !
 = calf age at vaccination (o = calf age at week 6 for 
final antibody level, age at initial vaccination for IVR and OVR, and age at week 3 for 
BVR) within year-season classification, and $! = average daily gain for each of the 
3 response variables (not fit for final antibody level) were fit as covariate effects. 
 ! = error term which was assumed to be normally distributed (mean = 0, 




variables with P < 0.05 remained in the models. This resulted in a model with only 
significant factors and  . 
Clustering 
Clustering of animals within a given virus category was done with SSClust3.0 
(Ma et al., 2006). The program was run with a chain number of 5, threshold of 0.1, 
and a cluster number of 2+ for each population of individuals for each of the 4 
viruses. Visual outputs from clustering analysis allowed for identification of 




The average age at initial vaccination was 138 days for BVDV1, 127 days for 
BVDV2, and 136 days for BHV1 and BRSV (SD = 31.3, 35.2, 29.6 in days). Average 
weight of calves at initial vaccination was 145.45 kg for BVDV1, 139.48 kg for 
BVDV2, and 150.51 kg for BRSV and BHV1 (SD = 5.1, 5.6, 5.1, respectively). Average 
age and weight of calves varied among the different antigens due to differences in 
the number of individuals with recorded serum titers for each antigen, which 
resulted in different total numbers of calves for each antigen group. The proportion 
of male calves to female calves was relatively equal, with males being slightly more 
common (males = 864 for BVDV1, 1191 for BVDV2, and 849 for BRSV and BHV1; 
females = 791 for BVDV1, 1041 for BVDV2, and 783 for BRSV and BHV1). Table 1 




as well as the mean, standard deviations and range for antibody titer, body weight, 
and age at each time point. 
 Pre-vaccination and initial vaccination antibody titers were affected by Year-
season, Dam age, Birth weight, and Age within year-season (Table 2). Dam age was 
positively correlated with increased initial titer levels for all viruses with the 
exception of BHV1 (Fig. 2). For BVDV1, maternal antibody titer increased as dam 
age increased up to 8 years of age. The spike in maternal antibody titer was likely 
due to the large standard error that resulted from low numbers of representative 
dams at this age. BVDV2, BRSV and BHV1 titer levels increased as dam age increase 
up to 7 years of age. Initial antibody titers decreased (P < 0.05) as calf age increased 
although at varying rates between the 4 viruses (Fig. 3). 
Maternal decay 
 Maternal antibody decay rate was evaluated for BVDV1 and BVDV2. No pre-
vaccination data was collected for BRSV or BHV1, so the rate of decay of serum 
antibody before the first vaccination could not be determined. Year-season 
classification, Dam age, Sex, Age within year-season classification, and Pre-
vaccination levels significantly affected the decay rate of BVDV2 maternal antibody 
level. For BVDV1 only Dam age, Age within year-season, and Pre-vaccination levels 
were significant (Table 2). The rate of decay of BVDV1 maternal antibody level 
generally decreased as dam age increased. In contrast, the rate of decay of BVDV2 
maternal antibody level remained relatively constant across dam age (Table 3). Calf 
age was inversely correlated with rate of decay for both BVDV1 and BVDV2, with 




and BVDV2, pre-vaccination maternal antibody titers were inversely correlated with 
rate of decay. A 1 unit increase in prevaccination maternal antibody titer 
corresponded to a 0.01698 titer units/day decrease in maternal antibody decay rate 
for BVDV1 and 0.01139 titer units/day for BVDV2 (P < 0.0001). 
Response to vaccination 
Response to vaccination may be influenced by factors other than circulating 
maternal antibodies. Thus, other environmental factors were evaluated for their 
effect on initial response to vaccination, booster response to vaccination, overall 
response to vaccination, and final antibody titer. All factors in Model 3 were tested, 
and results can be found in Table 4. Sex was only significant for initial vaccination 
titer for BRSV. Average daily gain of the calf was only significantly associated with 
the initial response of BVDV1 vaccination. The observed baseline titer, i.e. the 
antibody titer at the first time point used to calculate a vaccination trait (e.g. the 
titer at week 0 for IVR, OVR, and Final Antibody titer, or the week 3 antibody titer 
for BVR) was significant for every trait with the exception of the final antibody titer 
for BRSV and the IVR for BVDV1. Age within year-season classification was 
significant for all traits. Weaning date was significant for many traits, and 
individuals were classified as either weaned at week 0 or week 3. Weaning 
classification was associated with increased overall antibody response to BVDV1 
and BVDV2 when calves were weaned at initial vaccination. Weaning classification 
was also associated with increased OVR in BRSV and BHV1 when calves were 
weaned at booster vaccination (see for example results for calves receiving initial 




occurrence was statistically significant for only a few time points across all 4 viruses 
(BVDV1 Final titer level; BVDV2 IVR, OVR, Final titer level; BHV1 IVR). 
The effect of calf age at first vaccination within year-season classification was 
averaged across all year-seasons for a given virus and time point, and compared 
between the 4 viruses. This was done to help account for birthing conditions that 
can vary considerably between spring and late summer/early fall in the Midwest 
United States. For initial vaccination response, an increase in calf age resulted in a 
lower IVR for all viruses with the exception of BVDV1, which increased slightly as 
calf age increased (Fig. 6a). Booster vaccination response increased with calf age for 
all 4 viruses (Fig. 6b). Overall vaccination response increased with calf age for all 
viruses, with the exception of BRSV, which resulted in a slight decrease in OVR with 
increased age (Fig. 6c). Final titer increased with calf age for BVDV1 and BVDV2, yet 
decreased with age in BRSV and BHV1 (Fig. 6d). Supplemental Figures 1 to 4 show 
the aforementioned trends when not averaged across year-seasons. 
The observed baseline titer, i.e. the antibody titer at the start of a response to 
vaccination trait (e.g. titer score at week 0 for IVR, OVR, and final antibody titer, or 
week 3 antibody titer for BVR) was also averaged across all year-season 
classifications and compared between the 4 viruses (Fig. 7). Supplemental Figures 5 
to 8 show the same trends but not averaged across year-season. For all 4 response 
to vaccination traits (IVR, BVR, OVR and final antibody titer level) antibody titer 
decreased as their respective baseline titer increased. To have a positive initial 
vaccination response, initial antibody level (week 0) needed to be below 1.5 for 




positive booster vaccination response, the week 3 antibody level needed to be below 
1.73 for BVDV1, 3.32 for BVDV2, 4.50 for BRSV and 2.38 for BHV1 (Fig. 7b). To have 
a positive overall vaccination response, week 0 antibody level needed to be below 
1.55 for BVDV1, 2.71 for BVDV2, 4.12 for BRSV and 1.29 for BHV1 (Fig. 7c). Final 
antibody titer decreased for all viruses as week 0 antibody concentration increased. 
BRSV also saw a decrease in final antibody titer as week 0 antibody concentration 
increased, but at a slow decline compared to the other 3 viruses, with a theoretical 
final antibody titer score of zero only when initial antibody levels are at 184.92 titer 
units (Fig. 7d). Figures 6 and 7 show trends for calves aged 55 to 200 days of age, 
although the true age range for each virus at each time point can be seen in Table 1.  
The overall antibody titer level trend was plotted for each virus across the 3 
(or 4) serum collection time points (Fig. 8). The overall trend was fit utilizing model 
1, and all non-significant factors were removed before being fit. Each time point had 
age within year-season classification fit as the average age of calves with records. 
For BVDV1 and BVDV2, sex and birth-weight were included in the final model, while 
for BRSV and BHV1 they were not significant. Titers to BVDV1 and BVDV2 were 
observed to decrease from week -3 to week 3, and then increase from week 3 to 
week 6. Titers to BRSV and BHV1 increased from week 0 to week 6.  
Titer curves for each virus across all individuals are shown in Fig. 9. Average 
titer across time is plotted as green lines, while individuals were plotted as grey 
lines. Fig. 10 shows the titer curves for individual animals that had a titer of 0 for 
BVDV1, BVDV2, and BHV1 at week 6. BRSV was included for the sake of comparison 




seroconvert for BRSV at week 6. There were 367, 100 and 468 calves that had a titer 
of 0 at week 6 against BVDV1, BVDV2 and BHV1, respectively.  
Of the 367 individuals that had a final titer of 0 for BVDV1, 107 of these 
calves had a titer of 0 at all time points, 119 calves did not obtain a titer of 0 until 
week 6, 96 calves had a titer of 0 by week 3, 19 calves obtained and maintained a 
titer of 0 by week 0 (required pre-vaccination data), while 26 calves exhibited titers 
that oscillated or had missing data at weeks 0 or 3. Of the 100 individuals that had a 
final titer of 0 for BVDV2, 9 of these calves had a titer of 0 at all time points, 57 
calves did not obtain a titer of 0 until week 6, 27 calves had a titer of 0 by week 3, 3 
calves obtained and maintained a titer of 0 by week 0 (required pre-vaccination 
data), while 4 calves exhibited titers that oscillated or had missing data at weeks 0 
or 3. Of the 468 individuals that had a final titer of 0 for BHV1, 227 of these calves 
had a titer of 0 at all time points, 62 caves did not obtain a titer of 0 until week 6, 70 
calves had a titer of 0 by week 3, 109 calves obtained and maintained a titer of 0 by 
week 0 (required pre-vaccination data), while 109 exhibited titers that oscillated or 
had missing data at weeks 0 or 3. Oscillating titers for these plots was defined as a 
titer change from positive/0/positive, or from 0/positive/0 at some point across all 
measurement time points. 132 individuals for BRSV were shown who had a final 
titer of 3 (the lowest recorded titer score at week 6). 
Titer trends for each virus were plotted across time with SSClust3.0 (Ma et 
al., 2006). The mean curve for each cluster was obtained and plotted as a black line, 
alongside a 95% confidence interval in red. Curves for the four clusters within 




between each of the 4 time points (pre-vaccination [-3], initial vaccination [0], 
booster vaccination [3], and booster response [6]). The y-axis represents 
proportional titer level compared to a base level of 1 determined by SSClust3.0 for 
each cluster. Additional trends for the other 3 viruses can be found in supplemental 
Figures 9 to 11. 
 
Discussion 
An individual’s titer can be indicative of immunological health, and therefore 
may be useful for determining which individuals are more responsive to vaccination 
protocols and thus better contributors to herd immunity in livestock (Sharma et al., 
2016). By utilizing 4 viruses commonly associated with BRDC, we showed that there 
are various factors that impact response to vaccination in pre-feedlot calves, and 
that these factors may not be the same for all viruses. While we only measured 
responses to all 4 viruses from 1,273 calves, for some viruses we report results for 
more calves when they were available. The inclusion of additional data from more 
calves did not significantly alter observed results.  
Maternally-derived antibodies serve an important purpose in protection for 
calves during their early developmental lifetime, but the suppressive effects of 
maternal antibodies on vaccination may hamper the ability to determine the calf’s 
own immunological response for an individual as measured by seroconversion 
(Fulton et al., 2004; Guzman and Taylor, 2015). Maternal antibody decay was 
examined for both BVDV1 and BVDV2 by determining the rate of decay in antibody 




rate of decay for BVDV2 titers were always greater than for BVDV1 titers at a given 
calf age, although the change in rate of decay as calves aged was greater for BVDV1 
than for BVDV2. The greater rate of decay of BVDV2 was likely due to greater 
average maternal antibody titer levels compared to BVDV1 (O'Neill et al., 2006). It 
may also be due in part to fewer calves (622) with pre-vaccination data for BVDV1 
than the number with prevaccination data for BVDV2 (1137), however this is purely 
speculative in nature. The rate of maternal antibody decay increased with calf age, 
which was consistent with other studies on maternal circulating antibodies 
(Kirkpatrick et al., 2008), and followed closely with a previous work examining 
maternal decay and BVDV2 titers (Downey et al., 2013). Rates of decay for both 
BVDV1 and BVDV2 indicated that by initial vaccination at week 0, many individuals 
had low enough circulating maternally-derived antibodies to mount a resonse to 
vaccination. The level of circulating maternally-derived antibody was directly 
related to calf and dam age. Higher birth weights were found to be significantly 
associated with higher maternally-derived antibody levels at initial vaccination, 
although their actual effect was minor compared to other factors. All discussion on 
observed response to vaccination must be tempered with the knowledge that 
circulating maternally-derived antibodies may still have been binding to antigens. 
Therefore, the observed responses may have been different if calves had no 
maternal antibodies at the time of vaccination.  
Weaning has been associated with increased stress in calves, and stress has 
been implicated in negatively affecting the immune response of individuals (Hulbert 




the calves used for this study were weaned at initial vaccination (week 0) with the 
other half weaned at booster vaccination (week 3). Results indicate that titers to 
BVDV1 and BVDV2 increased significantly more when calves received their initial 
vaccination at the time of weaning; in contrast, titers to BHV1 and BRSV increased 
significantly more when calves received their initial vaccination 3 weeks before 
weaning. However, it is important to remember that titers for different calves were 
included in the model describing the responses to BVDV1/BVDV2, and BHV1/BRSV. 
Thus it may not be valid to make a comparison between the responses to 
BVDV1/BVDV2 and BRSV/BHV1. The same calves were included in the models 
describing BRSV and BHV1, so comparison between the responses to those viruses 
may be more appropriate. 
A decrease in initial antibody titer score for BVDV1 and BVDV2 was likely 
linked to greater baseline titer values, i.e. the antibody titer score at week 0, 
compared to BRSV and BHV1. Increased calf age was associated with greater overall 
vaccination response for all viruses with the exception of BRSV (rate of titer score 
increase as calf age increased was different for BVDV1, BVDV2 and BHV1). This was 
in agreement with a previous study which focused solely on BVDV2 (Downey et al., 
2013). The decrease in initial antibody titer is understandable as the lower maternal 
antibodies found in older individuals would allow for the immune system to 
respond with increased antibody production to the presence of viruses (Munoz-
Zanzi et al., 2002). For an antibody response to be mounted in the presence of viral 
antigens, it appears that an individual’s circulated antibodies to that antigen must be 




may bind the viral antigens while reducing stimulation of the individual’s immune 
system, as seen by decreasing titer levels for individuals with high initial vaccination 
titers. Changes in trends for each response variable as base titer level increased (e.g. 
titer score at week 0 for IVR, OVR, and Final antibody level or week 3 antibody titer 
level for BVR) were obtained to assist in identifying antibody response in relation to 
a respective antibody level at a given time. The intersection of the trend line with x-
axis indicates an observed titer level at which an individual would positively 
respond to the presence of the virus if circulating antibodies were below the x-value 
of the intersection, or fail to respond if circulating antibodies were above that value. 
For BVDV1 and BVDV2, the threshold was 0.38 and 1.5 log-base 2 titer, which 
explains the initial titer score decrease from week 0 to week 3 observed in BVDV1 
and BVDV2.  
The BRSV titer values remained relatively constant across calf age for all 
response variables, indicating that there would be a response at any calf age. While 
it was not possible to confirm an exact reason for this behavior, it may be due to the 
ubiquitous nature of BRSV in the environment (Ellis et al., 2005). This would 
indicate that most calves had already been exposed to BRSV at some point in their 
early life, and as such already have the ability to generate antibodies in the presence 
of the BRSV antigen. This indicated that calves, on average, were always able to 
respond to the presence of BRSV antigens and that vaccination may not be 
responsible for these observations. 
This ubiquitous nature of BRSV may also explain why every calf 




BRSV was 3 on the log base-2 scale, while BVDV1, BDVD2, and BHV1 all had some 
proportion of individuals with a final antibody titer of 0. The minimum possible 
record above 0 does differ between the four viruses, as BRSV and BHV1 had only 2 
assay replicates done per viral neutralization dilution compared to the 3 or 5 assay 
replicates for BVDV1 and BVDV2. This would only allow BRSV and BHV1 to have 
final titers between 1.7 and 3 at a minimum, however it would not prevent final 
titers of 0 as seen in BHV1 observations. Again, the likely presence of BRSV 
throughout the herd is the most probable cause for why some animals did not 
seroconvert for the other 3 viruses but every individual measured for antibody 
response to BRSV managed to seroconvert.  
A large amount of variation was found to be present in vaccine responses 
between individuals, leading to the question of if there were clusters of individuals 
who exhibited similar responses to vaccination. Average titer trends and the 95% 
confidence interval for each virus was plotted with SSClust3.0, which identified 
subsets of individuals (clusters) who exhibited similar responses to selection. These 
clusters may indicate differences of within herd antibody production or immune 
system strength, as some clusters appeared to respond less robustly than others. 
For the proportion of individuals who did not seroconvert by week 6 to 
BVDV1, BVDV2, and BHV1, there are individuals who never seroconvert at any time 
point, and those who had recorded antibody titers that dropped to 0 at some time 
period after the first measurement. The most interesting individuals are those that 
never seroconvert despite having maternal antibodies and 2 rounds of vaccination. 




never seroconverted to BVDV2, and 227 individuals that never seroconverted to 
BHV1. This is 6.5%, 0.4%, and 13.9% of the respective set of animals with records 
for the given virus studied who failed to seroconvert. One calf failed to seroconvert 
for both BVDV1 and BVDV2, and 12 calves failed to seroconvert for both BVDV1 and 
BHV1. There were no calves that failed to seroconvert for both BVDV2 and BHV1, 
and consequently no calves that failed to seroconvert for all 3 viruses. Growth traits 
did not significantly differ between animals who seroconverted and those who did 
not, indicating that development of the calves was not hindered by a lack of immune 
response up to the point at which serum samples were collected. Although 
individuals who did not seroconvert still grew normally and may be protected in 
herds due to herd immunity, these would be the most at risk individuals and 
therefore likely the ones to be culled so as to potentially reduce morbidity incidence 
in the herd. 
To address methodology, a reduction in assay replicates occurred in later 
years of BVDV2 (5 to 3 replicates). Additionally, BHV1 along with BRSV were 
analyzed with only 2 replicates as opposed to 5. While reduction in assay replicates 
is likely to reduce overall accuracy of recorded measurements, this was done to 
improve statistical power by increasing the number of individuals with measured 
serum levels. By improving our power to statistically analyze observed 
measurements, we are able to better estimate trends in the population. This does 
lower the ability to analyze individuals on a one-by-one basis, however this is not 




  In summary, an individual’s response to vaccination was influenced 
by multiple factors, including initial maternally-derived circulating antibodies, time 
of weaning, and age of the calf. When these factors are considered together, it 
indicates that calves have on average a more positive response to vaccination when 
they are older, likely due to a reduced quantity of circulating maternally-derived 
antibodies. Time of weaning relative to initial vaccination impacted overall response 
to vaccination for a given virus. Individuals with recorded BVDV1 and BVDV2 titers 
had more robust overall antibody responses when initially vaccinated at the time of 
weaning, while individuals with recorded BRSV and BHV1 titers had more robust 
overall antibody response to vaccination when weaned 3 weeks after that initial 
vaccination. This difference in robustness of response to vaccination indicates that 
the stress associated with weaning impacts response to vaccination differently for 
different viruses. It is still important to note that not all individuals had titers 
recorded for all 4 viruses, and therefore direct response comparisons cannot be 
made for every individual and can only be made based on overall herd averages. A 
proportion of the calf population was identified as non-responders or individuals 
who failed to seroconvert at week 6. No reduced growth or development was 
associated with that proportion of individuals at the time of serum collection, 
possibly due to the effect of herd immunity. Genomic analysis of these individuals 
will be important, however, due to their potentially weaker genetics in respect to 
antibody production. All of this together helps develop a more beneficial direction 
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Table 1: Means for titer, calf age, and calf weight at four time points for Bovine Viral Diarrhea Virus 1 (BVDV1), Bovine 






base-2 Range SD Age, days SD Range BW, kg SD 
Pre-vaccination1 622 2.68 (0-12.3) 2.68 111.8 27.9 (28-169) 133.4 30.6 
Initial Vaccination 1,648 2.14 (0-10.5) 2.15 138.0 29.4 (54-205) 149.2 34.5 
Booster 
Vaccination 1,488 1.5 (0-9.3) 1.7 158.6 29.7 (76-229) 173.8 39.7 
Final  1,348 2.3 (0-9.3) 1.8 177.9 29.1 (99-250) 190.1 40.0 
Decay, titer/day2 622 -0.023   0.06           
BVDV2 
Pre-vaccination1 1,137 4 (0-10.5) 2.32 109.1 28.7 (28-165) 145.3 34.1 
Initial Vaccination 2,177 3.24 (0-11.2) 2.38 127.0 35.0 (30-205) 143.2 37.5 
Booster 
Vaccination 1,927 2.5 (0-11.3) 1.98 152.9 31.4 (57-229) 164.3 39.7 
Final  1,917 4.17 (0-9.16) 1.91 174.9 30.9 (78-250) 182.3 42.6 
Decay, titer/day2 1,137 -0.041   0.045           
BRSV 
Initial Vaccination 1,632 1.08 (0-6) 1.81 136.3 29.6 (53-205) 150.5 36.1 
Booster 
Vaccination 1,310 3.73 (3-6) 0.81 151.1 28.0 (76-229) 170.9 39.1 
Final  1,483 5 (3-6.46) 0.89 177.3 35.0 (99-250) 189.5 40.3 
BHV1 
Initial Vaccination 1,621 0.87 (0-6) 1.45 136.3 29.6 (53-205) 150.3 36.1 
Booster 
Vaccination 1,351 2.1 (0-6) 1.79 156.8 29.7 (76-229) 170.4 38.9 
Final  1,377 2.98 (0-6.58) 2.3 177.5 34.0 (99-250) 189.6 40.2 
 
1Viral Neutralization titers to BRSV and BHV1 were not measured in pre-vaccination samples thus results for pre-
vaccination and decay are only reported for BVDV1 and BVDV2.  
2Titer reported as titer/day change for Maternal Decay.
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Table 2: Significance for fixed effects relating to initial antibody titer, pre-
vaccination antibody titer, and maternal decay for Bovine Viral Diarrhea Virus 1 
(BVDV1) and Bovine Viral Diarrhea Virus 2 (BVDV2)1 
 
BVDV1 Initial Pre-vaccination Decay 
Year-Season <0.0001 0.0012 0.471 
Dam Age <0.0001 <0.0001 0.0012 
Sex 0.2431 0.2201 0.9292 
Birth Weight 0.0006 0.0012 ***** 






BVDV2 Initial Pre-vaccination Decay 
Year-Season <0.0001 0.004 <0.0001 
Dam Age <0.0001 <0.0001 0.0012 
Sex 0.099 0.3292 0.1383 
Birth Weight <0.0001 0.0136 ***** 






    
1Viral Neutralization titers to BRSV and BHV1 were not measured in pre-vaccination 
samples, thus results are only reported for BVDV1 and BVDV2. 





Table 3: Rate of maternal antibody decay by dam age for Bovine Viral Diarrhea Virus 1 (BVDV1) and Bovine Viral 











2 Dam Age Rate of Decay Standard Error 
  2a -0.01911 ±0.008584   2a -0.06558 ±0.004561 
3b -0.04109 ±0.007251 3b -0.05428 ±0.003819 
4b -0.03863 ±0.007018 4b -0.04727 ±0.003845 
5ab -0.0339 ±0.009137 5b -0.05251 ±0.004357 
6a -0.00956 ±0.009723 6bc -0.04466 ±0.00471 
7a -0.00958 ±0.009905 7cd -0.03717 ±0.00474 
8a -0.00292 ±0.01236 8bde -0.0435 ±0.005412 
9a -0.00307 ±0.01422 9ab -0.04938 ±0.005677 
10ac 0.0232 ±0.02755 10ab -0.05465 ±0.008574 
11c 0.06686 ±0.03497 11ce -0.02878 ±0.00935 
12abc -0.05348 ±0.02315 
13abc -0.0683 ±0.03974 
          14abc -0.0554 ±0.03959 
 







Table 4: Class effects and covariates associated with initial response, booster response, overall response, and final 
antibody titer for Bovine Viral Diarrhea Virus 1 (BVDV1), Bovine Viral Diarrhea Virus 2 (BVDV2), Bovine Respiratory 
Syncytial Virus (BRSV), and Bovine Herpesvirus 1 (BHV1) 
 
BVDV1 Initial Response 
Booster 
Response Overall Response Final Antibody Level 
Year-season 0.05 0.0823 0.0047 <0.0001 
Sex 0.3856 0.904 0.984 0.9507 
Pink Eye 0.6824 0.2001 0.116 0.013 
Dam Age 0.0034 0.0256 0.0024 0.029 
Wean 0.2726 0.0526 0.0004 0.0022 
Titer 0.2605 <0.0001 <0.0001 <0.0001 
Titer*Titer <0.0001 <0.0001 <0.0001 <0.0001 
Age(Year-season) <0.0001 <0.0001 0.0003 <0.0001 
ADG 0.0015 0.7861 0.7427 ***** 
BVDV2 Initial Response 
Booster 
Response Overall Response Final Antibody Level 
Year-season 0.0007 <0.0001 <0.0001 <0.0001 
Sex 0.8879 0.0573 0.2283 0.2379 
Pink Eye 0.0055 0.2236 0.0195 0.0181 
Dam Age 0.0518 <0.0001 <0.0001 <0.0001 
Wean <0.0001 0.0746 0.0012 0.0005 
Titer <0.0001 <0.0001 <0.0001 <0.0001 
Titer*Titer <0.0001 <0.0001 <0.0001 <0.0001 
Age(Year-season) <0.0001 <0.0001 <0.0001 <0.0001 
ADG 0.3792 0.3478 0.1834 ***** 
BRSV Initial Response 
Booster 
Response Overall Response Final Antibody Level 



























Pink Eye 0.1375 0.5948 0.766 0.9354 
Dam Age 0.6456 0.04 0.0002 <0.0001 
Wean 0.5632 <0.0001 <0.0001 <0.0001 
Titer <0.0001 <0.0001 <0.0001 0.4414 
Titer*Titer 0.931 0.585 0.1151 0.124 
Age(Year-season) <0.0001 <0.0001 <0.0001 <0.0001 
ADG 0.9364 0.1578 0.958 ***** 
BHV1 Initial Response 
Booster 
Response Overall Response Final Antibody Level 
Year-season <0.0001 <0.0001 <0.0001 <0.0001 
Sex 0.0751 0.7596 0.4038 0.4557 
Pink Eye 0.0128 0.6701 0.6821 0.7563 
Dam Age <0.0001 0.0352 0.0021 0.0002 
Wean 0.0004 <0.0001 <0.0001 <0.0001 
Titer <0.0001 <0.0001 <0.0001 <0.0001 
Titer*Titer 0.7269 0.8379 <0.0001 <0.0001 
Age(Year-season) <0.0001 <0.0001 <0.0001 <0.0001 
ADG 0.3721 0.387 0.2336 ***** 
 
 









Figure 1: Timeline of serum sample collection. Pre-vaccination time point (-3 weeks) samples were only tested for 








Figure 2: Average initial antibody concentration by dam age in years for A) BVDV1, B) BVDV2, C) BRSV and D) BHV1. 
Pre-vaccination titers by dam age included for BVDV1 and BVDV2. Different letters indicate significantly different dam 
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Figure 3: Initial antibody titer (week 0) by calf age in days, averaged across year-season classification for BVDV1, 
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Figure 4: Weighted Average of Maternal antibody decay rate (titer unit/day) by prevaccination age of calf for BVDV1 
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Figure 5: Change in average overall antibody response by weaning time point for BVDV1, BVDV2, BRSV and BHV1. 
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Figure 6: Estimated response traits and final antibody titer by calf age in days for BVDV1 (n =1654), BVDV2 (n = 2231), BRSV 
(n=1631), BHV1 (n=1631). A) Initial vaccination response, B) Booster vaccination response, C) Overall vaccination Response, D) 
Final Antibody Titer. Covariates of weaning at initial vaccination, Pink Eye = yes, dam age = 5 years. Slope indicates weighted 
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Figure 7: Response traits and final antibody titer normalized by starting titer for BVDV1 (n =1654), BVDV2 (n = 2231), BRSV 
(n=1631), BHV1 (n=1631). A) Initial vaccination response, B) Booster vaccination response, C) Overall vaccination Response, D) 
Final Antibody Titer. Covariates of weaning at initial vaccination, Pink Eye = yes, dam age = 5 years. Slope indicates weighted 
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Figure 9: Titers across serum collection time points. A) BVDV1 (n =1654), B) 
BVDV2 (n = 2231), C) BRSV (n=1631), D) BHV1 (n=1631). Average titer level 
plotted in green, all individuals plotted in grey.  




























































































































Figure 10: Individuals with a final titer of zero. A) BVDV1 (n = 367), B) BVDV2 (n = 
100), C) BHV1 (n = 468). Average titer level across all individuals measured is 
plotted in green. D) BRSV (n = 132) shows individuals with the minimum titer 
calculated at week six (3 on a log base-2 scale). While it is not the same trend as 
shown in A, B and C, it was included to allow comparison.  
































































































































Figure 11: Trends within individuals with measured BVDV1 data. Four clusters were generated, with n = 163 calves for cluster 1, 
n = 524 calves for cluster 2, n = 136 calves for cluster 3, and n = 809 calves for cluster 4. X-axis shows titer measurement time 
points (pre-vaccination, initial vaccination, booster vaccination, and booster response). Y-axis represents average titer of cluster, 
calculated proportional to other time points, with a score of 1 being the reference. Black lines represent mean titer trends; red 
lines represent 95% confidence interval. 
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Background: Bovine respiratory disease complex (BRDC) is one of the most 
important sources of loss within the beef cattle industry in the USA. Steps have been 
taken to reduce the incidence of BRDC through vaccination. Despite the 
effectiveness of vaccines, large proportions of cattle still experience morbidity and 
mortality. Identification of genomic regions that are associated with variation in 
response to vaccination would allow for the selection of individuals genetically 
predisposed to respond to vaccination based on specific markers, while heritability 
and accuracy estimates would help facilitate genomic selection. This in turn may 
lead to selection for beef cattle herds that may have lower incidence rate of BRDC 
after vaccination. This study utilizes an Angus herd of more than 2000 head of cattle 
to identify these regions of association. 
Results: Genome wide association studies were performed for viral neutralization 
antibody level and response to vaccination traits against four different viruses 
associated with BRDC: bovine viral diarrhea virus 1 and 2 (BVDV1 and BVDV2), 
bovine respiratory syncytial virus (BRSV), and bovine herpesvirus (BHV1). A total of 
six 1-Mb windows were associated with greater than 1% of the genetic variance for 
the analyzed vaccination response traits. Heritabilities ranged from 0.08 to 0.21 and 
prediction accuracy ranged from 0.01 to 0.33 across 7 different vaccination traits. 
Conclusions: Although six 1-Mb windows were identified as associated with 1% or 
greater genetic variance for viral neutralization antibody level and response to 
vaccination traits, few genes around these windows could readily be considered 
candidates. This indicates the need for further functional genomic annotation, as 
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these regions appear to be gene deserts. Traits ranged from lowly to moderately 
heritable, which indicated the potential for selection of individuals that are 
genetically pre-disposed to respond to vaccination. The relatively low amount of 
genetic variance accounted for by any 1-Mb window indicated that viral 
neutralization antibody level and response to vaccination traits are polygenic in 
nature. Selection for these traits is possible, but likely to be slow due to the low 
heritabilities and absence of markers with high genetic variation associated with 
them. 
 
Key Words: accuracy, beef cattle, bovine respiratory disease complex, genome-wide 
association study, heritability, immune response, vaccination 
 
Background 
Bovine respiratory disease complex (BRDC) is one of the most costly and pervasive 
disease conditions facing beef cattle producers. With more than $750 million dollars 
in losses each year due to morbidity, mortality, and performance loss, vaccines have 
been one method used in an attempt to reduce overall incidence rates and by 
extension economic losses[1-4]. Despite widespread adoption of vaccination 
protocols in the beef cattle industry, BRDC remains extremely prevalent due to 
varying levels of vaccine efficacy[5, 6]. Research into response to vaccination has 
identified multiple environmental and management variables which impact an 
individual calf’s ability to mount an antibody response[7-9]. Factors such as 
maternally derived antibody levels from colostrum, calf age, seasonality, and 
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weaning status all impact a calf’s individual immune system, and result in variability 
in its response to vaccination[10-12].  
In order to improve efficacy of vaccination for BRDC, it is desired that all calves 
exhibit an adequate immune response after vaccination. If this is the case, calves 
would likely be better protected against future exposure to BRDC viruses after a 
multi-shot vaccination procedure and thereby result in less economic loss due to 
BRDC. One way to improve beef cattle response to vaccination may be through 
genomic selection. Previously, we reported on variables that influenced response to 
vaccination against bovine viral diarrhea virus 1 (BVDV1), bovine viral diarrhea 
virus 2 (BVDV2), bovine respiratory syncytial virus (BRSV), and bovine herpesvirus 
(BHV1)[13-15]. A genome-wide association study was performed on five different 
responses to vaccination/viral antibody titer traits across all four viruses (initial 
titer, final titer, initial vaccination response [IVR], booster vaccination response 
[BVR], overall vaccination response [OVR]) with an additional two traits analyzed 
only on BVDV1 and BVDV2 (maternal decay and maternal antibody titer) due to 
availability of data (Figure 1). Through heritability and accuracy estimates for 
response to vaccination and viral antibody titer level traits, producers would be 
afforded the opportunity to select for cattle with higher immune response to 
vaccination. As such, the goal of this study was to identify regions of the genome that 
were associated with response to vaccination and viral antibody level and evaluate 
the potential for genomic selection for calves with improved immune response to 





Estimates of genetic and residual variance, and heritability 
Estimates of heritabilities and variances were obtained for each viral antibody titer 
levels and response to vaccination traits (Table 1). Heritability (h2) estimates, which 
were the proportion of additive genetic variance out of the total phenotypic 
variance, ranged from 0.08 to 0.22. The greatest spread of heritabilities was found 
within BVDV2 with a minimum estimated heritability of 0.08 and a maximum of 
0.22. In contrast, BRSV had the smallest spread with a minimum heritability of 0.12 
and a maximum of 0.18. Maternal decay and maternal antibody titer traits were only 
available for BVDV1 and BVDV2. Total genetic and residual posterior variances were 
relatively similar across all viral neutralization antibody level and response to 
vaccination traits. Maternal decay of BVDV2 titer level had the lowest posterior 
genetic variance (0.005) and residual variance (0.02). In contrast, no single antibody 
titer level or response to vaccination trait had both the highest genetic and residual 
posterior variance.  
 
Whole Genome Association: 
The amount of genetic variance that every 1-Mb window across the bovine genome 
could account for was estimated based on the model for a viral neutralization 
antibody level or response to vaccination trait. Furthermore, the posterior 
probability of inclusion for each SNP and 1-Mb window was calculated as well. 
There were no 1-Mb regions across all viral neutralization antibody level and 
response to vaccination traits for all four viruses that exceeded a 0.9 posterior 
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probability of inclusion. Six 1-Mb windows across the genome across traits could 
account for greater than 1% of the trait genetic variance (Table 2). The percent 
variance accounted by these windows ranged from 1.01% to 1.93%. These six 1-Mb 
windows were associated with four antibody titer levels or response to vaccination 
traits: two windows for BVDV1 initial titer (Figure 2), two for BVDV1 overall 
vaccination response (Figure 3), one for BVDV2 booster vaccination response 
(Figure 4), and the final 1-Mb window for BRSV overall vaccination response 
(Figure 5). 
All genes within these windows were evaluated as potential candidate genes. 
Unfortunately, none of the genes within these windows were annotated with 
immune function Gene Ontology terms. However, higher order gene families names, 
e.g. TRIML, may have some function related to immune system response [18]. 
Additionally, multiple transcription factors were identified such as EST1, which may 
have some functional relationship with immune response. 
Traits were also analyzed categorically, with phenotypes being set as their integer 
value. This marginally improved the heritability of the response to vaccination and 
viral neutralization antibody levels (Table 3). However, in these analyses no 
windows accounted for greater than 1% of the estimated genetic variation. 
 
Correlations and Accuracies 
Individuals were separated into five groups that exhibited high genetic diversity 
between groups while maintaining genetic similarity within groups. The number of 
individuals in each of the five groups can be seen in Table 4. Different numbers of 
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individuals were present in the different clusters between different viral antibody 
titer levels and responses to vaccination traits was due to different numbers of 
calves with phenotype data and the presence or absence of various data time points. 
BVDV2 was the initial viral antigen studied at the inception of this study. As such, 
the individuals that could be analyzed for the other 3 viral antigens came from a 
smaller pool and are therefore more variable in the total number utilized. The 
pooled correlation between direct genetic value estimates and the true phenotype 
ranged from -0.10 for BHV1 overall vaccination response to 0.09 for BVDV1 final 
titer and overall vaccination response. Prediction accuracies ranged from an 
absolute value of 0.002 to 0.31 (Table 5). Maternal decay traits for BVDV1 and 
BVDV2 were unable to be estimated due to a failure to converge, and so could not be 
calculated for correlation or accuracy. 
 
Discussion 
In this study, we set out to identify regions of the genome that were associated with 
viral neutralization antibody level and response to vaccination traits for four viruses 
associated with BRDC. To do so, a genome wide association study was performed to 
characterize regions based on the proportion of genetic variance they could account 
for within a trait. Heritability estimates for viral neutralization antibody level and 
response to vaccination traits were lowly to moderately heritable. Ranging from 
0.08 to 0.22, we determined that the heritability of viral neutralization antibody 
level and response to vaccination traits varied the most in BVDV1 and BVDV2, and 
the least in BRSV. However, when only traits measured on all four viruses are 
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compared, BVDV1 and BVDV2 have a much more concentrated range in 
heritabilities than the other two. Additionally, as described in Kramer et al 2017, 
BRSV was the singular virus out of the four studied that did not contain individual 
calves that failed to seroconvert, potentially due to the ubiquitous nature of 
BRSV[16, 19]. This represented a smaller range in the titer sample data and may 
impact its ability to be compared to the other three viruses. Heritability estimates 
for immune related traits in other studies range from lowly (0.11) to highly 
heritable (0.47), dependent on the immune trait evaluated, whether it is due to a 
infectious challenge or vaccination, and species [20-24]. The heritability estimates 
based on estimated direct genetic variation are on the lower end of this previously 
found range. This is likely due to response to vaccination as a complex trait with 
many non-genetic influences as noted in Kramer et al 2017, and will make selection 
for these antibody titer level and response to vaccination traits slower than if they 
were more heritable.  
Low correlations were calculated between direct genetic value and the true 
phenotype, with a range of -0.10 to 0.09. Accuracies also ranged from an absolute 
value of 0.002 to 0.31. These accuracies are a direct result of low heritabilities as 
accuracy was calculated as correlation divided by the square root of heritability. 
While the correlation between true and predicted phenotype is low, and accuracies 
are on average 0.11, some traits such as BHV1 overall vaccination response and 
BVDV1 final titer may have a level of accuracy such that they could be utilized in a 
selection index. These determined correlations and accuracies underscore the point 
that responses to vaccination traits remain complicated even after fitting 
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management practices and other environmental and physiological factors in a 
model. With a greater number of individuals, it may be possible to improve the 
accuracy closer to its maximum, although it will be capped by the heritability 
estimates of response to vaccination traits (0.28-0.45 range for maximums). If 
accuracies of genomic predictions can be increased towards these maximums, then 
the rate of genetic progress for response to vaccination and viral neutralization 
antibody level traits will increase.  
These traits appear to be highly polygenic, as no singular region was able to account 
for a large proportion of genetic variation and only six regions were estimated to 
account for more than 1% of that variation (Figure 2-5). The polygenic nature of 
viral neutralization antibody level, response to vaccination, and immune related 
traits is something that has been previously reported in numerous studies such as 
those focused on porcine[17, 25], chicken[26, 27], cattle[28-31], and mice[32]. In 
the six windows that accounted for more than 1% of the genetic variance in this 
study, no candidate genes were identified as none of the genes in those regions were 
annotated with Gene Ontology terms associated with immune response functions. 
The TRIM gene family is present, however, and may have some further functional 
relevance that is not currently described in published literature [18]. 
 
Conclusions 
 This study aimed to examine response to vaccination against viruses 
associated with BRDC in Angus calves using genome wide association studies. 
Vaccination is one of the most widely used tools by producers to reduce and/or 
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prevent BRDC incidence in herds. Efficacy remains lower than desired; therefore 
selection of cattle for response to vaccination could increase the effectiveness of 
vaccine use. This would potentially reduce losses associated with BRDC and 
improve animal welfare. Using serum samples across a 6-9 week period we were 
able to identify genomic regions associated with multiple response to vaccination 
traits, and determine the predictive accuracy of response to vaccination. Windows 
of size 1-Mb were found to account for up to 1.93% of genetic variation, indicating 
the polygenic nature of response to vaccination. With low to moderate heritabilities 
across response to vaccination traits, there appears to be room for selection of 
animals with improved vaccination response. Genes within the associated regions 
had little functional annotation associated with them, which may be resolved in 
future builds of the Bos taurus genome along with the help of the Functional 
Annotation of Animal Genomes (FAANG) initiative. All of this together provides a 
solid foundation for genetic variation within response to vaccination in Angus 
calves, and a basis for selection procedures. 
 
Methods 
Population: Calves (n = 2,518) from a purebred American Angus herd located at 
Iowa State University Ames, IA, were used in this study. Not all individuals were 
utilized for all response to vaccination traits due to limited availability of recorded 
data at specific time points and non-genotyped calves. Therefore, the number of 
calves analyzed for each response to vaccination trait was less than the total 
122 
 
number of genotyped calves. Calves were born in either a spring season or fall 
season classification, and across multiple years (2006-2012, 2014). 
 
Phenotypic Data: Phenotypic data was collected as described in previous work [13-
15]. Briefly; individuals were vaccinated with a modified live vaccine (Bovi-Shield 
Gold 5, Zoetis, Inc. Parsippany NJ). Serum samples were collected from the calves at 
multiple time points and then a viral neutralization assay was performed for each 
sample to quantify the level of antibodies present against one of four viruses 
(BVDV1, BVDV2, BRSV, BHV1). Dilutions were performed to identify the greatest 
dilution where neutralizing antibodies could still be detected, and a log2 titer was 
recorded. This was based on the Spearman-Kärber method for initial calculation 
[33]. Response traits were calculated as the change in titer values between serum 
sample collection time points (initial, booster, and overall vaccination response), or 
as the calculated titer value for a given time (maternal, initial, and final antibody 
titer). 
 
Genotypic Data: The BovineSNP50 BeadChip (Illumina, San Diego, CA) and 
BovineHD BeadChip (Illumina, San Diego, CA) were used by Neogen GeneSeek 
Operations (Lincoln, NE) to perform SNP genotyping. Individuals were imputed by 
using the SNPipeline package (Hailin Su, 
https://github.com/cbkmephisto/SNPipeline) and FImpute [34] from the 
BovineSNP50 BeadChip to the BovineHD BeadChip using 820 Angus individuals 
genotyped natively for the Bovine HD BeadChip, both within and outside the ISU 
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herd. Accuracy of imputation was about 97%, and was tested by randomly removing 
5,000 markers from the 50k genotype, and then comparing imputed genotypes of 
these 5,000 markers to the original genotypes. 574,662 single nucleotide 
polymorphisms (SNPs) remained after editing for a minor allele frequency (MAF) of 
0.05. All SNPs were assigned a UMD3.1 bovine genome build position[35].  
 
Statistical Model: All 574,662 SNPs were used alongside phenotypic titer 
measurements or differences to determine an estimate of each SNP effect for a 
respective trait. Single SNP effect estimates were obtained using BayesB approach 
through the program GenSel[36]. This method assumes a model in which a portion 
of SNP markers have zero effect on a trait, denoted as a π, and markers not assigned 
zero effect are used in prediction by estimating individual SNP effects. Models were 
generally fit as follows: 
 = &' + () +   
 
where y was a vector of response to vaccination trait observations; b is a set of 
vectors of fixed effects; u is a vector of SNPS as random effects sampled through 
BayesB; and e was the remaining vector of residuals corresponding to each 
phenotypic record[37]. Fixed effects and Covariates are explained in detail within, 
but included the fixed effects of: Year-Season classification, Sex, Dam Age, Weaned 
Status, Pink Eye Status; covariates of Calf Age within Year-Season classification, 
Titer score, Titer-by-Titer score, and Average Daily Gain[13]. A π value of 0.999 was 
used for BayesB[38] analysis of each trait (approximately 575 SNP markers with a 
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non-zero effect), while genetic and residual variances for each trait were estimated 
using BayesC (initial variances set as half the total phenotypic variance) before 
being used in BayesB[37, 39]. A total of 50,000 iterations were used with Monte 
Carlo Markov Chain, with the first 5,000 thrown out as a burn in, to obtain posterior 
means of SNP marker effects and posterior probabilities of inclusion. 
BayesB analysis outputs included SNP marker effect estimates, 1-Mb window effect 
estimates, and a direct genetic value prediction for every individual. Each SNP 
marker and 1-Mb window was estimated a % genetic variance that it accounted for, 
and a posterior probability of inclusion to indicate the frequency in which it was 
included in the BayesB analysis. 
Response to vaccination and viral titer level traits were also analyzed as categorical 
traits in addition to the above analysis, and models for these traits as categorical 
were fit and run as above. Phenotypes were set as the truncated integer value for a 
recorded phenotypic measurement (1.0-1.99 =1, etc…) rather than rounding to 
integer values.  All other fixed effects, covariates, and the matrix of random marker 
effects remained the same. 
 
Heritability: Heritability estimates for each trait were obtained through BayesC 
with a π value of 0. This was chosen due to BayesB shrinking small effects to allow 
for the detection of relatively larger effects, and therefore biasing heritability 
estimates[37, 39]. Heritability was calculated as the posterior genetic variance over 




Accuracy of Prediction: Prediction accuracies were estimated through cross 
validation for the direct genetic values that were predicted for each individual in 
BayesC. Genotyped individuals were initially classified into 9 unequal groups 
through K-means clustering [40] after creating a genomic relationship matrix [41]. 
Using this method, each group was made to be as genetically similar as possible 
within group, while remaining genetically distinct to the other 8 groups. Through 
this, groups can be used as predictors of other groups due to genetic similarity. The 
9 initial groups were clustered down to 5 total groups by merging numerically 
smaller groups together so that groups were more consistently sized. BayesC with a 
π value of 0 was used to perform training and validation for these groups as follows: 
1 group was excluded from the BayesC π = 0 analysis, and direct genetic values were 
calculated on the remaining 4 groups of animals. Those single SNP marker estimates 
were then used validate the final 5th group. Each group was rotated so that every 
individual was validated once and used as training set four times. Accuracy was 
calculated by taking the correlation between predicted direct genetic value and 
phenotypes for all individuals in a given trait divided by the square root of 
heritability for that trait. 
 
Candidate Gene Identification: The 1-Mb genomic regions accounting for more 
than 1% OF genetic variation for response to vaccination traits were identified for 
candidate gene investigation. A region extending half a mega base on either side of 
the identified 1-Mb regions, for a total of 2Mb in length, was analyzed by looking at 
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the biological function of every gene currently annotated in the UMD 3.1 Bos taurus 
assembly of the genome. 
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Genome-wide Association Study: GWAS 
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Bovine Herpesvirus: BHV1 
Single Nucleotide Polymorphism: SNP 
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1All trait titers measured in log2 transformations from serum neutralization dilutions. Maternal 
Decay measured as log2 titer change per day 












0.01 0.03 0.22 
 Maternal Antibody Titer
2 
0.28 1.58 0.15 
 Initial Titer 0.41 1.58 0.21 
 Initial Vaccination Response 0.17 0.73 0.18 
 Booster Vaccination 
Response 
0.33 1.42 0.19 
 Overall Vaccination 
Response 
0.29 1.48 0.16 
 Final Titer 0.33 1.65 0.17 
     
BVDV2 Maternal Decay
2 
0.005 0.02 0.21 
 Maternal Antibody Titer
2 
0.23 2.03 0.10 
 Initial Titer 0.17 1.94 0.08 
 Initial Vaccination Response 0.11 1.16 0.09 
 Booster Vaccination 
Response 
0.21 2.25 0.08 
 Overall Vaccination 
Response 
0.18 2.02 0.08 
 Final Titer 0.20 2.01 0.09 
     
BRSV Initial Titer 0.18 1.38 0.12 
 Initial Vaccination Response 0.07 0.35 0.16 
 Booster Vaccination 
Response 
0.09 0.42 0.18 
 Overall Vaccination 
Response 
0.09 0.47 0.16 
 Final Titer 0.08 0.49 0.14 
     
BHV1 Initial Titer 0.14 1.24 0.10 
 Initial Vaccination Response 0.22 1.52 0.13 
 Booster Vaccination 
Response 
0.29 2.20 0.18 
 Overall Vaccination 
Response 
0.30 2.28 0.12 
 Final Titer 0.27 2.36 0.10 








Table 2: 1-Mb genomic windows that accounted for greater than 1% genetic variance for response to vaccination traits. 
 










220 1.64 0.57 
  18_9 rs43715906 rs29024678 400 1.01 0.65 
        






172 1.93 0.61 
  29_32 rs43727482 rs13760987
0 
253 1.15 0.51 
        




rs43207573 300 1.03 0.54 
        




rs42965155 296 1.03 0.49 
        
 
1All trait titers measured in log2 transformations from serum neutralization dilutions 
21-Mb window defined by chromosome and mega base position. UMD3.1 build of Bos taurus genome 





Table 3: Categorical analysis posterior estimates of genetic (σg2) and residual (σe2) 




1All trait titers measured in log2 transformations from serum neutralization 
dilutions 











BVDV1 Maternal Antibody Titer
2
 0.33 1.00 0.25 
 
Initial Vaccination 0.22 1.00 0.18 
 
Initial Vaccination Response 0.22 1.00 0.18 
 
Booster Vaccination Response 0.15 1.00 0.13 
 
Overall Vaccination Response 0.16 1.00 0.14 
 
Final Titer 0.52 1.00 0.34 
     BVDV2 Maternal Antibody Titer
2
 0.24 1.00 0.19 
 
Initial Vaccination 0.15 1.00 0.13 
 
Initial Vaccination Response 0.11 1.00 0.10 
 
Booster Vaccination Response 0.11 1.00 0.10 
 
Overall Vaccination Response 0.11 1.00 0.10 
 
Final Titer 0.27 1.00 0.21 
     BRSV Initial Vaccination 0.61 1.00 0.38 
 
Initial Vaccination Response 0.17 1.00 0.14 
 
Booster Vaccination Response 0.51 1.00 0.34 
 
Overall Vaccination Response 0.29 1.00 0.23 
 
Final Titer 0.47 1.00 0.32 
     BHV1 Initial Vaccination 0.61 1.00 0.38 
 
Initial Vaccination Response 0.14 1.00 0.12 
 
Booster Vaccination Response 0.14 1.00 0.13 
 
Overall Vaccination Response 0.15 1.00 0.13 










1All trait titers measured in log2 transformations from serum neutralization dilutions. 
Maternal Decay measured as log2 titer change per day 
2Maternal Decay and Maternal antibody titer data only available for BVDV1 and BVDV2 
  K Means 
Groups 
   Total 
Virus Trait
1
 1 2 3 4 5  
BVDV1 Maternal Decay
2 
131 89 126 90 133 569 
 Maternal Antibody Titer
2 
130 88 125 90 133 566 
 Initial Vaccination 314 289 306 290 319 1518 
 Initial Vaccination Response 244 236 253 234 273 1240 
 Booster Vaccination Response 211 214 213 208 245 1091 
 Overall Vaccination Response 198 187 210 206 243 1044 
 Final Titer 234 236 238 240 281 1229 
        
BVDV2 Maternal Decay
2 
198 194 150 161 192 895 
 Maternal Antibody Titer
2 
232 210 185 195 227 1049 
 Initial Vaccination 408 353 291 354 332 1738 
 Initial Vaccination Response 426 353 314 371 351 1815 
 Booster Vaccination Response 425 350 313 371 347 1806 
 Overall Vaccination Response 424 350 312 372 347 1805 
 Final Titer 425 350 312 372 347 1805 
        
BRSV Initial Vaccination 312 285 312 281 318 1508 
 Initial Vaccination Response 268 217 248 230 246 1209 
 Booster Vaccination Response 250 200 230 214 222 1116 
 Overall Vaccination Response 286 256 273 252 270 1337 
 Final Titer 287 263 276 261 280 1367 
        
BHV1 Initial Vaccination 312 283 301 280 315 1491 
 Initial Vaccination Response 312 285 302 281 318 1498 
 Booster Vaccination Response 254 230 243 218 234 1179 
 Overall Vaccination Response 256 236 253 226 245 1216 
 Final Titer 257 244 256 234 254 1245 





Table 5: Pooled correlation between phenotype and predicted direct genetic value, 
and accuracy of prediction.  
 
Virus  Trait1 Correlation Accuracy2 
BVDV1 Maternal Antibody Titer3 0.02 0.04 
 Initial Vaccination 0.06 0.12 
 Initial Vaccination Response 0.02 0.05 
 Booster Vaccination Response 0.08 0.19 
 Overall Vaccination Response 0.09 0.22 
 Final Titer 0.09 0.22 
    
BVDV2 Maternal Antibody Titer3 -0.05 0.15 
 Initial Vaccination -0.02 0.08 
 Initial Vaccination Response 0.04 0.15 
 Booster Vaccination Response -0.01 0.03 
 Overall Vaccination Response 0.00 0.00 
 Final Titer -0.03 0.11 
    
BRSV Initial Vaccination 0.07 0.22 
 Initial Vaccination Response 0.00 0.01 
 Booster Vaccination Response -0.05 0.11 
 Overall Vaccination Response 0.00 0.01 
 Final Titer 0.01 0.04 
    
BHV1 Initial Vaccination 0.02 0.05 
 Initial Vaccination Response 0.05 0.13 
 Booster Vaccination Response 0.01 0.03 
 Overall Vaccination Response -0.10 0.31 
 Final Titer -0.06 0.19 
    
 
1All trait titers measured in log2 transformations from serum neutralization dilutions 
2Accuracy calculated as correlation between direct genetic value and phenotype divided by 
square root of heritability 






Figure 1: Study sample collection timeline. Colored boxes correspond to data 
availability of that trait to one of the four viruses. Bovine Viral Diarrhea Virus 1 
(BVDV1) in blue, Bovine Viral Diarrhea Virus 2 (BVDV2) in red, Bovine Respiratory 
Syncytial Virus (BRSV) in green, Bovine Herpesvirus (BHV1) in purple. For each 
virus 3 response variables were calculated: 1) initial vaccination response = booster 
titer – initial titer; 2) booster vaccination response = final titer – booster titer; 3) 
overall vaccination response = final titer – initial titer.  For BVDV1 and BVDV2 rate 
of maternal antibody decay was calculated: (initial titer – maternal titer) / number 













Figure 2: Manhattan plot for 1-Mb windows for Bovine viral diarrhea virus type 1 
initial titer. A Manhattan plot showing every 1-Mb window by %variance accounted 
for by that window across the entire Bos taurus genome. Two singular windows 
exceeded the 1% genetic variance threshold: chromosome 2, Mb 24 with 1.64% 



















Figure 3: Manhattan plot for 1-Mb windows for Bovine viral diarrhea virus type 1 
overall vaccination response. A Manhattan plot showing every 1-Mb window by 
%variance accounted for by that window across the entire Bos taurus genome. Two 
singular windows exceeded the 1% genetic variance threshold: chromosome 4, Mb 




















Figure 4: Manhattan plot for 1-Mb windows for Bovine viral diarrhea virus type 2 
booster vaccination response. A Manhattan plot showing every 1-Mb window by 
%variance accounted for by that window across the entire Bos taurus genome. One 
window exceeded the 1% genetic variance threshold: chromosome 27, Mb 16 with 



















Figure 5: Manhattan plot for 1-Mb windows for Bovine respiratory syncytial virus 
overall vaccination response. A Manhattan plot showing every 1-Mb window by 
%variance accounted for by that window across the entire Bos taurus genome. One 
window exceeded the 1% genetic variance threshold: chromosome 1, Mb 144 with 
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Background: Consumers are becoming increasingly conscientious about the 
nutritional value of their food. Consumption of some fatty acids has been associated 
with human health traits such as blood pressure and cardiovascular disease. 
Therefore, it is important to investigate genetic variation in content of fatty acids 
present in meat. Previously publications report regions of the cattle genome that are 
additively associated with variation in fatty acid content. This study evaluated 
epistatic interactions, which could account for additional genetic variation in fatty 
acid content. 
Results: Epistatic interactions for forty-four fatty acid traits in a population of 
Angus beef cattle were evaluated with EpiSNPmpi. False discovery rate (FDR) was 
controlled at 5% and was limited to well-represented genotypic combinations. 
Epistatic interactions were detected for thirty-seven triacylglyceride (TAG), thirty-
six phospholipid (PL) fatty acid traits, and three weight traits. A total of 6,181, 7,168, 
and 0 significant epistatic interactions (FDR < 0.05, 50-animals per genotype 
combination) were associated with Triacylglyceride fatty acids, Phospholipid fatty 
acids, and weight traits respectively and most were additive-by-additive 
interactions. A large number of interactions occurred in potential regions of 
regulatory control along the chromosomes where genes related to fatty acid 
metabolism reside. 
Conclusions: Many fatty acids were associated with epistatic interactions. Despite a 
large number of significant interactions, there are a limited number of genomic 




to accurately validate and quantify these epistatic interactions, the current findings 
point towards additional genetic variance that can be accounted for within these 
fatty acid traits.  
Key Words: Epistatic Interaction, Beef Cattle, Fatty Acids, Triacylglyceride, 
Phospholipid   
Background 
Beef cattle producers must contend with the desires of their consumers. Health 
consciousness amongst consumers has grown as more information and 
misinformation is publicized about the effects of food components, e.g. fatty acids, 
on human health. The health risks associated with increased fat consumption are a 
consideration for many consumers [1, 2] and beef is traditionally thought of as a 
high fat foodstuff. Producers can select for beef with a healthier fatty acid 
composition as fatty acid content of beef is highly heritable [3, 4] and genetic 
markers account for a large amount of this genetic variation [5-9]. However, the 
impact of non-additive genetic variation on fatty acid variation remains unknown. 
One of these non-additive genetic factors is the presence of epistatic interactions 
throughout a genome. While most research focuses on the additive portion of 
genetic variation, it often cannot account for all the genetic variation predicted. This 
additional variation may be explained with the identification and characterization of 
epistatic interactions. Although selection on fatty acid content in cattle with the 
inclusion of epistatic effects may not be very advantageous due to the breakdown of 
epistasis during selection [10], the ability to identify the interactions may lead to 




acid content. This study aimed to identify the extent to which epistatic interactions 
could account for additional genetic variation in fatty acid composition of beef. 
 
Results and Discussion 
Phenotypic summary statistics for TAG and PL fatty acids are reported in Table 1. 
Phenotypic summary statistics for Weight Traits are reported in Table 2. 
 
A total of 6,181 and 7,168 SNP by SNP interactions (TAG and PL respectively) 
had a FDR < 0.05 with data analysis limited to pairs of loci on different 
chromosomes in which at least 50-animals were represented for every combination 
of genotypes at the two loci under consideration as in Table 3. A stricter animal 
number filter was utilized to further restrict the number of identified interactions. 
The filter were used to determine if increasing genotype combination frequency 
impacted the number of significant results identified, which may indicate that low 
frequency genotype combinations were responsible for the generation of spurious 
significance. The filter was applied by increasing the number of animals present 
within each genotype combination to 100 animals per genotype combination (data 
not shown for 5, 10, 20 animal filters). The numbers of significant inter-
chromosomal interactions (FDR < 0.05) with either a 50-animal filter or 100-animal 
filter for both TAG and PL fatty acid fractions are shown in Table 3. The 100-animal 
filter was the strictest applied and resulted in a steep reduction in the number of 
significant interactions identified for every fatty acid trait analyzed. This reduction 




interactions among all possible interactions were similar at both 5 and 100 animal 
filters. As shown in Figure 1 and Figure 2, the number of interactions identified for a 
given animal filter continues to decrease as the filter became more stringent, with 
the total represented by all values to the right of the cutoff. A larger population of 
animals would be needed to truly represent the real proportion of animals per 
genotype combination. Once a suitable population is used, a stricter filter (such as 
the 100-animal filter) could be utilized to further reduce spuriously significant 
epistatic interactions. 
The observed modes of inheritance of the identified epistatic interactions 
included all the possible combinations, namely additive-by-additive (AA), additive-
by-dominance or dominance-by-additive (AD), and dominance-by-dominance (DD). 
The fatty acids in Table 4 are sorted by fatty acid fraction (TAG and PL) as well as 
the four fatty acid categories (SFA, MUFA, PUFA, and Ratio/Calculation) at a filter of 
FDR < 0.05 and 50-animals per genotype combination. TAG and PL fatty acid 
fractions had similar proportions of epistatic modes of inheritance (AA, AD, DD) 
between the four fatty acid categories. Dominance-by-dominance was the least 
commonly observed (summed across all fatty acid traits) mode of inheritance 
within the TAG fatty acids (0.06% of total significant interactions) as well as within 
PL fatty acids (0.01% of total significant interactions. For both fatty acid fractions 
(TAG and PL) additive-by-additive interactions made up the largest proportion of 
significant interactions, with 98.53% and 98.45% respectively (e.g. for PL 16:1 
represented in figure 3). Polyunsaturated fatty acids made up the smallest 




fraction. Interactions by type (AA, AD, or DD) were similar in levels and proportions 
between TAG and PL fractions, although a few traits exhibited different 
compositions of interactions (e.g. 14:0 – predominantly AA in TAG fraction while 
nearly non-existent in PL fraction). Visualization of additional fatty acids in both 
fractions can be found in the supplemental information, all charted at 50-animals 
per genotype combination. 
The distribution of identified epistatic interactions across fatty acid traits is 
of more interest. The number of interactions that met our minimum filter criteria 
(inter-chromosomal, 50-animals per genotype combination, FDR < 0.05) varied 
greatly between traits within each fatty acid fraction, and even between fractions for 
the same trait. For example, there were no significant (FDR < 0.05) interactions 
detected for 17 TAG fatty acids at 50-animals per genotype combination, while 
2,594 significant (FDR < 0.05) interactions were associated with fatty acid 
18:1t10pt11. No significant (FDR < 0.05) interactions were detected for 17 PL fatty 
acids at 50-animals per genotype combination, but 3,145 significant (FDR < 0.05) 
interactions were associated with PL fatty acid 18:1c11. This range in number of 
significant interactions identified for each trait was not confined to any specific fatty 
acid isoform or category (SFA, MUFA, PUFA, Ratio/Calculation) for either of the two 
fractions of fatty acids. Many exhibited a similar number of significant interactions 
in both TAG and PL fatty acid fractions, although there are exceptions such as fatty 
acids 14:0 which had a greater than 10-fold difference in number of interactions 




Polyunsaturated fatty acids had the lowest number of significant (FDR < 
0.05) interactions of all fatty acid types, in that all eleven fatty acids had less than 
100 significant (FDR < 0.05) epistatic interactions for the TAG fraction, and 10 out of 
11 fatty acids for the PL fraction. Only n6 fatty acids (the sum of all omega-6 fatty 
acids) had more than 100 significant (FDR < 0.05) interactions, and this was only in 
the PL fraction. Over half of the significant (FDR < 0.05) interactions associated with 
polyunsaturated fatty acids were with n6 fatty acids for both TAG and PL fractions. 
Among 18:1-cis fatty acids, there was a large range in the number of 
observed significant interactions. Triacylglyceride fatty acids 18:1c9 and 18:1c12 
were not significantly (FDR < 0.05) associated with any epistatic interactions while 
fatty acids 18:1c11 and 18:1c13 were associated with 775 and 7 significant (FDR < 
0.05) epistatic interactions, respectively. The same trend was observed in the PL 
fatty acid fraction, fatty acids 18:1c9 and 18:1c12 having no significant epistatic 
interactions, while 18:1c11 and 18:1c13 had 3,145 and 4 significant (FDR < 0.05) 
epistatic interactions respectively. This was also seen within the 18:1-trans fatty 
acids, which had numbers of interactions ranging from zero for 18:1t6t9 and 
18:1t12, up to 2,594 interactions for 18:1t10t11 (FDR < 0.05) for the TAG fatty acid 
fraction. Within the 18:1-trans fatty acid isoforms of PL fatty acid fraction, 18:1t6t9 
was association with zero epistatic interactions, 18:1t15 was significantly 
associated with 266 epistatic interactions (FDR <0.05), while 18:1t10p11 was 
significantly associated (FDR < 0.05) with 1,466 epistatic interactions. 
Variation in the number of associated significant epistatic interactions within 




isoforms. Understanding exactly what controls exist within these genomic regions, 
however, would require a larger population of animals and is therefore not within 
the bounds of this study.  This same range of significant interaction numbers can be 
seen in the saturated fatty acids. In the TAG fatty acid fraction, the number of 
significant interactions (FDR < 0.05) ranged from zero (eg. 16:0) up to 835 (14:0), 
with a range of interactions in-between for the other fatty acid traits. In the PL fatty 
acid fraction, the number of significant interactions (FDR < 0.05) ranged from zero 
(eg. 16:0) to 406 (18:1c11).  
In the TAG fatty acid fraction, nineteen of the thirty-seven traits examined 
had no significant interactions detected (FDR < 0.05, 100-animals per genotype). 
Polyunsaturated fatty acid (PUFA) was the only fatty acid category (Saturated: SFA; 
Monounsaturated: MUFA; Polyunsaturated: PUFA; Ratio/calculation) which did not 
contain any fatty acid traits with greater than 100 significant interactions after 
application of the FDR (<0.05) and the 100-animal filter, while the other three 
categories (SFA, MUFA, Ratio/Calculation) all contained multiple traits with over 
100 significant interactions after application of the 100 animal filter. Fatty acid 
18:1t10t11 was the sole fatty acid which still had over 1,000 significant interactions 
after the most conservative filter was applied, with a total of 1,925 significant 
interactions (FDR < 0.05).  For the PL fatty acid fraction, twenty-one of the thirty-six 
fatty acid traits had zero significant interactions (FDR < 0.05, 100-animals per 
genotype), and just like the TAG fatty acid fraction, PUFA was the only category that 
did not have any traits with over 100 significant interactions. The fatty acid trait 




both FDR < 0.05 and the 100-animals per genotype filter. Differences in the number 
of identified significant interactions for each fatty acid trait may be related to the 
biological role of the fatty acid. Those fatty acids essential to tissues or biological 
processes may have more epistatic interactions (similar to the concept of genetic 
redundancy) to ensure their functionality. Fatty acids with less important biological 
roles or more commonly available through the environment may be under less or no 
genetic control under normal conditions. The presence of few significant PUFA 
interactions compared to MUFA interactions is an example of the importance of 
specific fatty acids. Oleic acid (18:1) is one of the most common MUFA found in 
animals, and is a building block for the production of linoleic acid (18:2). For this 
reason the production of oleic acid may be more important to maintain due to its 
use in the production of more complex fatty acids. 
Due to the detection of many significant epistatic interactions, other 
phenotypic weight traits also collected on these cattle were analyzed utilizing the 
same methodology to determine if the observed modes of inheritance were unique 
to fatty acid traits. The body traits used were hot carcass weight, yearling weight, 
and weaning weight. An FDR filter of < 0.05 and a minimum of 50-animals per 
genotype combination was used to determine and identify significant SNP 
interactions. For each of the weight traits, fewer than five significant interactions 
were observed (WW – 1, YW – 3, HCW - 0)[Table 5]. The small number of 
interactions identified may be due to selection on these traits, as this would work on 
additive genetic variance and break down epistatic genetic variance[10]. Strong 




explanation for the variability in number of identified interactions, but this is 
beyond the scope of the current research. 
 It became apparent a few regions of the genome were potential regions of 
regulatory control while visualizing the genomic regions of significant inter-
chromosomal interactions. These include regions like the beginning of 
chromosomes 1, 18, 20, 21, 24, 28, the middles of chromosomes 3, 8, 10, and the end 
of chromosomes 2, 4, 14, 17, 21, 28, 29. These locations tended to contain a large 
number of the identified epistatic interactions within relatively small regions on 
their respective chromosome. These regions tend to be maintained across TAG and 
PL fractions of fatty acids, although there are some inconsistencies (fatty acid 12:0 
regions in TAG fraction versus relatively low activity in the PL fraction). A total of 
206 regions were evaluated with Generic Gene Ontology Term Finder, and terms 
with an FDR < 0.05 were investigated for relevance to fatty acids. A total of 118 
Genes were found associated with the 206 regions. 11 genes were found associated 
with GO terms related to lipid metabolism. GO terms found included: Lipid 
metabolic process, very long-chain fatty acid metabolic process, unsaturated fatty 
acid metabolic process, and membrane lipid biosynthetic process. Of the 11 genes 
associated with the GO terms, three (ALOX5, PIK3IP1, and PLA2G2F) were found 
within the regions analyzed, and also associated with regulatory processes. The 
relatively small number of genes identified may be due to the presence of LD in the 
regions, 
 The effect size of detected significant epistatic interactions were compared 




the largest 1 Mb windows had effects reported by Saatchi et al. for fatty acid trait 
14:0 which were compared to the effect sizes of significant TAG epistatic results 
(Figure 4) for the same trait. Absolute effect values for epistatic interactions were 
plotted against the three largest windows by effect size identified in the 
aforementioned publication given a minor/major allele frequency of 0.4/0.6 (to 
allow for conservative estimations of effect size). The location of these single 
window markers relative to SNP interaction effect sizes in figure 4 indicated that 
few if any of the epistatic interactions were of comparable effect size to those 
explained by the additive effects of SNP windows. When calculating the amount of 
genetic variance accounted for by the epistatic interactions with GenSel [11], it was 
determined that the total variance accounted for was already accounted for by 
single SNP variance. Each epistatic window included in the BayesC analysis resulted 
in 0.00% additional genetic variation accounted for with low posterior probabilities 
of inclusion. The lack of any epistatic interactions being included in the model is 
likely due to variation from epistasis being accounted for in the single SNP models. 
Based on this result it would appear that epistatic interactions do not contribute 
much to additional genomic variation for fatty acid traits. A potential reason for this 
could be the fact that most of the epistatic interactions can be explained as linear 
combinations of SNPs, and so are already taken into account in methods such as 
used by Saatchi et al [6] that simultaneously fit the effects of many loci. Research has 
found that although epistatic interactions can be identified for various traits in beef 
cattle, they are usually non-informative due to difficulty in accurately estimating 




 Validation by sampling a random proportion of the total population studied 
and retesting for significant interactions yielded results similar to what was 
expected based on other studies. As illustrated in Figure 5, there was a rapid 
decrease in total number of significant interactions identified as the population size 
decreases. The number of significantly identifiable interactions had dropped nearly 
five-fold when 90% of the original population was used. Unique significant epistatic 
interactions were not conserved as the proportion of individuals changed, indicating 
a lack of power to identify true significant interactions. This remained true even 
after repeating the 50% proportion 5 times in a row. The significant interactions at 
the 100-animal filter did not reappear when the subset of individuals was re-
randomized. The sharp increase in number of interactions as we approached the 
total number of animals used in this study indicated that the population size must 
be greater than that currently available in order to effectively validate any results 
through cross validation approaches. There is no way to know the inflection point at 
which additional animals yield less new information based solely on the current 
results [12, 13]. An increase in the number of animals would be required to 
appropriately carry out a training-validation study, due to the number of animals 




 Many epistatic interactions were identified in two fractions of fatty acid 




within each of these fractions. Interactions were significant if they met two filter 
requirements: a false discovery rate of <0.05, and an animal filter of at least 50-
animals per genotype combination. An additional filter was applied at 100 animals 
per genotype combination. A total of 6,181 interactions were identified as 
significant for the TAG fraction, and 7,168 interactions significant for the PL fraction 
at a 50-animal per genotypic combination filter. At the 100-animal filter there were 
still 4,211 and 4,401 significant interactions for the TAG and PL fractions 
respectively. The number of significant interactions per fatty acid trait varied 
greatly. This may indicate that some fatty acid traits may need varying amounts of 
genetic redundancy or control for the creation of fatty acids critical to fitness. 
Visualization of significant epistatic interactions revealed many regions of potential 
regulatory control across multiple chromosomes within both the TAG and PL 
fractions. These regions did not match previously identified windows that 
accounted for high-genomic variation [6], but they did map to regions that 
contained relevant genes for fatty acid metabolism. In particular, three genes 
associated with lipid metabolism GO terms (ALOX5, PLA2G2F and PIK3IP1) were 
found to exist in regions with large numbers of epistatic interactions. This likely 
indicates that many interactions involved in a single region may be picking up a 
single effect, with the SNPs of the region being in LD with the causal mutation(s). 
Other regions may be mapping to QTL in LD with lipid metabolic controlling genes 
throughout the genome. 
 Although large numbers of interactions were identified, validation of these 




to perform a training-validation test proved futile as even when dropping the 
number of animals by 10%, there appeared a steep decline in the number of 
identifiable interactions. Accordingly, unique epistatic interactions were not 
conserved during validation between proportions of the population. Despite this, 
the presence of so many interactions at even a filter of 100-animals per genotype 
combination indicates that some of the identified interactions may be real. 
Nevertheless, our access to this large population of animals provided the unique 
opportunity to set a higher bar for requirements when analyzing epistatic 
interactions than have been used in the past. Comparison of epistatic interaction 
effect levels compared to SNP windows with previously identified QTL effects helps 
validate the possibility that the epistatic effects identified in this study may be real, 
indicating that some have nearly as large an effect as the additive QTL effects of the 
SNP windows themselves. This research has shown that while limitations still exist 
with identifying epistatic interactions, there are ways to help minimize these 
shortcomings as well as further identifying what needs to be accomplished to 
overcome the deficiencies. 
 
Materials and Methods 
Population: A subset (1,721 head for TAG fatty acid, 1,442 for PL fatty acid, 2,342 






Phenotypic Data: The triacylglyceride (TAG) and phospholipid (PL) fraction of the 
longissimus dorsi was analyzed for fatty acid content. Fatty acid data was collected 
and characterized as described in Saatchi et al [2]. Briefly, total lipid quantities were 
extracted from 1.27-cm steaks using a chloroform and methanol mixture. The TAG 
and PL fractions were separated via thin-layer chromatography, and individual lipid 
spots were characterized via gas chromatography.  The PL portion was calculated by 
measuring total phosphorus amount from the total lipid portion [15]. The index of 
atherogenicity was calculated as a ratio of C14:0 and C16:0 fatty acids over the sum 
of both MUFA and PUFA [16]. 
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Genotype Data: The BovineSNP50 BeadChip (Illumina, San Diego, CA) was used to 
perform SNP genotyping at GeneSeek (Lincoln, NE). SNPs were curated at a call rate 
of 0.95. SNP genotypes were split into individual chromosome files, which were 
reformatted with in-house R and shell scripts to calculate minor allele frequencies 
(MAF) for each SNP in order to allow for proper usage with EpiSNPmpi. All SNPs 
with MAF less than or equal to 0.1 were removed from the study due to lack of 
power to detect plausible epistatic interactions, resulting in a total of 45,219 SNPs. 
All SNP markers were assigned a UMD3.1 bovine genome build position.  
 
Analysis of pairwise SNP epistatic interactions:  EpiSNPmpi was used to 




Covariate of carcass contemporary group and lab sampling contemporary group, as 
well as pedigree and sex data were used in the model. Individuals with unknown 
sires were assigned a dummy Sire ID unique to them. EpiSNPmpi took each SNP 
locus in the genotype file, and compared it to every other SNP with a statistical test 
for four pairwise epistatic effects: additive-by-additive (AA), additive-by-dominance 
or dominance-by-additive (AD), and dominance-by-dominance (DD). For each fatty 
acid trait, the top 10,000 pairwise SNP interactions based on significance were 
obtained. Interactions (AA, AD, and DD) between two SNP on the same chromosome 
were not considered to limit the chance that detected interactions were markers for 
a haplotype effect containing a single QTL. The remaining SNP interactions were 
further filtered such that only those with at least 5 animals in every genotype 
combination were considered. Thus, any interaction that consisted of even a single 
genotype combination containing less than 50 observations in 1,721 total (2.9E-02) 
for TAG and 50 in 1,442 total (3.46E-02) for PL was removed from consideration.  
An even more stringent 100 animal per genotype filter was also applied to attempt 
to remove spurious epistatic associations (Table 3). Filters based on 5, 10, and 20 
animals per genotype combination are included in supplemental files. 
 
Multiple testing correction: A false discovery rate (FDR) correction (<0.05) was 
applied to each trait to correct for multiple testing. Briefly, interactions were sorted 
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Only interactions that fell within FDR <0.05 were reported. 
 
Window Analysis: A BayesC model was used in GenSel to fit SNP and epistatic 
effects [19]. To calculate the amount of genetic variance that could be accounted for 
by epistatic interactions, markers were created to represent the possible genotype 
combinations for a given interaction. Gensel [11] was run with each window 
representing an entire epistatic interaction (1 window = total effect of a single 
epistatic interaction). Each window was repurposed as a single marker and added to 
the map file with a dummy megabase region. GenSel was then run to compare single 
SNP effects to the addition of interaction SNP effects. Total genetic variation 
accounted for was compared between two models (SNPs + window markers vs 
single SNP model [6]) and used to determine how much additional variation could 
be accounted for through the addition of epistatic interactions. 
 
Validation: Animals were randomly sampled to obtain different proportions of the 
total animal population, and then all SNPS were retested with EpiSNPmpi with an 
FDR (<0.05) and 50 animals per genotype combination filter (Figure 5). The number 
of identified interactions was plotted against proportion of animals used to identify 
the number of significantly identified epistatic interactions within each given 




proportion to determine conserved interactions. Individuals used in the 50% 
proportion were randomly divided into two groups, with half of the remaining 
individuals added to each of the two groups as well. This resulted in two groups of 
50% the total animals used. This process was repeated five times to see if the same 
interactions at a 100 animal filter would reappear in the repeated process 
 
Gene Enrichment Analysis and GO Term identification: Regions of potential 
epistatic regulation were determined by requiring 10 or more interactions to lie 
within a single megabase region. Locations and windows were determined from the 
UMD3.1 Bos taurus genome build to obtain the chromosome positions [20]. The 
resulting chromosome positions were combined and a chromosomal window was 
examined to either side of these SNP locations. Regions were defined as half a 
megabase upstream and downstream from the central location of the SNPs 
identified. Regions were put in ENSEMBL Biomart, and the associated Gene Name 
was obtained for all genes present in the regions. These genes were then run 
through the Generic Gene Ontology Term Finder [21], and GO terms were obtained 
by requiring an FDR < 0.05. Terms associated with fatty acid metabolic processes 
were used to identify genes associated with fatty acid epistasis. 
 
Availability of supporting data: 





PLFAinteractions.xlsx - All PL FA interactions at a minimum of 5 animals per 
genotype combination 
CarcassInteractions.xlsx – All Carcass interactions at a minimum of 5 animals per 
genotype combination 
Circos Plots in FileName.png form– TAG or PL start of name signifies fraction. 
Individual fatty acid traits are second portion of name. All plots are at 50-animals 
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1IA: Index of Atherogenicity 
Mean, Standard Deviation (SD), Coefficient of variation (CV) calculated for all 1,721 and 1,442 head of 
cattle used to identify significant epistatic interactions in triacylglyceride and phospholipids fatty 





(N=1721) SD CV Trait
Mean 
(N=1442) SD CV
Saturated Fatty Acids Saturated Fatty Acids
SFA 45.8 2.5 0.05 SFA 38.44 5.26 0.14
12:0 0.13 0.19 1.46 12:0 1.4 1.8 1.28
14:0 3.08 0.51 0.16 14:0 3.33 4.55 1.37
16:0 27.35 1.75 0.06 16:0 20.2 3.49 0.17
17:0 1.42 0.39 0.28 17:0 1.75 2.6 1.48
18:0 13.23 1.9 0.14 18:0 9.88 2.51 0.25
22:0 0.02 0.06 2.73 22:0 0.85 1.07 1.26
23:0 0.01 0.06 3.84 23:0 0.17 0.43 2.47
24:0 0.03 0.08 2.83 24:0 0.45 0.66 1.45
Monounsaturated Fatty Acids Monounsaturated Fatty Acids
MUFA 51.57 2.56 0.05 MUFA 24.07 7.7 0.32
14:1 0.7 0.21 0.3 14:1 0.22 0.54 2.43
16:1 3.82 0.61 0.16 16:1 0.72 0.83 1.15
17:1 1.01 0.33 0.32 17:1 1.21 1.02 0.84
18:1 cis-9 40.26 2.86 0.07 18:1 cis-9 19.31 6.71 0.35
18:1 cis-11 0.11 0.1 0.92 18:1 cis-11 0.08 0.3 3.91
18:1 cis-12 0.3 0.16 0.52 18:1 cis-12 0.04 0.35 9.22
18:1 cis-13 0.11 0.12 1.17 18:1 cis-13 0.09 0.51 5.97
18:1, trans-6/9 0.19 0.45 2.4 18:1, trans-6/9 0.04 0.33 8.29
18:1, trans-10/11 3.69 1.57 0.43 18:1, trans-10/11 0.59 1.18 2.01
18:1, trans-12 0.18 1.15 6.21 18:1, trans-12 0.03 0.19 6.48
18:1, trans-15 1.15 0.36 0.31 18:1, trans-15 1.51 1.68 1.11
Polyunsaturated Fatty Acids Polyunsaturated Fatty Acids
PUFA 2.63 0.89 0.34 PUFA 37.49 8.72 0.23
18:2 2.01 0.52 0.26 18:2 25.67 6.72 0.26
18:3, n-3 0.16 0.16 0.99 18:3, n-3 0.12 0.71 5.85
20:2 0.08 0.11 1.4 20:2 0.05 0.27 5.32
20:4 0.02 0.08 3.55 20:4 8.4 2.73 0.32
20:5 0.1 0.16 1.68 20:5 0.37 0.56 1.51
22:6 0.06 0.26 4.65 22:6 0.19 0.79 4.14
CLA cis-9 trans-11 0.04 0.09 2.08 CLA cis-9 trans-11 0.06 0.6 10.08
CLA trans-10 cis-12 0.12 0.12 1.03 CLA trans-10 cis-12 0.04 0.29 6.87
n-3 0.33 0.4 1.22 n-3 2.31 2.09 0.91
n-6 2.3 0.63 0.28 n-6 35.18 8.31 0.24
Ratio/Calculation Ratio/Calculation
n-6:n-3 0.14 0.15 1.05 n-6:n-3 0.07 0.07 1.07
PUFASFA 0.06 0.02 0.36 PUFASFA 1.01 0.31 0.31
MCFA 4.42 0.8 0.18 MCFA 5.21 4.01 0.77
LCFA 95.58 0.8 0.01 LCFA 94.79 4.01 0.04











Mean, Standard Deviation (SD), Coefficient of variation (CV) calculated for 2,324 head of cattle used 








































(N=2342) SD CV 
Hot Carcass Weight 733 72 0.098
Yearling Weight 951.49 182.06 0.19





Table 3: Number of significant interactions at 50 and 100 animals per genotype 




1IA: Index of Atherogenicity 
Number of significant identified epistatic interactions are displayed from left to right as filtered by 
FDR < 0.05, 50-animals per genotype combination with FDR < 0.05, and 100-animals per genotype 
combination with FDR < 0.05 for each fatty acid trait analyzed in both the Triacylclyceride and 
Phospholipid fatty acid fraction. This sum of the total significant interactions at each of these filters is 
then provided at the bottom of the table. 










Saturated Fatty Acids Saturated Fatty Acids
SFA 3671 249 179 SFA 2595 148 117
12:0 9559 6 5 12:0 1227 39 14
14:0 1017 835 511 14:0 7 7 5
16:0 9559 0 0 16:0 9563 0 0
17:0 164 160 128 17:0 426 406 296
18:0 9449 226 156 18:0 9435 156 94
22:0 9451 1 0 22:0 9458 3 0
23:0 2472 1 0 23:0 9483 1 0
24:0 9569 0 0 24:0 9561 0 0
Monounsaturated Fatty Acids Monounsaturated Fatty Acids
MUFA 1 1 1 MUFA 0 0 0
14:1 3 3 0 14:1 9512 0 0
16:1 9440 229 161 16:1 9511 43 27
17:1 265 261 215 17:1 326 315 241
18:1 cis-9 9528 0 0 18:1 cis-9 9567 0 0
18:1 cis-11 922 775 451 18:1 cis-11 3959 3145 1861
18:1 cis-12 1 0 0 18:1 cis-12 0 0 0
18:1 cis-13 9536 7 0 18:1 cis-13 9577 4 0
18:1, trans-6/9 2619 0 0 18:1, trans-6/9 9637 0 0
18:1, trans-10/11 2918 2594 1925 18:1, trans-10/11 1924 1466 933
18:1, trans-12 0 0 0 18:1, trans-12 - - -
18:1, trans-15 54 36 26 18:1, trans-15 301 266 180
Polyunsaturated Fatty Acids Polyunsaturated Fatty Acids
PUFA 9574 0 0 PUFA 9586 0 0
18:2 1 0 0 18:2 1 0 0
18:3, n-3 9723 0 0 18:3, n-3 9622 0 0
20:2 9442 2 2 20:2 9459 0 0
20:4 9455 0 0 20:4 9489 0 0
20:5 9625 0 0 20:5 9634 0 0
22:6 9499 0 0 22:6 9546 1 0
CLA cis-9 trans-11 9559 0 0 CLA cis-9 trans-11 9536 0 0
CLA trans-10 cis-12 53 17 13 CLA trans-10 cis-12 2853 90 52
n-3 9555 0 0 n-3 9588 0 0
n-6 9433 94 58 n-6 9431 155 91
Ratio/Calculation Ratio/Calculation
n-6:n-3 9556 2 2 n-6:n-3 9601 2 2
PUFASFA 9575 0 0 PUFASFA 9585 0 0
MCFA 8793 337 189 MCFA 8628 461 244
LCFA 8771 341 188 LCFA 8596 460 244
IA 1 12 4 1 IA1 3 0 0









1IA: Index of Atherogenicity 
Number of Additive-by-Additive (AA), Additive-by-Dominance and Dominance-by-Additive (AD), 
Dominance-by-Dominance (DD) significant epistatic interactions by type for Triacylclyceride and 
Phospholipid fatty acid traits by trait category (Saturated Fatty Acid [SFA], Monounsaturated Fatty 
Acid [MUFA], Polyunsaturated Fatty Acid [PUFA], Ratio/Calculation). All interactions are post FDR 
<5% correction.  
Total Phospholipid Fatty Acids Total
Trait AA AD DD Interactions Trait AA AD DD Interactions
Saturated Fatty Acids Saturated Fatty Acids
SFA 226 23 0 249 SFA 131 16 1 148
12:0 6 0 0 6 12:0 34 5 0 39
14:0 817 16 2 835 14:0 7 0 0 7
16:0 0 0 0 0 16:0 0 0 0 0
17:0 158 2 0 160 17:0 399 7 0 406
18:0 223 3 0 226 18:0 155 1 0 156
22:0 0 1 0 1 22:0 2 1 0 3
23:0 0 1 0 1 23:0 0 1 0 1
24:0 0 0 0 0 24:0 0 0 0 0
Monounsaturated Fatty Acids Monounsaturated Fatty Acids
MUFA 1 0 0 1 MUFA 0 0 0 0
14:1 3 0 0 3 14:1 0 0 0 0
16:1 224 5 0 229 16:1 43 0 0 43
17:1 260 1 0 261 17:1 313 2 0 315
18:1 cis-9 0 0 0 0 18:1 cis-9 0 0 0 0
18:1 cis-11 769 6 0 775 18:1 cis-11 3110 35 0 3145
18:1 cis-12 0 0 0 0 18:1 cis-12 0 0 0 0
18:1 cis-13 7 0 0 7 18:1 cis-13 4 0 0 4
18:1, trans-6/9 0 0 0 0 18:1, trans-6/9 0 0 0 0
18:1, trans-10/11 2569 23 2 2594 18:1, trans-10/11 1449 17 0 1466
18:1, trans-12 0 0 0 0 18:1, trans-12 - - - -
18:1, trans-15 36 0 0 36 18:1, trans-15 265 1 0 266
Polyunsaturated Fatty Acids Polyunsaturated Fatty Acids
PUFA 0 0 0 0 PUFA 0 0 0 0
18:2 0 0 0 0 18:2 0 0 0 0
18:3, n-3 0 0 0 0 18:3, n-3 0 0 0 0
20:2 2 0 0 2 20:2 0 0 0 0
20:4 0 0 0 0 20:4 0 0 0 0
20:5 0 0 0 0 20:5 0 0 0 0
22:6 0 0 0 0 22:6 1 0 0 1
CLA cis-9 trans-11 0 0 0 0 CLA cis-9 trans-11 0 0 0 0
CLA trans-10 cis-12 15 2 0 17 CLA trans-10 cis-12 73 17 0 90
n-3 0 0 0 0 n-3 0 0 0 0
n-6 92 2 0 94 n-6 150 5 0 155
Ratio/Calculation Ratio/Calculation
n-6:n-3 2 0 0 2 n-6:n-3 2 0 0 2
PUFASFA 0 0 0 0 PUFASFA 0 0 0 0
MCFA 336 1 0 337 MCFA 460 1 0 461
LCFA 340 1 0 341 LCFA 459 1 0 460
IA1 4 0 0 4 IA1 0 0 0 0











Number of Additive-by-Additive (AA), Additive-by-Dominance and Dominance-by-Additive (AD), 
Dominance-by-Dominance (DD) significant epistatic interactions by type for Weight traits Weaning 
Weight (WW), Yearling Weight (YW), and Hot Carcass Weight (HCW). All interactions are post FDR 
<5% correction.  




WW 1 0 0 1
YW 2 1 0 3
HCW 0 0 0 0






Figure 1: Number of Animals in Lowest Genotype Combination by Interaction Count 
in TAG Fatty Acids. Histograms of number of animals found in the smallest genotype 
combination for each TAG interaction against the frequency of their occurrence. All 
sections left of a given animal cut off represent the number of interactions that 






















Figure 2: Number of Animals in Lowest Genotype Combination by Interaction Count 
in PL Fatty Acids. Histograms of number of animals found in the smallest genotype 
combination for each PL interaction against the frequency of their occurrence. All 
sections left of a given animal cut off representing the number of interactions that 























Figure 3: Epistatic interactions plotted for PL fatty acid 16:1 at 50-animals per genotype. 265 total 
interactions plotted. Black lines: Additive x Additive interactions. Red lines: Additive x Dominance 
interactions. Blue lines: Dominance x Dominance interactions. Chromosomes ordered around outside 
with distance ticks every 12.5 MB. Black marks represent previously discovered 1MB regions 















Figure 4: Epistatic effect size frequency compared to individual SNP window effects. The frequency 
of epistatic genotype combination substitution effects by effect size is plotted for Epistatic 
interactions in TAG Fatty Acid 14:0. They are compared to the three largest individual SNP window 
effects for Fatty Acid 14:0 with a minor/major allele frequency 0.4/0.6 represented with vertical 
lines red (Chr:Mb start – 19:51), green (Chr:Mb start – 29:18), and blue (Chr:Mb – 10:19) identified in 






Figure 5: Number of Significant Epistatic Interactions identified with a random proportion of total 
animals. The proportion of animals out of the total number of animals was randomized each time, 
and was done at 50%, 60%, 70%, 80%, 90%, 91-100%. This analysis was performed using the TAG 
18:1c11 fatty acid trait. Filters used: FDR (<0.05), 5 animals per genotype combination; points 
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In previous work by our group, regions of both single marker effects and epistatic 
interactions were identified as associated with various fatty acid measurements 
taken from Angus sired cattle. With access to whole genome sequence, it became 
possible to further investigate regions previously reported to identify potential 
causative variants, and better understand the extent of epistasis. Two regions that 
harbor Fatty acid synthase gene (FASN) and Thyroid hormone responsive gene 
(THRSP) were imputed to whole genome sequence using FImpute, and then 
analyzed for epistatic interactions with epiSNPmpi. These two regions were chosen 
based on their importance to fatty acids and presence in both single marker and 




acid content were all located in intergenic or intronic regions, yet none were located 
within the initial candidate genes FASN or THRSP. SNP by SNP interactions were 
filtered on a minimum of 50 individuals per genotype combination across 22 traits 
from two categories: 11 total weight percentage (WP) and 11 Triacylglyceride 
(TAG). A total of 10 significant epistatic interactions were identified, all within the 
TAG traits. All interactions were dominant x additive in type, and were found only 
within four of the TAG fatty acid traits. Eight of these interactions were within the 
same location on chromosome 19, and were all within two kilo-bases on 
chromosome 29. This set of interactions common between fatty acid traits medium 
chain fatty acids (MCFA) and long chain fatty acids (LCFA), may indicate that the 
true interaction between the previously identified regions may actually be between 
previously unsuspecting genes CHMP6 and TENM4. 
 




Fatty acids have been shown to have biological effects, e.g. anchoring proteins to the 
cell membrane (citation) or activating transcription factor (citation), as well as, 
impact meat quality and flavor (citation). As such, it would be beneficial for the beef 
industry to understand the genetic variation in fatty acid content such that selection 




 Previous investigation into fatty acid epistasis looked at interactions across 
the whole genome to identify regions of the genome that interacted with on another 
(Kramer et al. 2016). With the availability of whole genome sequence, the 
opportunity to delve deeper into these regions of genetic association becomes an 
attractive option. By looking into regions already known to be associated with fatty 
acid traits, it becomes possible to potentially identify causal variation. Previous 
work done with this set of phenotypes identified two regions on two different 
chromosomes of the UMD3.1 build of bos taurus. Chromosome 19, mega-base 51, 
harbors the fatty acid synthase gene (FASN) known to take part in the synthesis of 
fatty acid chains (Zhang et al. 2008), while chromosome 29, mega-base 18, harbors 
the Thyroid hormone responsive gene (THRSP) which has been associated with 
fatty acid composition (La et al. 2013). This study aims to identify epistatic 
interactions present in these previously identified regions to more finely determine 
the associated regions with fatty acid epistasis. This study evaluated 11 fatty acid 
traits (12:0, 14:0, 16:0, 18:0, 20:0, 22:0, monounsaturated fatty acids [MUFA], 
polyunsaturated fatty acids [PUFA], saturated fatty acids [SFA], medium chain fatty 
acids [MCFA], long chain fatty acids [LCFA]) across two fatty acid categories, whole 
fat percentage (WP) and triacylglyceride fatty acid (TAG), in order to identify 
potentially causal variants within these two well known fatty acid associated 







Materials and Methods 
Population 
Individuals in this study come from an ISU/industry Angus population as previously 
noted by Garmyn et al. (2011). Two subsets of this population were chosen based on 
phenotypic data availability: 1818 individuals for Triacylglyceride (TAG) fatty acids, 
and 2162 individuals for total weight percentage (WP). All animals fall under IACUC 
protocols as described in Saatchi et al. (2013) 
 
Genotype and phenotypic Data 
Whole genome sequence was obtained by imputing individuals with 770k 
genotypes using 255 Angus bulls from the 1000 bulls genome project (run 4) and 
from within the ISU herd (Daetwyler et al. 2014). Imputation was performed with 
FImpute (Sargolzaei et al. 2014). The WGS utilized was in 3Mb windows that 
surrounded FASN and THRSP genes (Chr19:51Mb, Chr29:18Mb). Markers were 
removed if their minor allele frequency was below 0.1. Collection, processing, and 
recording of phenotype data are described in Saatchi et al. (2013). 
 
Analysis of single marker and pairwise SNP epistatic interactions 
The program epiSNPmpi was used to test for epistatic interactions between the 
aforementioned two 3Mb windows as described in Ma el al. (2008). Optimization of 
epiSNPmpi is described in Weeks et al. (2016). 10,000 pairwise SNP interactions 
were obtained for each fatty acid trait. Intra-chromosomal interactions were 




interactions required 50 individuals to exhibit each genotype combination to 
consider it as real. This required a proportion of animals per genotype of 2.75E-02 
for TAG fatty acids, and 2.31E-02 for WP. Additionally, epiSNPmpi provides the top 
1000 single marker effects per trait, which were filtered on a bonferroni correction 
of 4.7E-7. 
To correct for multiple testing, a FDR correction (<0.05) was applied by 
ranking interactions on nominal p-values, and then calculated corrected p-values 
by: 
 
A! B CDEBFG# !H I!IB JBJFBI! K
LB  !H IMG  IGNBJI! 
                          (1) 
 
Results and Discussion 
10 significant epistatic interactions were identified after filtering for a 
corrected FDR (<0.05) and 50 individuals per genotype combination. All 10 of the 
significant interactions were additive x dominant in type and only in TAG fatty acid 
traits. No significant epistatic interactions were found within the WP fatty acid traits 
(Table 1).  
Of these significant interactions, the four within TAG LCFA were identical to 
those in MCFA (Table 2). The variant on chromosome 19 that was associated with 
LCFA and MCFA is located within the first intron of gene CHMP6. The variants on 
chromosome 29, which were with 1.3 kilo-bases of each other, are located within 
the TENM4 gene. While these genes are not directly related to fatty acids, TENM4 




other tissues with bos taurus (epidb.animalgenome.org). CHMP6 is a core 
component of the ESCRT-III transport system, and TENM4 itself is a transmembrane 
protein, indicating the two may interact within the cellular system.  
 
The top 1000 single marker effects had their –log10 p-values plotted across 
the three megabase region. Interestingly, those markers that were significant after a 
bonferroni correction did not appear to be near either FASN on chromosome 19 
(figure 1), or THRSP on chromosome 29 (figure 2). This may indicate that the causal 
variants may not be associated with either FASN or THRSP. 
 
Conclusion 
The interactions detected by epiSNPmpi indicate that epistatic interactions 
exist between chromosome 19 and 29. Initially suspected to be between FASN and 
THRSP, this interaction may potentially be between CHMP6 and TENM4. These two 
genes may be interacting based on current annotation, and the increased expression 
level of TENM4 in adipose and subcutaneous may indicate a connection between 
these regions and fatty acid traits. Although whole genome sequence allows for finer 
precision on the location of epistatic interactions, findings still must be tempered, as 
the actual presence of an interaction between the CHMP6 and TENM4 cannot be 
proven beyond the existence of statistical epistatic interactions. Investigation into 
single marker effects also may indicate that other genes than FASN and THRSP are 
being associated with fatty acid traits in TAG and WP categories. Further analysis 




regions of the bos taurus genome and lead to better understanding on which genes 
are potentially interacting. 
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Table 1. Number of significantly identified epistatic interactions by fatty acid 




1LCFA: Long chain fatty acids 
2MCFA: Medium chain fatty acids 
3SFA: Saturated fatty acids 
 
 














Figure 1: 339 single marker effects within the megabase 50 to 53 region of 
chromosome 19 for TAG 16:0, with a –log10(P) cutoff of 6.327. FASN gene location 
shown relative to single marker effects. 
 
 









Figure 2: 661 single marker effects within the megabase 17 to 20 region of 
chromosome 29 for TAG 16:0, with a –log10(P) cutoff of 6.327. THRSP gene location 
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Background: Genomic analysis tends to focus on additive genetic variation over 
non-additive, often due to its use and more simplistic mode of determination. 
Conversely, non-additive genetic variation is typically not studied due to the 
difficulty to accurately detect and explain. Epistasis is an important yet complex 
portion of genetic variation that, if studied, can account for additional genetic 
variation usually left unexplained. Epistatic interactions can be detected both within 
and between chromosomes, but identified interactions within a single chromosome 
may be haplotype effects if care is not taken. In this study, we show how marker 
density impacts the ability to detect intrachromosomal interactions and how large 
numbers of individuals are needed to appropriately detect significant two-way 
epistatic interactions.  
Results: The program epiSNPmpi was used to identify significant SNP-by-SNP 
epistatic interactions for 24 antibody titer and response to vaccination traits, as well 
as 73 fatty acid traits. Interactions were considered significantly associated if they 
met a false discover rate (FDR) of 5% and a minimum of 50 individuals were 
represented in each genotype combination. Haplotype block identification using 
PLINK was done to identify a tag SNPs, which were used for epistatic analysis. When 
using SNP densities such as the 770k SNP chip, then selecting tag markers sharply 
reduces the number of markers while at lower densities markers are not reduced 
due to lower density. Only two of the 24 antibody traits had significant epistatic 
interactions (FDR <0.05), for a total of 730 significant interactions prior to tag SNP 




intrachromosomal interactions were identified for TAG fatty acid traits and 25,146 
intrachromosomal interactions were identified for PL fatty acid traits. The use of 
WGCNA allowed for the detection of epistatic networks, which indicates the 
presence of interactions beyond two loci epistasis in addition to the potential 
complexity that epistasis is involved in. 
Conclusions: In order to identify epistasis within the same chromosome, tag 
markers were selected to represent haplotype blocks and then used for analysis. A 
reduction in the number of markers usable at higher density chips appears to result 
in every previously identified regions of interaction failing to be detected, 
potentially due to an inability to represent each haplotype within a block. It may be 
possible to use haplotype blocks to perform epistatic analysis, but only if blocks 
were small enough to ensure enough density to represent each haplotype. Using tag 
SNPs appears to not retain previously identified interactions or identify new 
intrachromosomal interactions from high-density chips. A lower density chip such 
as used with the fatty acid traits does not need filtering for tag SNPs so 
intrachromosomal detection becomes viable. WGCNA provides a way of identifying 
networks of epistatic interaction that can provide insight into how epistasis is 
structured for traits. Larger population sizes, along with improved methodology for 
identification of tag markers across a genome will likely lead to a potential increase 
in detected epistatic interaction. 
 
Key Words: beef cattle, bovine respiratory disease complex, epistatic interactions, 





Studies with a goal to identify genetic variation often do so to understand 
which regions are associated with variation for a specific trait. This involves the 
identification of either SNPs or quantitative trait loci (QTL) associated with a trait of 
interest. Typically only additive genetic variation is investigated as it tends to be 
both the easiest to detect and utilize, but doing so ignores non-additive genetic 
variation that is also present. This is usually done through a genome wide 
associations study (GWAS) to identify the regions or SNPs that can account for a 
portion of the genetic variation of a trait. If the scope of detection is broadened to 
include non-additive genetic variation, then it may become possible to account for a 
larger portion of the genetic variation in a trait resulting in a more complete 
understanding.  
Epistasis is frequently not utilized due to its smaller effect sizes and difficulty 
to identify. It has a more complex method of inheritance than additive genetic 
variation, as it requires the interaction between two or more SNPs within the 
genome[1]. By studying epistasis, the functional importance of various genes can be 
better understood through their interactions with other already functionally 
annotated genes [2, 3]. Additionally, investigation and characterization of epistasis 
can push the total understanding of a trait forward through improving the total 
quantity of genetic variation accounted for and by potentially linking a trait with 
other biologically relevant features. These mechanisms can be difficult to identify 




create a genetic map of how a trait is controlled and interactions with the systems 
around it. 
Complicating the identification of epistatic interactions is the presence of 
haplotype blocks throughout the genome [4]. Interactions may be identified 
between two markers on the same chromosome, an intrachromosomal interaction, 
yet may be difficult to correctly identify as an epistatic interaction if both markers 
are present within the same haplotype block. This can lead to false positives in 
epistatic identification, and hinder intrachromosomal interaction detection. This 
study looks to examine the possibility of identifying epistatic interactions within 
chromosomes through the use of tag SNPs to represent haplotype blocks. It also 
looks into the effect of marker density on the viability of this approach through data 
from two different studies. 
 
Results 
A total of 730 significant (FDR of < 0.05, and a minimum of 50-animals per genotype 
combination) inter-chromosomal SNP-by-SNP interactions were associated with 
one of the 24 antibody titer and response to vaccination traits (Table 1). An 
additional filter of 100-animals per genotype combination was applied to further 
validate the presence of epistatic interactions. Of the 24 antibody titer and response 
to vaccination traits examined, only three had detectable significant epistatic 
interactions after multiple testing corrections FDR < 0.05, and only two bovine viral 
syncytial virus traits (BRSV; BRSV Initial Titer, BRSV Overall Vaccination Response) 




genotype combination was applied (Figure 1, Figure 2). When tag SNP filter was 
applied to the genome, there was a sharp reduction in the number of markers 
meeting a 0.05 minor allele frequency, from 574,662 to 151,884 total SNPs. After tag 
SNPs identification and epistatic analysis, only one single significant epistatic 
interaction was obtained for the trait BVDV2 initial titer, with no recovery of 
interactions identified with the complete genotype data (Figure 3).  
Within the fatty acid traits, all significant interchromosomal interactions 
were previously reported in Kramer et al. 2016 [5], so the following will only refer 
to intrachromosomal interactions. A total of 29,306 significant intrachromosomal 
SNP-by-SNP interactions were identified for 37 triacylglyceride (TAG) fatty acid 
traits and a total of 25,146 significant intrachromosmal SNP-by-SNP interactions 
were identified for 36 phospholipid (PL) fatty acid traits (Table 2). All interactions 
had a corrected FDR of <0.05, and a minimum of 50-animals per genotype 
combination. Additionally, a filter of 100-animals per genotype combination was 
applied to further validate interactions (Table 2). The inclusion of 
intrachromosomal interactions for fatty acid traits indicated new epistatic 
interactions previous undetected, such as with TAG 16:1 (Figure 4). 
SNP-by-SNP epistatic interactions can be in four inheritance combinations: 
Additive-by-Additive (AA), Additive-by-Dominance or Dominance-by-Additive (AD 
and DA), and Dominance-by-Dominance (DD). All epistatic interactions identified 
for the two BRSV traits were found to be Additive-by-Additive (Table 3). Nearly all 
significant intrachromosomal epistatic interactions identified for fatty acid traits 




Additive-by-Dominance and even less Dominance-by-Dominance interactions 
(Table 4). 
WGCNA was used to obtain clusters of markers with similar nominal P-
values. Traits were analyzed only if the total number of significant inter- and 
intrachromosomal interactions exceeded 500. A total of 14 fatty acid traits were 
analyzed, with seven in both the TAG and PL fatty acid fraction. Markers were 
clustered into groups based on the similarity of p-value with a minimum of five 
interactions per group. Traits had between 56 and 626 total clusters (Table 5; 
Supplemental A). Phospholipid fatty acid 18:1 trans10/11 was unable to recover 
any clusters due to the distribution of the p-values. WGCNA on tag marker filtered 
antibody titer and response to vaccination traits recovered no interactions. Markers 
from obtained clusters were used to identify potential epistatic interactions beyond 
just SNP-by-SNP by plotting all original interactions between markers in a cluster in 
Circos[6], such as with TAG 18:1c11 (Figure 5).  
 
Discussion 
 The purpose of this study was to evaluate a way to identify 
intrachromosomal SNP-by-SNP epistatic interactions and improve overall epistatic 
interaction detection. With most populations being woefully underpowered to 
identify epistatic interactions, extra restrictions were needed to reduce the chance 
of false positives. One such way to avoid the possibility of reported epistatic 
interactions being haplotypes due to proximity of markers on the same marker is to 




filters such as 50/100-animals per genotype combination can help restrict the 
investigation space and improve the ability to detect true interactions. As the 
number of animals per genotype combination increases, a decrease in the number of 
significantly detected markers occurs as found in the previous study[5]. An 
additional filter of 10-animals per genotype combination was also tested to identify 
if low population size was responsible for the lack of detectable epistatic 
interactions in antibody titer and response to vaccination traits. No increase in the 
number of significant interactions was observed with this less stringent filter. While 
using only interchromosomal interactions for analysis allows for the identification 
of epistatic interactions, it ignores the entire class of intrachromosomal interactions 
that may exist in a trait. To identify intrachromosomal interactions, we proposed the 
use of tag SNPs to represent each haplotype block. By reducing the number of 
markers across the genome to only those representing haplotype groups or markers 
in regions without haplotype blocks, it would allow for an analysis of all interactions 
both inter and intrachromosomal [7].  
 Filtering for tag markers representing haplotype blocks saw no reduction 
in the number of markers when utilizing the 50k marker genotype for individuals 
with fatty acid trait phenotypes. This allowed for the direct analysis of all remaining 
interactions from the previous study Kramer et al. 2016 [5] as it could be inferred 
that no interactions would be within one haplotype block. The addition of detected 
intrachromosomal interactions resulted in an increase in the total number of 
significant epistatic interactions, such as with TAG 16:1 fatty acid (Figure 4). Despite 




traits happened to have detectable epistasis. It frequently added a large number of 
additional significant SNP-by-SNP interactions to traits already found to have 
interchromosomal epistasis (such as 17:0, 17:1, 18:1 cis-11, and 18:1 trans-10/11) 
(Table 4), indicating that the presence of interchromosomal epistatic interactions 
does not preclude intrachromosomal interactions. 
 By utilizing tag SNPs, it was again possible to detect intrachromosomal 
interactions instead of detected what was a haplotype block effects instead. Prior to 
tag SNP filtering, two traits for antibody titer and response to vaccination traits had 
identifiably epistatic interactions, BRSV initial titer and BRSV overall vaccination 
response. These two traits contained regions with a high quantity of their respective 
epistatic interactions: chromosomes 9 to 23 for BRSV initial titer (Figure 1) and 
chromosomes 2 to 11 for BRSV overall vaccination response (Figure 2). These two 
interacting regions accounted for 100% and 66% of the total significant interactions 
identified for the two traits respectively. The distribution of interactions for these 
traits indicates a shortcoming of high-density interactions, as many are likely 
picking up the same epistatic interaction due to LD or position within a haplotype 
block. A failure to detect interactions in many of the antibody titer and response to 
vaccination traits may indicate the number of individuals being is too small to 
identify the interactions, or that filters are too strict for the analysis.  
 None of the originally detected 730 interactions were rediscovered with 
the new set of tag markers, with only a single interaction being identified using the 
tag marker filtered genotype. This was not due to a lack of markers within the 




identified significant interactions were also present as tag SNPs. This failure to 
redetect previously identified interchromosomal interactions may be due to the 
number of haplotypes within the blocks now represented by a single SNP. An initial 
analysis with Eagle 2.4.1 identified a large number of haplotypes within each block 
for the 4 highly interacting regions in BRSV initial titer and BRSV overall vaccination 
response. By representing each haplotype block with a single tag SNP, we fail to 
represent the various haplotypes within each block. As such, it may not be possible 
to detect some interactions, as the real interaction may be due to specific haplotype 
interaction combinations across chromosomes. Therefore, with a single tag SNP in 
each haplotype block we could not accurately represent all potential interactions. To 
optimally resolve this concern, shrinking of haplotype blocks to be stricter could 
help to keep the number of haplotypes within a block to a minimum and improve 
haplotype representation within each block. This would increase the number of 
markers to work with, which is a trade off in terms of power to detect due to a large 
number of interactions being calculated. A balance between power to detect and 
representation of haplotypes within blocks would need to be achieved for the best 
results. 
 When working with high-density genomes, epistatic interactions become 
more difficult to detect as the number of calculations needed to be performed 
increases quickly. Furthermore, the proposed usage of tag SNPs appears to lose the 
granularity to detect epistasis. This may also be due to the choosing of the single 
marker with the highest minor allele frequency within a haplotype block. To 




a block may help. This may not be enough given a large enough SNP density, such as 
when working with whole genome sequences. To resolve this, Kramer et al. 2018 [8] 
reduced the region of investigation to limit the number of interactions that needed 
to be calculated. This appeared to resolve issues with detection, but picking 
appropriate regions is not a strongly examined procedure at the moment and could 
result in a loss of detection if chosen poorly. 
 That is not to say that the 50k genotype for fatty acid traits had detectable 
epistasis within every trait. The BovineSNP50 BeadChip (Illumina, San Diego, CA) 
was designed to have markers relatively evenly across the genome to aid in GWAS 
efforts and QTL detection. Markers were chosen somewhat arbitrarily based on this 
goal, and there could be even more epistatic interactions that are not possible to 
detect purely on this bias of SNP choice. This possibility extends to both inter- and 
intrachromosomal interactions, as additional SNP density could allow for the 
opportunity to find additional interactions. 
 In both high and low density parts of this study, nearly all interactions 
detected were Additive-by-Additive, with very few being of the other three SNP-by-
SNP types. This is likely because Additive-by-Additive is the least complex of the 
four types in its interaction structure, and when an animal filter is applied it is least 
affected. To detect Additive-by-Dominance, Dominance-by-Additive, or Dominance-
by-Dominance, the number of individuals in a study would need to increase many 
times before it might be possible to detect larger quantities. 
 With most antibody titer and response to vaccination traits lacking 




stated that some traits may just not have much associated epistasis with them. The 
polyunsaturated fatty acid traits in both TAG and PL fractions are a prime example 
of this, with little to no detectable epistasis in both intrachromosomal (Table 2) and 
interchromosomal [5] forms. This may be due to selection, random chance, or some 
other biological factor that is currently uninvestigated.  
 For those traits with sufficient numbers of detectable epistasis it then leads 
to the idea of epistasis beyond solely SNP-by-SNP interactions. To detect 3-way or 
greater epistasis, the number of individuals needed likely extends far beyond what 
most research has available, so the use of WGCNA to identify networks could solve 
this. By identifying clusters of markers that are highly correlated in their interaction 
significance, it becomes possible to visualize what could be 3+ way epistatic 
interactions. As seen in figure 5, the use of WGCNA to identify networks of epistasis 
potentially indicates epistasis beyond the initial SNP-by-SNP interactions without 
requiring vast additional numbers of genotyped and phenotyped individuals. These 
networks can be found in condensed regions of a single chromosome as well as 
sprawl between multiple chromosomes. Generated networks do come with a risk 




This study aimed to identify and test a method to detect intrachromosomal epistatic 
interactions and improve overall detection ability of epistasis for traits. Utilizing tag 




working with high density genotypes, while for lower densities such as the 50k SNP 
chip tag SNP filtering did not have any effect on the total number of markers. Due to 
tag SNP filtering for the 50k SNP chip not having any impact, it was possible to 
identify an additional 29,306 intrachromosomal interactions for TAG fatty acid 
traits and 25,146 intrachromosomal interactions for PL fatty acid traits. Conversely, 
utilizing tag SNPs resulted in a failure to detect any meaningful number of epistatic 
interactions for the 24 antibody titer and response to vaccination traits. The 
difference between the analyses of these two sets of traits was the reduction in 
marker density in antibody titer and response to vaccination traits compared to the 
density remaining unchanged for fatty acid traits. Utilization of denser marker 
genotypes allows for an increased ability to detect single marker effects through 
GWAS, but appears to make detection of intrachromosomal interactions more 
difficult. This could be resolved by selecting a number of tag markers within a 
haplotype block to represent the number of haplotypes within that block. It may 
also be viable to increase the strictness of haplotype block detection, which in turn 
would increase the density of blocks across the genome. Both solutions have merit, 
however the balance between these two is currently uninvestigated. Additionally, 
the use of network analysis such as WGCNA appears to allow for the identification of 
epistatic networks that infer interactions more complex than SNP-by-SNP 
interactions. This allows for further description of the way epistasis exists in a trait, 
but it is important to note that while WGCNA and the detection of intrachromosomal 
interactions increases the total interactions being discovered, it does not provide 




population size continues to remain a limiting source of power in epistatic analyses. 
Increasing the number of individuals, both genotyped and phenotyped, will improve 
the detection of significant epistatic interactions. This manuscript describes 
potential ways to resolve these issues, and has demonstrated the usefulness of tag 
SNPs for identifying intrachromosomal interactions. 
 
Materials and Methods 
Population: Calves (n = 2,386) from an Iowa State University purebred American 
Angus herd was used for the response to vaccination portion of this study. Not all 
calves had serum samples available for each of the 5 viruses being vaccinated 
against. Individuals were born in either a spring or fall season, and calves used in 
the study were born between 2006-2012, and 2014. Therefore, not all traits are of 
equal sample size. 
 A portion of the cattle from a population that was described in Garmyn et al. 
2011 [9] were used for the analysis of the fatty acid traits: 1,721 head of cattle for 
triacylglyceride fatty acid traits and 1,442 for phospholipid fatty acid traits. 
Phenotypic Data: Phenotypes and their corresponding class effects and covariates 
were collected as described in previous publications [10-12]. To describe the 
process in short for antibody and response to vaccination traits: calves were 
vaccinated with Bovi-Shield Gold 5 (Zoetis, Inc. Parsippany NJ). Serum samples were 
drawn at up to four time points, after which a viral neutralization assay was done on 
each sample. This was done to determine the quantity of antibodies within a sample 




1 and 2 (BVDV1, BVDV2), bovine respiratory syncytial virus (BRSV), and bovine 
herpesvirus 1 (BHV1). The Spearman-Kärber method was used to calculate the 
individual time point titer scores after undergoing serial dilutions until no antibody 
could be detected [13]. Traits were either calculated as the titer value at a specific 
time (maternal, initial, final antibody titer), rate of titer value change between time 
points (maternal titer decay), or as the change in titer values between serum 
sampling time points (initial, booster, overall vaccination response). 
 For fatty acid traits, the two fractions of the fatty acids, TAG and PL, were 
obtained from the longissimus dorsi muscle[14]. Lipid was extracted and diluted 
into its two respective fractions through a chloroform and methanol mixture 
followed by thin-layer chromatography. Characterization of the lipids was done with 
gas chromatography, and the index of atherogenicity was calculated as follows[15]: 
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Genotypes and Imputation: Individuals with response to vaccination traits were 
genotyped as previously described in Kramer et al. 2017 [10]. Briefly, individuals 
were genotyped with either the BovineSNP50 BeadChip (Illumina, San Diego, CA) or 
BovineHD BeadChip (Illumina, San Diego, CA) by Neogen GeneSeek Operations 
(Lincoln, NE). Individuals on the BovineSNP50 BeadChip were then imputed to the 
BovineHD BeadChip density using the SNPipeline package (Hailin Su, 
https://github.com/cbkmephisto/SNPipeline) and FImpute [16]. Accuracy of 




for the Bovine HD BeadChip from a mix of the ISU herd and other populations. Single 
nucleotide polymorphisms (SNPs) were filtered on a minor allele frequency of 0.05, 
resulting in 574,662 SNPs remaining. All SNPs were assigned a ARS-UCD1.2 bovine 
genome build position[17].  
 Individuals with fatty acid traits were genotyped as described in Kramer et 
al. 2016 [5]. Briefly, individuals were genotyped with the BovineSNP50 BeadChip 
(Illumina, San Diego, CA) and this was performed at GeneSeek (Lincoln, NE). SNPs 
were filtered on a minor allele frequency of 0.1, resulting in 45,219 SNPs. All SNPs 
were mapped using the UMD3.1 bovine genome build. 
 
Analysis of pairwise SNP epistatic interactions: The program epiSNPmpi was 
used to statistically identify significantly associated epistatic interactions with each 
of the fatty acid, antibody titer, and response to vaccination traits [18-20]. The 
statistical model fit for antibody titer and response to vaccination within epiSNPmpi 
was described in a previous work, but briefly was as follows: class effects of dam 
age, pink eye status, sex, weaning time, year-season classification; covariates of 
average daily gain, calf age within year-season classification, titer score, titer-by-
titer score [10]. For fatty acid traits, the statistical model included covariates of 
carcass contemporary group and lab sampling contemporary group, in addition to 
pedigree and sex [5]. Individuals with missing pedigree information were assigned 
dummy parents unique to each individual. Each SNP-by-SNP combination was 
tested four ways to obtain all forms of 2-SNP epistatic interactions: AA, AD and DA 




interactions output the top 10,000 SNP-by-SNP interactions by significance. 
Interactions between two SNPs both located on the same chromosome were 
removed to limit the possibility of haplotypes being considered as an epistatic 
interaction. Remaining interactions were filtered on FDR (<0.05) and a minimum of 
50 individuals in each genotype combination possible for a given interaction type 
(AA, AD, DD). If an interaction failed to contain 50 individuals within even 1 
genotype combination, it was removed from consideration. This was done to 
prevent a small number of individual in a genotype combination from biasing 
results.  
 
Multiple Testing Correction: To account for only the top 10,000 most significant 
interactions being reported by epiSNPmpi for each trait, an FDR correction (<0.05) 
was used. Interactions were ranked on nominal p-values, and then calculated 
through the following formula: 
2= =  




Tag Marker and Haplotype identification: Identification of tag markers to 
represent haplotype blocks were identified using PLINK with both the 50k genotype 
data and 770k genotype data separately [21]. PLINK version 1.07 was downloaded 
in April of 2018, and utilized the --indep-pairwise function with parameters 100, 10, 
0.9. The data did not utilize any phenotypes. Marker position was assigned from the 




although both were generated from the UMD3.1 assembly. This resulted in a 
reduction of the minor allele filtered 770k genotype files down to 151,884 total 
markers, and did not reduce the number of markers from the 50k genotyped 
individuals. Eagle 2.4.1 was used to identify the number of different haplotypes 
within specific haplotype.  
 
Weighted Gene Co-expression Network Analysis (WGCNA): The WGCNA R 
package [22] was used to identify network modules from single nucleotide 
polymorphism (SNP) interactions (epistasis) detected by epiSNP software [18-20]. 
Briefly, an adjacency matrix was formed with elements rij, which were nominal p-
values for putative pairwise SNP interactions. In order to make input data 
compatible with WGCNA, p-values were rescaled to range between 1 and 0 
(equivalent to lowest and highest p-values in each dataset, respectively). Rescaled p-
values were considered as connection strength between SNP interactions. A 
connectivity measure (k) per SNP was calculated by summing the connection 
strengths with other SNPs. Subsequently as described by Zhao et al. [23]the 
adjacency matrix was replaced with the weighted adjacency matrix based on the β 
parameter with a scalefree topology criterion. The goodness of fit of the scale-free 
topology was evaluated by the Scale-Free Topology Fitting Index (R2), which was 
the square of the correlation between log (p (k)) and log (k). A β coefficient resulted 
to R2 of 0.9 was used to develop a weighted adjacency matrix. The weighted 
adjacency matrix was used to then develop the topological overlap matrix (TOM) as 




between two SNPs based on their degree of shared neighbors across the whole 
network [22]. Dynamic Tree Cut algorithm [24], which utilized a SNP tree 
dendrogram that was developed based on TOM-based dissimilarity (1-TOM) using 
hclust algorithm [25], was used to place SNPs into modules. Within the 
cutreeDynamic function, deep split was set to two and minimum module size was 
set to 5. All other WGCNA parameters remained at their default settings. 
 
Availability of supporting data: 
BRDC_Epistasis.xlsx – All significant interactions at 50-animals per genotype 
combination and greater 
FattyAcid_Epistasis.xlsx – All significant interactions at 50 animals per genotype 
combination and greater 
Supplemental A: All clusters for all TAG and PL traits generated through WGCNA. 
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Table 1: Number of significant antibody titer and response to vaccination trait interactions 




Number of significant interchromosmal identified epistatic interactions filtered by FDR < 0.05, 50-
animals per genotype combination after FDR, and 100-animals per genotype combination after FDR. 






Bovine Viral Diarrhea Virus 1
Initial Titer 0 0 0
Pre-vaccination Titer 0 0 0
Maternal Decay 0 0 0
Initial Vaccination Response 0 0 0
Booster Vaccination Response 0 0 0
Overall Vaccination Response 0 0 0
Final Titer 0 0 0
Bovine Viral Diarrhea Virus 1
Initial Titer 0 0 0
Pre-vaccination Titer 0 0 0
Maternal Decay 9686 0 0
Initial Vaccination Response 0 0 0
Booster Vaccination Response 0 0 0
Overall Vaccination Response 0 0 0
Final Titer 0 0 0
Bovine Respiratory Syncytial Virus
Initial Titer 43 35 35
Initial Vaccination Response 0 0 0
Booster Vaccination Response 0 0 0
Overall Vaccination Response 1650 695 23
Final Titer 0 0 0
Bovine Herpesvirus 1
Initial Titer 0 0 0
Initial Vaccination Response 0 0 0
Booster Vaccination Response 0 0 0
Overall Vaccination Response 0 0 0
Final Titer 0 0 0
Total 11379 730 58






Table 2: Number of significant fatty acid trait interactions at 50 and 100 animals per 




1IA: Index of Atherogenicity 
Number of significant intrachromosomal epistatic interactions filtered by 50-animals per 
genotype combination after FDR, and 100-animals per genotype combination after FDR. The 
sum of the total interactions per filter level is shown at the bottom of the table










Saturated Fatty Acids Saturated Fatty Acids
SFA 29 24 SFA 27 17
12:0 0 0 12:0 0 0
14:0 1796 1271 14:0 18 11
16:0 0 0 16:0 0 0
17:0 9414 6901 17:0 8679 5464
18:0 166 120 18:0 180 110
22:0 0 0 22:0 0 0
23:0 0 0 23:0 0 0
24:0 0 0 24:0 0 0
Monounsaturated Fatty Acids Monounsaturated Fatty Acids
MUFA 0 0 MUFA 0 0
14:1 124 99 14:1 0 0
16:1 94 78 16:1 24 19
17:1 9322 6843 17:1 8813 5604
18:1 cis-9 0 0 18:1 cis-9 0 0
18:1 cis-11 416 26 18:1 cis-11 1418 849
18:1 cis-12 2 2 18:1 cis-12 3 2
18:1 cis-13 1 1 18:1 cis-13 1 0
18:1, trans-6/9 0 0 18:1, trans-6/9 0 0
18:1, trans-10/11 5644 3958 18:1, trans-10/11 2122 1256
18:1, trans-12 0 0 18:1, trans-12 - -
18:1, trans-15 392 234 18:1, trans-15 1711 1072
Polyunsaturated Fatty Acids Polyunsaturated Fatty Acids
PUFA 0 0 PUFA 0 0
18:2 0 0 18:2 0 0
18:3, n-3 0 0 18:3, n-3 0 0
20:2 0 0 20:2 0 0
20:4 0 0 20:4 0 0
20:5 0 0 20:5 0 0
22:6 0 0 22:6 0 0
CLA cis-9 trans-11 0 0 CLA cis-9 trans-11 0 0
CLA trans-10 cis-12 6 2 CLA trans-10 cis-12 1 0
n-3 0 0 n-3 0 0
n-6 84 68 n-6 105 73
Ratio/Calculation Ratio/Calculation
n-6:n-3 0 0 n-6:n-3 1 0
PUFASFA 0 0 PUFASFA 0 0
MCFA 840 611 MCFA 959 628
LCFA 858 620 LCFA 985 643
IA1 118 106 IA1 99 86





Table 3: Significant antibody titer and response to vaccination response trait interactions 




Number of Additive-by-Additive (AA), Additive-by-Dominance and Dominance-by-Additive 
(AD), and Dominance-by-Dominance (DD) significant interactions for each trait. All 
interactions are post FDR < 0.05 and 50-animals per genotype combination. 
Trait AA AD DD
Total 
Interactions
Bovine Viral Diarrhea Virus 1
Initial Titer - - - 0
Pre-vaccination Titer - - - 0
Maternal Decay - - - 0
Initial Vaccination Response - - - 0
Booster Vaccination Response - - - 0
Overall Vaccination Response - - - 0
Final Titer - - - 0
Bovine Viral Diarrhea Virus 1
Initial Titer - - - 0
Pre-vaccination Titer - - - 0
Maternal Decay - - - 0
Initial Vaccination Response - - - 0
Booster Vaccination Response - - - 0
Overall Vaccination Response - - - 0
Final Titer - - - 0
Bovine Respiratory Syncytial Virus
Initial Titer 35 0 0 35
Initial Vaccination Response - - - 0
Booster Vaccination Response - - - 0
Overall Vaccination Response 695 0 0 695
Final Titer - - - 0
Bovine Herpesvirus 1
Initial Titer - - - 0
Initial Vaccination Response - - - 0
Booster Vaccination Response - - - 0
Overall Vaccination Response - - - 0
Final Titer - - - 0
Total 730 0 0 730





Table 4: Significant fatty acid intrachromosomal epistatic interactions by type of 




1IA: Index of Atherogenicity 
Number of Additive-by-Additive (AA), Additive-by-Dominance and Dominance-by-Additive (AD), 
Dominance-by-Dominance (DD) significant intrachromosomal epistatic interactions by type for 
Triacylclyceride and Phospholipid fatty acid traits by trait category (Saturated Fatty Acid [SFA], 
Monounsaturated Fatty Acid [MUFA], Polyunsaturated Fatty Acid [PUFA], Ratio/Calculation).  
Total Phospholipid Fatty Acids Total
Trait AA AD DD Interactions Trait AA AD DD Interactions
Saturated Fatty Acids Saturated Fatty Acids
SFA 29 0 0 29 SFA 26 1 0 27
12:0 0 0 0 0 12:0 0 0 0 0
14:0 1793 3 0 1796 14:0 18 0 0 18
16:0 0 0 0 0 16:0 0 0 0 0
17:0 9414 0 0 9414 17:0 8677 2 0 8679
18:0 166 0 0 166 18:0 180 0 0 180
22:0 0 0 0 0 22:0 0 0 0 0
23:0 0 0 0 0 23:0 0 0 0 0
24:0 0 0 0 0 24:0 0 0 0 0
Monounsaturated Fatty Acids Monounsaturated Fatty Acids
MUFA 0 0 0 0 MUFA 0 0 0 0
14:1 124 0 0 124 14:1 0 0 0 0
16:1 94 0 0 94 16:1 24 0 0 24
17:1 9322 0 0 9322 17:1 8813 0 0 8813
18:1 cis-9 0 0 0 0 18:1 cis-9 0 0 0 0
18:1 cis-11 414 2 0 416 18:1 cis-11 1415 3 0 1418
18:1 cis-12 2 0 0 2 18:1 cis-12 3 0 0 3
18:1 cis-13 1 0 0 1 18:1 cis-13 1 0 0 1
18:1, trans-6/9 0 0 0 0 18:1, trans-6/9 0 0 0 0
18:1, trans-10/11 5640 2 2 5644 18:1, trans-10/11 2117 5 0 2122
18:1, trans-12 0 0 0 0 18:1, trans-12 - - - -
18:1, trans-15 329 0 0 392 18:1, trans-15 1709 2 0 1711
Polyunsaturated Fatty Acids Polyunsaturated Fatty Acids
PUFA 0 0 0 0 PUFA 0 0 0 0
18:2 0 0 0 0 18:2 0 0 0 0
18:3, n-3 0 0 0 0 18:3, n-3 0 0 0 0
20:2 0 0 0 0 20:2 0 0 0 0
20:4 0 0 0 0 20:4 0 0 0 0
20:5 0 0 0 0 20:5 0 0 0 0
22:6 0 0 0 0 22:6 0 0 0 0
CLA cis-9 trans-11 0 0 0 0 CLA cis-9 trans-11 0 0 0 0
CLA trans-10 cis-12 6 0 0 6 CLA trans-10 cis-12 1 0 0 1
n-3 0 0 0 0 n-3 0 0 0 0
n-6 84 0 0 84 n-6 105 0 0 105
Ratio/Calculation Ratio/Calculation
n-6:n-3 0 0 0 0 n-6:n-3 1 0 0 1
PUFASFA 0 0 0 0 PUFASFA 0 0 0 0
MCFA 840 0 0 840 MCFA 959 0 0 959
LCFA 858 0 0 858 LCFA 985 0 0 985
IA1 118 0 0 118 IA1 99 0 0 99






Table 5: Number of WGCNA modules identified within each fatty acid trait with greater 







































Figure 1: Epistatic interactions plotted for BRSV Initial Titer at 50-animals per 
genotype. 35 total significant interactions were plotted for BRSV initial titer, 
completely between two small regions on chromosome 9 and 23. Chromosomes are 
ordered around in a circle, with distance markers every 12.5 Mb. Chromosome 30 is 








Figure 2: Epistatic interactions plotted for BRSV overall vaccination response at 50-
animals per genotype. 695 total significant interactions were plotted for BRSV 
overall vaccination response, with two-thirds represented by interactions between 
chromosome 2 and 11. Chromosomes are ordered around in a circle, with distance 







Figure 3: Epistatic interaction detection for BRSV overall vaccination response 
between 770k and tag filtered genotype. A visualization of failure to retain epistatic 
interactions when tag SNP filtering is applied to the 770k genotype for the trait 
BRSV overall vaccination response. Left: BRSV overall vaccination response at 770k; 
Right: BRSV overall vaccination after tag filtering.  Chromosomes are ordered 













Figure 4: Intrachromosomal epistatic interactions plotted for TAG 16:1 fatty acid at 
50-animals per genotype. 94 total significant intrachromosomal interactions were 
plotted for TAG 16:1 fatty acid. Interactions can be seen both in confined regions 
and across complete chromosomes. Chromosomes are ordered around in a circle, 











Figure 5: WGCNA plot of TAG 18:1c11 fatty acid group blue. A set of 16 markers 
from WGCNA group blue, with all corresponding SNP-by-SNP interactions that exist 
within that set of 16. Both inter- and intrachromosomal interactions can be seen, 
and the potential network of these 16 markers.  Chromosomes are ordered around 






CHAPTER 8. GENERAL CONCLUSIONS 
 
 This thesis sought to identify factors that influence response to vaccination 
against viruses contributing to the bovine respiratory disease complex (BRDC). It 
also investigated methodology to improve epistatic interaction detection of traits. 
With animal welfare becoming an increasing decision factor with consumers year 
after year, the effective treatment and prevention of cattle for BRDC will only 
increase in concern. Producers will work to not only meet these consumer demands 
of animal welfare, but also to ensure their herds remain healthy and can yield 
positive returns for their production cycle. Vaccination is one of the primary 
methods used to protect herds against BRDC, but the protocols for the vaccination 
itself and the genetic receptiveness of individual animals to the vaccine have not 
been well investigated.  With phenotypic and genotype data on greater than 2,300 
head of cattle from the Iowa State University Angus herd, it became possible to 
examine a wide variety of environmental and managerial factors that impact a calf’s 
ability to respond robustly to vaccination. By better describing the effect of these 
factors, it may help inform producers and the beef industry on how vaccination of 
herds should be approached and what needs to be taken into account. Additionally, 
genomic selection of individuals that are genetically predisposed to respond more 
robustly to vaccination provides yet another mechanism for improved animal 






Chapter 3 investigated factors such as year-season, age of dam, time of 
weaning, and pink eye status to identify which are significantly important in a model 
estimating phenotypic response to vaccination. This was done by taking extensive 
phenotypic records and antibody titers from serum serial dilutions and fitting 
statistical models to identify significance and direction of effects. Chapter 4 was a 
genome-wide association study (GWAS) to identify regions of the genome 
associated with antibody titer and response to vaccination traits and accounting for 
at least 1% of the additive genetic variation in the trait. This was achieved by fitting 
fixed effects and covariates identified from the study in Chapter 3 and Downey et al. 
2013 [1]. Heritabilities were obtained through Bayesian analyses in GenSel, and 
prediction accuracies were calculated by creating training and validation groups 
through K means clustering [2-4]. Chapters 5 and 6 investigated interchromosomal 
interactions for fatty acid traits with the use of both 50k genotypes and imputed 
whole genome sequence to identify specific interactions within a small area 
identified on lower density. Chapter 7 investigated the ability to detect 
intrachromosomal epistatic interactions through the use of tag markers for 
haplotype blocks, in addition to determining the viability of identifying epistatic 
networks. EpiSNPmpi was used to obtain the top 10,000 epistatic interactions for 
each trait [5, 6], using both BRD antibody titer and response to vaccination data and 
fatty acid traits from a previous epistatic study (Chapter 5). Determination of tag 
markers, adjusted p-values, and a minimum number of animals per genotype 
combination were applied to identify significant interactions both inter- and 





linked in via epistasis. These chapters can inform vaccination protocol decisions, 
indicate locations that could be considered for use in genomic selection of 
individuals, in addition to improving our understanding of epistatic genetics and the 
variation it may account for. 
 To improve animal welfare and increase production of beef cattle herds, 
vaccination needs to work effectively. Vaccines are usually either killed virus or 
modified live, and come in either a single pathogen or multivalent form. The benefits 
and detriments to these were listed in chapter 2 of this thesis, but they all have the 
same goal: provide protection against a given pathogen or set of pathogens. Current 
vaccination protocols are often described by the companies who make the vaccines 
themselves, likely based on research they performed during the development of the 
vaccines. Actual practice and implementation may not fit those recommendations 
and could alter the efficacy of the vaccines. The research described in chapter 3 
indicates that, within the population studied, the current vaccination protocols 
recommended by the vaccine manufacturer may not be the most ideal from a purely 
response to vaccination stance. Delayed weaning appeared to improve individual 
response to vaccination against BRSV and BHV1, while vaccinating at the same time 
of weaning was more beneficial for the antibody response to BVDV1 and BVDV2 
antigens. Those findings indicate that a split vaccination protocol may improve 
overall antibody response to vaccination, but also presents additional work for 
producers who would now need an additional vaccination date and the labor and 
time costs that come with it. This research indicates that, should producers wish to 





improvements in the vaccination protocols. While it cannot be said that these 
improvements will be more protective, it does indicate a higher immune response 
that may be indicative of protectiveness [7]. Furthermore, these alterations and 
improvements may cause additional stress to the cattle. The impact of additional 
stress would also need to be taken into consideration to identify if the protocol 
improvements would offset this increase [8, 9]. 
 In addition to management and vaccination protocol changes, producers can 
use genomic selection to improve response to vaccination and increase overall 
animal welfare[10-13]. Findings described in chapter 4 indicate that for overall 
vaccination response it is possible to select individuals for mating with an overall 
goal of increasing the response to vaccination across all four viruses studied. Overall 
vaccination response heritabilities ranged from 0.08 to 0.16 when taking response 
as a continuous trait, but when considered as categorical heritabilities ranged from 
0.13 to 0.23.  Conversely, the accuracy of predicting the genetic merit of individuals 
was not very high. Prediction accuracies were estimated from 0 to 0.23, indicating 
that while there can be genetic progress made through genomic selection, it may 
require a large number of cattle to work with and may proceed slowly [14, 15]. To 
most accurately select individuals, actual phenotypes would need to be collected 
although this also incurs further cost and time investment. Combined with the 
findings from chapter 3, vaccination response can be improved in both genetic and 
non-genetic ways that when combined allow for a greater overall increase in cattle 





A study examining the non-additive epistatic interactions present in fatty 
acid traits was explained in chapters 5 and 6. These chapters delved into the initial 
identification and characterization of these interactions, by applying stringent filters 
for interchromosomal interaction detection. These filters allowed for the detection 
of many epistatic interactions across multiple fatty acid traits, with some regions 
containing these epistatic interactions being associated with GO terms related to 
fatty acid creation, maintenance and use. The use of whole genome imputed 
sequence was able to give an insight into how interactions may be indicative of 
regions which are interacting, but which may not be the actually interacting SNPs. 
Indeed, the interactions found to truly be interacting were nearby and not the ones 
that were expected. This has given insight into how identification of epistasis is not 
able to explain the whole story without further analysis. 
Additional non-additive epistatic interactions were identified in chapter 7, 
and the testing of tag SNP filtering and WGCNA was used to determine the ability to 
detect both inter- and intrachromosomal interactions and epistatic networks. 
Interactions were found in both fatty acid and BRD traits, but tag SNP filtering 
resulted in a drastic loss of detectable interactions in BRD traits. In BRD traits, tag 
SNP filtering resulted in a reduction in the total number of usable markers and saw 
a near complete lose of any detectable interactions, while for fatty acid traits tag 
filtering did not reduce total markers allow for intrachromosomal interaction 
detection. We hypothesized that by reducing the number of markers through a tag 
SNP filtering, we failed to capture all haplotypes likely present within each block. To 





haplotype within a block. This would increase the number of total markers, and may 
render tag filtering unnecessary and more manual filtering of intrachromosomal 
interactions would be needed. Another option would be to require more stringent 
haplotype blocks, which again would increase the number of markers but reduce the 
potential number of haplotypes per block. 
 The program WGCNA was used to take known SNP-by-SNP epistatic 
interactions and cluster the markers from them into modules. These modules were 
then used to visualize how the various markers were interacting. We determined 
that clusters determined through WGCNA analysis contained markers that formed 
connections with one another, and by visualizing these connections we determined 
that these markers formed interactions beyond simple SNP-by-SNP epistasis. In all 
modules examined, every marker within the module was linked together to form a 
complete network. These networks and the use of WGCNA provide a potential way 
to get around low power to calculate 3+ SNP epistatic interactions that would 
normally require extremely large populations.  It also provides insight into how 
both inter- and intrachromosomal interactions could be connected and may lead to 
further understanding on how epistasis functions within traits. Our findings with 
SNP-by-SNP epistasis and the use of WGCNA to identify clusters could potentially 
indicate the presence of epistatic networks. These, alongside improved inter- and 
intrachromosomal interactions could be used to better explain some of the 
remaining genetic variation in traits and its genetic structure.  
 Bovine respiratory disease complex will likely, for the foreseeable future, 





factors exasperating the incidence rate of BRDC it may be possible to make 
immediate changes for the betterment of the beef industry and for the wellbeing of 
the animals. Other research with a focus on identifying regions of the genome 
accounting for significant genetic variation in traits aids in the long term solution of 
selecting for more resistant individuals, or for individuals who respond more 
robustly to vaccines against BRDC.  Epistasis, while not usually a focus of current 
day studies, may become more important for explaining genetic variation and 
understanding the genetic architecture of traits as technology improves and the 
processing power of data increases. The findings in chapter 7 help to indicate 
potential pitfalls and solutions towards epistatic detection and analysis, and will 
help future analyses in their process. 
 The chapters of this thesis describe the process of identifying both non-
genetic and genetic factors associated with antibody titer and response to 
vaccination traits in addition to investigating new ways of epistatic detection. It is 
hoped that this adds to the literature already available on BRDC and epistasis, with a 
goal of helping both fields achieve progress towards a better understand and in the 
case of BRDC a reduction in the cases of BRDC. Long-term gains in beef production 
will be needed in order to feed the world with an increasing consumer population, 
and therefore finding solutions for one of the most costly concerns facing the 
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